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 Shiga toxin-producing Escherichia coli (STEC) are enteric pathogens of humans. 
Cattle serve as a reservoir and harbor STEC in their intestines. Intimin-positive STEC are 
referred to as enterohemorrhagic E.coli (EHEC). Seven serogroups (O26, O45, O103, 
O111, O121, O145, and O157) account for the majority of illness due to STEC and are 
hereafter referred to as STEC/EHEC-7. To improve detection, enrichment broths were 
compared for supporting growth of STEC-7 and STEC O104:H4 (STEC-8). In pure 
culture, STEC enriched in trypticase soy broth (TSB) had significantly greater growth 
compared to TSB containing antimicrobials. In fecal samples, E. coli broth enrichment 
yielded growth of STEC-8 that was significantly greater than in TSB. Optimized culture 
conditions allow for greater detection of EHEC-7 in cattle. To determine the prevalence 
of EHEC-7 in feedlot cattle, culture-based methods and molecular screening assays were 
used. In 576 feedlot cattle, EHEC-7 prevalence in hide samples as detected by NeoSEEK 
(NS) was 80.7% compared to 1.2% by culture. The prevalence of EHEC-7 on carcasses 
was 6.0% detected by NS.  Additionally, EHEC-7 prevalence was determined in 100 
culled dairy cows. The EHEC-7 prevalence in feces, hides, and carcasses, respectively, 
was 6.5%, 15.6%, and 1.0% by culture, and 25.9%, 64.9%, and 7.0% by NS. These 
studies provide evidence that EHEC are ubiquitous on cattle hides and to a lesser extent 
feces and carcasses. Given the discordant results, continued improvement in EHEC-7 
detection methods is needed. Comparison studies were performed using CHROMagar 
STEC, Possé differential agar (Possé), Possé with modified antimicrobials, STEC heart 
infusion washed blood agar with mitomycin C (SHIBAM), and SHIBAM with modified 
antimicrobials. CHROMagar STEC performed better than Possé or SHIBAM for 
detection of EHEC-7 in cattle feces, but modifications of the antimicrobials in the latter 
two media resulted in significant improvements. STEC attachment facilitates colonization 
of the intestine. All STEC-8 strains tested adhered to bovine colonic explants and Caco-2 
cells. One strain invaded both bovine colonic epithelial cells and Caco-2 cells. STEC 
O104:H4 had significantly higher levels of adherence on Caco-2 cells compared to most 
STEC. Interventions which block adherence may be effective for pre-harvest control.   
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CHAPTER 1 
 
LITERATURE REVIEW 
 
Shiga toxin-producing Escherichia coli (STEC) 
Introduction 
 Escherichia coli (E. coli) belongs to the genus Escherichia and family 
Enterobacteriaceae. E. coli is a Gram-negative, facultative anaerobic, non-sporulating 
bacterium that is found in the environment, intestinal tract and extra-intestinal sites of 
mammals (Kaper et al., 2004). E. coli was first isolated in 1885, by Theodor Escherich 
from the feces of a healthy human (republished in English; Escherich, 1988). Several 
different strains of E. coli exist that inhabit different ecological niches (Kaper et al., 
2004). Strains of E. coli are 2.0 µm long rods that possess peritrichous flagella and are 
motile. E. coli can grow rapidly at 37°C with a doubling time between 20 to 30 minutes 
in rich media, and is used as a model organism in genetics and biochemistry studies 
because it can be grown easily and it has a well described genetic system. Biochemically, 
E. coli are positive for indole, methyl red, and lactose, and negative for Voges-Proskauer 
reaction and citrate test. 
 The gastrointestinal tract of humans is colonized after birth with bacteria, and 
typically E. coli is found within the first week in the colonic flora (Nataro and Kaper, 
1998). It is found in relatively low concentration compared to other commensal bacteria 
(Berg, 1996). Recently, delayed colonization of E. coli in newborns has been reported 
(Nowrouzian et al., 2003). Reduced exposure to bacteria and reduction in fecal bacteria 
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in hospitals has been suggested to account for why some infants are not colonized until 
six months after birth (Nowrouzian et al., 2003). Strains can persist for months to years in 
the intestinal microflora or can colonize transiently. Strains with genes encoding 
virulence factors were more likely to persist for at least three weeks in the microflora 
(Nowrouzian et al., 2003).   
 Commensal E. coli play vital roles in maintaining the gastrointestinal tract. E. coli 
produces vitamin K (Kindberg et al., 1987), helps breakdown food, aids in food 
absorption, and helps to prevent colonization by pathogenic bacteria (Tenaillon et al., 
2010). The external layer of the gastrointestinal tract, the mucosa, is constantly exposed 
to bacteria. The mucosa and the associated bacteria help protect the gastrointestinal tract 
from the external environment (Tenaillon et al., 2010). Goblet cells play a role in 
protection by continuously secreting mucus to act as a lubricant along the gastrointestinal 
tract and to prevent bacterial adherence (Birchenough et al., 2015).  
 In the harsh environment of the gastrointestinal tract, E. coli must be equipped not 
only to survive, but also replicate and thrive. One way E. coli is equipped to survive is by 
expressing acid resistant genes that allow for protection and survival in the low pH 
environment of the intestine (Hong et al., 2012). E. coli must not only survive the 
extremely acidic environment, but also acquire nutrients for growth. Strains are provided 
with ample nutrients from the breakdown of food that allow for their growth in the 
gastrointestinal tract. In order to grow and thrive in the gut, E.coli uses simple sugars 
from the breakdown of complex polysaccharides by commensal anaerobes (Alteri and 
Mobley, 2012). Additionally, mucus can provide E. coli with sugars that allow growth 
(Tenaillon et al., 2010). In conditions where sugars are limited, E. coli can use 
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gluconeogenic substrates such as aspartate and tryptophan (Miranda et al., 2004), which 
are important for survival in the varying environment of the intestine. Due to the 
association with the gastrointestinal tract, E. coli has been used as an indicator for fecal 
contamination (Gruber et al., 2014).  
 To represent the diversity of E. coli strains, the E. coli collection of reference 
(ECOR) strains was initiated by Ochman and Selander (1984). The ECOR strains were 
used to classify E. coli into phylogenetic groups A, B1, B2, D, and E. Commensal E. coli 
are associated with groups A and B1, extraintestinal E. coli are associated with B2 and D, 
and it is unclear if the diarrheagenic E. coli (DEC) associate with a particular phylogenic 
group. In addition to genetic differences, DEC colonize the intestine compared to  
extraintestinal E. coli which colonize sites outside the intestine including surgical sites, 
the blood stream, and the urinary tract (Smith et al., 2007). Group E is a separate clade 
made up of Shiga toxin-producing E. coli (STEC) O157:H7 and enteropathogenic E. coli 
O55:H7 (Leimbach et al., 2013). Recently, Mosquito et al. (2015) found that DEC strains 
from patients with diarrhea were more frequently associated with group D compared to 
DEC strains from healthy patients. STEC strains commonly belong to groups A, B1 
(Donnenberg and Whittam, 2001; Escobar-Páramo et al., 2004), and D (Bidet et al., 
2005), but may fall into any phylogenetic group. 
 
Pathogenic E. coli  
 In order to adapt to different environments, E. coli has altered its genome through 
acquisition of plasmids, pathogenicity islands, transposons, genes from phage, or by gene 
subtraction (black holes or pseudogenes; Maurelli et al., 1998; Leimbach et al., 2013). 
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The genomic plasticity of E. coli allows it to survive in a variety of ecological niches and 
be a versatile species. E. coli can enhance pathogenicity through gene acquisitions or 
deletions. Acquisition of virulence factors may change a non-pathogenic strain into a 
pathogen. The core genome of E. coli is fairly conserved across phylogenetic groups, but 
diversity can arise through differences in the flexible or dispensable genome (Touchon et 
al., 2009). Even within strains, diversity can occur through point mutations and accessory 
elements (Leimbach et al., 2013). Since E. coli colonizes the gut, a diverse gene pool 
exists for horizontal gene transfer from other microbes. Thus, E. coli can draw from 
foreign genes in their environment that may increase survival and ability to thrive in the 
gastrointestinal tract. Addition of genes must not disturb the organization of essential 
function such as replication, transcription and translation in the bacterial chromosome. 
Therefore, there may be regions in the chromosome that are more permissive to gene 
acquisition such that these regions remain undisturbed (Leimbach et al., 2013). Deletion 
of genes can enhance pathogenicity by eliminating factors that are unfavorable to 
pathogenicity such as deletion of a gene that is involved in production of a toxin inhibitor 
(Maurelli et al., 1998). E. coli can change their genomes to fit the environment by 
interacting with viruses to acquire genes crucial for their survival (Goldenfeld and 
Woese, 2007). 
 Some strains of E. coli can cause disease in humans. Globally, it is estimated that 
pathogenic E. coli kills approximately two million people per year (Tenaillon et al., 
2010). E. coli can infect the gastrointestinal tract, urinary tract, enter the blood stream and 
cause sepsis, or cause meningitis, particularly in neonates (Tenaillon et al., 2010). Bray 
(1945) first described the association between strains of E. coli and patients with diarrhea 
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in what was called “summer diarrhea”.  Bray (1945) noted that there was a seasonal 
pattern to illness and that these strains were not seen in healthy infants. This led to the 
hypothesis that there were both pathogenic and non-pathogenic strains of E. coli. This 
was tested by giving adult volunteers cultures of E. coli isolated from infants with 
diarrhea. Healthy volunteers suffered similar illness to infants, including diarrhea, 
vomiting and abdominal discomfort when given E. coli from infants with diarrhea (Kirby 
et al., 1950). When E. coli from healthy infants was given to volunteers, no illness 
occurred (Kirby et al., 1950). 
 DEC have been subdivided into pathotypes. Nataro and Kaper (1998) classified 
DEC in six major pathotypes as follows: enteropathogenic E. coli (EPEC), 
enterotoxigenic E. coli (ETEC), enterohemorrhagic E. coli (EHEC), enteroinvasive E. 
coli (EIEC), enteroaggregative E. coli (EAEC), and diffusely adherent E. coli (DAEC) 
based on the virulence and molecular markers found in each pathotype. EPEC are similar 
to EHEC in that they carry intimin as a major adherence factor, but EPEC lack Shiga 
toxin (Stx) and have the bundle forming pili (bfp). EHEC strains evolved from EPEC 
through acquisition of genes that encode for Stx (Feng et al., 1998). A large EHEC 
outbreak was caused by a strain that had a combination of EHEC and EAEC 
characteristics by an E. coli O104:H4 strain (Brzuszkiewicz et al., 2011). This outbreak 
strain demonstrated how dangerous new pathogenic E. coli variants can be.  
  
STEC 
 STEC are also referred to as verocytotoxin-producing E. coli (VTEC). The term 
VTEC originated from the observation that some strains of E. coli caused irreversible 
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cytopathic effect in Vero cells, but not in Y-1 or CHO cells (Konowalchuk et al. 1977). It 
is now known that Stx caused cytopathic effects in Vero cells (Karmali, 1989). Vero cells 
were susceptible to Stx along with HeLa, Daudi, and human liver cells, likely because 
they have the receptor for Stx and were given a sufficient dose of Stx, but Y-1, CHO, 
Henle 407, WI-38, BHK, and other cell lines are not susceptible because they lack the 
receptor for Stx (Karmali, 1989). Shiga toxin is the main virulence factor for STEC, but 
some strains may also have a major adherence factor, intimin. Intimin along with secreted 
proteins encoded on the locus of enterocyte effacement (LEE) cause attaching-effacing 
(A/E) lesion formation in the large intestine (Gyles, 2007). 
 Intimin-positive STEC are known as classical enterohemorrhagic E. coli (EHEC; 
Croxen et al., 2013). Intimin-negative STEC strains that have caused hemorrhagic colitis 
in humans are termed non-classical EHEC. EHEC O157 is the prototype EHEC strain. 
Comparative genomics have revealed key findings of EHEC. EHEC have much larger 
genomes (5.5-5.9 Mb) compared to K-12 E. coli strains (4.6 Mb; Perna et al., 2001). On 
average, an E. coli strain will contain 4,800 genes (Alteri and Mobley, 2012). EHEC are 
divided into two major lineages with EHEC O55 and O157 forming EHEC 1 and non-
O157/O55 EHEC forming EHEC 2 (Sadiq et al., 2014). EHEC O157:H7 has been 
proposed to be derived from an EPEC O55:H7 ancestor (Feng et al., 1998). The EPEC 
O55:H7 ancestor strain gained the Stx2 phage, a mutation in the rfb gene changed the O-
group from O55 to O157, and a single point mutation (SNP) occurred in uidA gene, 
which encodes for β-glucuronidase. Next, the Stx1 phage was gained and sorbitol 
fermentation was lost, and then loss of β-glucuronidase activity occurred. These changes 
made EHEC O157:H7 distinct from other EHEC. 
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Epidemiology of STEC in humans 
 STEC is transmitted by the fecal-oral route to humans and can cause hemorrhagic 
colitis (HC) and hemolytic uremic syndrome (HUS; Croxen et al., 2013). STEC was first 
recognized as a cause of HUS in 1982 when it was associated with consuming 
undercooked meat (Riley et al., 1983). The estimated infectious dose of STEC O157 is 
<50 bacterial cells (Tilden et al., 1996). STEC have a low infectious dose due to the 
potency of Stx. In contrast to STEC, the infectious dose for EPEC is 10
8
 bacterial cells 
(Mellies et al., 2007) and for Salmonella Typhi at least 10
5
 cells (Leggett et al., 2012).  
 STEC is the leading cause of kidney failure in children less than five years old 
(Mayer et al., 2012). In the overall population, the incidence of STEC is one to three per 
100,000 and increases to six per 100,000 in children less than five years old (Cheung and 
Trachtman, 2014). Humans play a role in the transmission of STEC. Asymptomatic 
carriers can transmit STEC leading to outbreaks, with person-to-person transmission 
occurring in about 15 to 20% of outbreaks (Persad and LeJeune, 2014). STEC O157:H7 
accounts for the majority of clinical infections due to STEC, but other serogroups such as 
STEC O26, O45, O103, O111, O121, and O145 (STEC-6) are frequently detected and 
associated with HC and HUS (Brooks et al., 2005). STEC other than STEC O157 are 
termed non-O157 STEC (Bettelheim, 2007). Recently, there has been an increase in 
detection of non-O157 STEC in clinical illness with STEC-6 causing over 70% of the 
illnesses due to non-O157 STEC (Brooks et al., 2005). Collectively, STEC-6 and STEC 
O157 are referred to as “Top7” (Delannoy et al., 2013) or STEC-7, and intimin-positive 
STEC-7 referred to as EHEC-7 in this dissertation.  
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 Many STEC serogroups are geographically distributed, but certain serogroups are 
more prevalent in certain regions. In the U.S., outbreaks due to STEC O157 are more 
common in northern states compared to southern states separated by 37° N latitude 
(Heiman et al., 2015). The reason for this perceived difference is unknown. Factors such 
as cattle density, temperature, and diet have been suggested to play a role (Heiman et al., 
2015). STEC O113 is commonly found in Australia and STEC O91 is frequently found in 
Europe (Bettelheim, 2007). Differences in STEC serogroup prevalence could be 
explained by differences in animal populations. One of the largest outbreaks due to STEC 
was caused not by a STEC-7 but by STEC O104:H4 associated with contaminated 
fenugreek sprouts (Bucholz et al., 2011). This strain was an enteroaggregative E. coli that 
acquired Shiga toxin, lacked intimin, but had characteristics of enteroaggregative E. coli.  
 After ingestion of STEC, an incubation period occurs for three to seven days 
before the first loose stool (Tarr et al., 2005). Typically one to three days of non-bloody 
diarrhea precedes bloody diarrhea (Tarr et al., 2005). HUS will occur in about 15% of 
patients with bloody diarrhea and the other 85% will recover (Tarr et al., 2005). Patients 
infected with STEC develop neutralizing antibodies for Stx, which can be used to 
diagnose infection (Karmali, 1989). In addition to severe disease, STEC illness is a 
tremendous economic burden. The average cost as estimated in 2003 dollars per patient 
with STEC O157 infection is $5,515 and increases with severity of disease (Frenzen et 
al., 2005). The average cost of patients who develop HUS and die is estimated to be 
$6,175,500 in 2003 dollars (Frenzen et al., 2005). In 2003, the annual cost to the U.S. 
economy for illness due to STEC O157 alone was $405 million (Frenzen et al., 2005). 
Certainly the total burden due to all STEC is much higher. Thus, interventions that reduce 
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STEC, novel therapeutics for STEC infection, and better detection systems for STEC in 
food are a priority. 
 Based on clinical studies, the use of antibiotics to treat STEC infections is not 
recommended (Tarr et al., 2005), but Agger et al. (2015) suggested that antibiotics could 
be useful to treat some STEC infections. Hydration is the main course of therapy for 
patients infected with STEC (Croxen et al., 2013). In vitro studies have demonstrated that 
STEC strains increase toxin production when under conditions with antibiotics such as 
ciprofloxacin compared to those without (Bielaszewska et al., 2012). Conversely, other 
antibiotics, such as chloramphenicol, meropenem, azithromycin, rifaximin and 
tigecycline significantly decreased induction of Stx (Bielaszewska et al., 2012). This 
study tested antibiotics on only one STEC strain, and should be interpreted with caution. 
Further studies would need to be done to warrant the use of antibiotics to treat STEC 
infection. Agger et al. (2015) suggested treatment by using a combination of antibiotics 
such as azithromycin and fosfomycin to inhibit protein and cell wall synthesis. However, 
this antibiotic treatment scheme is still in question. Other treatments, such as proteasome 
inhibitors have shown promise to prolong the survival of mice when given Stx (Hattori et 
al., 2015), but have not been thoroughly investigated for human use. The microbiome and 
certain species in the microbiome may have a protective effect. Bifidobacteria is 
associated with protection of STEC infection in mice, and the use of dietary 
modifications to increase Bifidobacteria could be a strategy to reduce the risk of STEC 
infection (Fukuda et al., 2011). 
  
Regulatory concerns of STEC 
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 Meat sold to consumers is inspected by the U.S. Department of Agriculture 
(USDA). In 1993, a large outbreak due to the consumption of undercooked hamburgers 
contaminated with EHEC O157:H7 occurred in a fast food chain (Tuttle et al., 1999). A 
year later in 1994, the Food Safety and Inspection Service (FSIS), an agency of the 
USDA, declared EHEC O157:H7 as adulterants in raw, non-intact beef. Then in 2012, 
EHEC O26, O45, O103, O111, O121, and O145 (EHEC-6) were declared as additional 
adulterants in raw, non-intact beef by the USDA FSIS (USDA, 2012). The USDA FSIS 
has imposed a “zero tolerance” policy on EHEC-7.  
 Ground beef can become contaminated with EHEC-7 and poses a risk to public 
health. The internal portions of ground beef patties may contain viable organisms if heat 
does not penetrate the meat and inactivate the bacteria. Also, meat from one patty comes 
from multiple cows making it difficult to trace back to one animal. A small fraction of 
contaminated animals can lead to large levels of contaminated ground beef. This has led 
to an increased risk of STEC contamination in undercooked hamburgers. Proper handling 
instructions are listed on packages of meat for consumer benefit (Reicks et al., 2008). 
 The Food and Drug Administration (FDA) regulates food except for meat and 
poultry products. Similar to the USDA FSIS, the FDA had previously focused on EHEC 
O157:H7 as the only regulated STEC, but have expanded their regulations to include any 
pathogenic STEC (Feng et al., 2011). Any pathogenic STEC found is of concern and 
needs to be additionally tested to discriminate between STEC that have not been 
associated with illness from those that are pathogenic (Feng et al., 2011).  
 
Food products  
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 Numerous food products have been associated with STEC illness. Beef products 
have been one of the most common sources (Hussein and Bollinger, 2005). In addition to 
beef products, STEC has caused large outbreaks from contaminated potatoes, radish 
sprouts, mesclun lettuce, alfalfa and clover sprouts, packaged spinach, fenugreek sprouts, 
sausage, cheese, mushrooms, and shellfish (Erickson and Doyle, 2007; van Overbeek et 
al., 2014). Contaminated liquids, milk, punch, unpasteurized apple juice, and water have 
also been suspected in exposing humans to STEC (Brooks et al., 2005). 
 Foods are contaminated through environmental exposure that can occur in the 
field or during processing. Processing equipment used in preparing foods can become 
contaminated, and in turn, cross-contaminate multiple food products (Erickson and 
Doyle, 2007). Survival studies show that STEC can tolerate refrigerated temperatures 
(4°C), low pH (pH < 4.0), and reduced water activity (Erickson and Doyle, 2007). The 
extreme versatility of STEC allows it to survive in multiple food products. 
 
STEC in ruminants 
 Ruminants, most notably cattle are the primary reservoir for STEC (Gyles, 2007). 
For STEC O157, the colon and recto-anal junction are main sites of colonization in cattle 
(Naylor et al., 2003; Persad and LeJeune, 2014). Carriage of STEC has been found in 
cattle, buffalo, sheep, goat, deer, and non-ruminant animals such as pig, horse, pigeon, 
and fox (Persad and LeJeune, 2014). Petting zoos with ruminant animals have been 
linked to outbreaks (Heuvelink et al., 2002; DebRoy and Roberts, 2006). Ruminants 
carry STEC asymptomatically and no ruminant species have been identified to have the 
vascular receptor for Stx (Persad and LeJeune, 2014). Carriage of STEC in cattle depends 
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on a number of factors such as age, immune status, diet, environment, microbiome, and 
sanitation (Persad and LeJeune, 2014). 
 The prevalence of STEC in cattle is variable and unpredictable. Most studies have 
focused on the prevalence of STEC O157, because it causes the majority of disease due 
to STEC infections in humans in the U.S. (Gould et al., 2013). Increased shedding of 
STEC O157 occurs during summer months and is decreased during winter months with 
the same pattern observed for frequency of human infections (Barkocy-Gallagher et al., 
2003). Based on testing of fecal samples of feedlot cattle, this same seasonal pattern 
could not be established for EHEC-6 (Dewsbury et al., 2015). However, a low number of 
fecal samples were positive for EHEC-6 in the summer, and no EHEC-6 positive samples 
were found in winter months. Season is associated with STEC shedding in both beef and 
dairy cattle (Hancock et al., 1994; Hancock et al., 1997; Smith et al., 2005).  
 Colonization occurs throughout the gastrointestinal tract, but mainly in the large 
intestine (Keen and Elder, 2002; Gyles, 2007). Some STEC strains may proliferate in the 
rumen before reaching the large intestine (Free et al., 2012). For STEC O157, in both 
experimental and naturally infected cattle the terminal rectum was determined to be an 
additional site of colonization (Naylor et al., 2003). It was previously thought that STEC 
may not cause disease in adult cattle (Sandhu and Gyles, 2002). This has been disputed 
by cases of STEC infection causing attaching-effacing lesions and diarrheal disease in 
cattle over a year old (Wada et al., 1994; Pearson et al., 1999; Moxley et al., 2015).  
 Environmental factors influence the prevalence of STEC in cattle. In the 
environment, STEC can survive on vegetable plants (Xicohtencatl-Cortes et al., 2009a) 
and fruits (Fremaux et al., 2008). STEC are commonly found in soil where cattle have 
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been or are being housed, and can contaminate surrounding areas during periods of rain 
(Fremaux et al., 2008). Factors such as protozoa (Burow et al., 2005) and fly populations 
(Ghosh and Zurek, 2015) may also influence STEC prevalence. Protozoa in the rumen or 
in the environment can ingest STEC (Steinberg and Levin, 2007), which may account for 
decreased transmission. Conversely, flies are more prevalent during the summer and may 
serve as a vector for transmitting STEC (Ghosh and Zurek, 2015). 
 Cattle shed STEC O157 at levels between <1 CFU/g of feces to 1 x 10
7
 CFU/g of 
feces (Chase-Topping et al., 2008). Animals shedding STEC O157 greater than 10
4
 
CFU/g of feces are a small fraction of STEC O157 positive animals, but are responsible 
for the majority of the environmental contamination (Arthur et al., 2009). These cattle 
have been termed “super-shedders” (Chase-Topping et al., 2008). Thus, use of cattle 
feces in fertilizer applications should be handled properly to reduce environmental 
contamination. 
 Calves shed STEC at higher concentrations compared to adult cattle. Although a 
few cases of disease have been reported in adult cattle, most cases of diarrhea associated 
with STEC occur in calves between one to three weeks (Moxley and Smith, 2010). 
Calves experimentally inoculated with STEC O157 developed watery diarrhea (Dean-
Nystrom et al., 1999). Development of the rumen and the immune system in adult cattle 
may act to inhibit STEC colonization. Diet is an important factor in E. coli colonization. 
STEC O157 prevalence has been associated with the percent of distiller’s grains in feed 
(Smith, 2014a). Feeding cattle a barley based diet, was associated with an increase in 
STEC O157 prevalence compared to corn-based rations (Berg et al., 2004). There are 
conflicting reports on whether forage or grain-based diets reduce STEC O157 
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colonization and shedding (Smith, 2014a). Diet does seem to affect STEC colonization, 
but its role in the process is not fully understood. 
 Cattle genetics may play a role in colonization. In experimental studies, some 
cattle were never colonized when orally inoculated with STEC O157 (Shere et al., 2002).  
This suggests that some genetic factors may lead cattle to be more resistant to STEC 
colonization. Shere et al. (2002) found that bulls were significantly (P = 0.022) more 
likely to shed STEC O157 at higher levels (>10
5
 CFU) compared to steers, but there was 
no difference in the prevalence of STEC O157 between the two groups. However the 
number of cattle found shedding high levels was very small (Shere et al., 2002). They 
also examined six different breed groups to test the role of genetic factors. Brahman 
calves shed lower concentrations of STEC O157 compared to Angus, and resistance only 
existed in 100% Brahman calves (Shere et al., 2002). In this study, STEC O157 strains 
isolated from different cattle were tested for similarity. Strains of STEC O157 isolated 
from cattle shedding low, medium, and high levels had matching profiles based on 
pulsed-field gel electrophoresis (PFGE). This supports the hypothesis that genetic factors 
of cattle influence the shedding of STEC O157, and not strain specific factors. 
 Cattle type may also play a role in STEC colonization. Islam et al. (2014) 
evaluated the prevalence of STEC O157 in different cattle types using a meta-analysis. 
The prevalence of STEC O157 in intestinal samples (fecal, rectal swab, and intestinal 
content) from dairy cattle was 1.75%, 6.84% for beef cattle, and 19.58% for feedlot cattle 
(Islam et al., 2014). Dairy cattle are normally older animals that have been in the 
production setting longer and turnover is lower. The dairy operation reduces the number 
of new cattle introduced that could be colonized with STEC, and may reduce the 
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prevalence of STEC. STEC O157 shedding in dairy cattle can lead to both environmental 
and milk contamination. STEC can contaminate surfaces of dairy cow udders and 
equipment, which can lead to milk contamination (Mohammed et al., 2015). 
Contaminated raw milk, which does not employ a step to inactivate bacterial pathogens, 
poses as a source of pathogen exposure to humans. 
 STEC are geographically well distributed and found in cattle across most 
countries. The global prevalence of STEC O157 was estimated as 5.68% in intestinal 
samples (Islam et al., 2014). In North America, the prevalence of STEC O157 was 
slightly higher (7.35%) compared to the global estimate (Islam et al., 2014). Cattle 
sampled in Asia had a prevalence of 4.69%, 5.15% in Europe, 1.65% in Latin America 
and the Caribbean, and 31.20% in Africa (Islam et al., 2014). There were a limited 
number of studies used to determine prevalence in Africa, which may have led to 
overestimation in this region. Higher prevalence in certain regions may relate to 
increased risk of STEC infection from interaction with animals harboring STEC. It is 
unclear if cattle in North America have a higher prevalence of non-O157 STEC as well, 
because there is limited available data.  
  
 Cattle feces 
 After colonization and proliferation of STEC in the large intestines of cattle, these 
organisms are shed in feces (Gyles, 2007). STEC O157 can survive close to two years in 
undisturbed manure samples from the environment and at low temperatures (-20°C) for 
100 days in cattle feces (Kudva et al., 1998). Generally, fecal samples are collected off of 
pen floors, from intestinal contents, or by rectal swab. There are conflicting reports on the 
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sensitivity for detection of STEC O157 between collection by recto-anal mucosal swabs 
and collection of rectal contents (Naylor et al., 2003; Khaitsa et al., 2005). The influence 
of sample collection method on sensitivity of non-O157 STEC detection has not been 
determined. Sample collection method is likely to be based on convenience and 
experimental design. Unless cattle are isolated, matching the pen floor sample to a 
specific cow can be difficult, but these samples are relatively easy to collect compared to 
rectal grabs and swabs.  
 A number of studies have estimated the prevalence of STEC in cattle feces over 
geographically different regions and times (Hancock et al., 1994; Elder et al., 2000; 
Cobbold et al., 2004; Renter et al., 2005; Thomas et al., 2012 Bosilevac et al., 2013). For 
beef cattle, STEC O157 prevalence has ranged from 0.2% to 27.8% at slaughter and for 
non-O157 STEC it was 2.1% to 70.1% at slaughter (Hussein and Bollinger, 2005). 
 Cattle are transient carriers of STEC and only rarely reported to consistently shed 
STEC over months to years. In one study, cattle were sampled 12 times over a year at 
approximately one month intervals for STEC O157 (Besser et al., 1997). Most cattle 
were positive for only a single sampling, but some cattle were repeatedly positive with 
two positive samples in sequential months (Besser et al., 1997). Similar heterogeneous 
shedding was observed in a longitudinal study sampling cattle 18 times at weekly 
intervals for STEC O157 (Williams et al., 2014).  
 Numerous studies have estimated the prevalence of STEC O157, but few have 
estimated the prevalence of EHEC-7 in cattle feces or other cattle matrices. Some studies 
have investigated EHEC serogroups within EHEC-7, with EHEC O26 as one of the most 
studied non-O157 EHEC. EHEC O26 causes the majority of clinical cases due to non-
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O157 EHEC in the U.S. (Brooks et al., 2005), and thus is of particular concern. In beef 
cattle, 10 out of 2436 fecal samples tested positive for EHEC O26 (Sasaki et al., 2011). 
In 160 fecal samples, Bonardi et al. (2015) found three EHEC O26, one EHEC O111, 
and five EHEC O157 positive fecal samples. Dewsbury et al. (2015) found the 
prevalence of EHEC O26 was 1.0%, EHEC O103 was 1.6%, EHEC O145 was 0.8%, and 
EHEC O157 was 41.4% in 576 fecal samples collected during summer months. In 
contrast, during winter months no EHEC-7 were recovered (Dewsbury et al., 2015). E. 
coli serogroups O26, O45, O91, O111, O121, O145, and O157 were isolated from fecal 
samples of Australian beef cattle, but only E. coli O157 contained the genes for Shiga 
toxin (stx) and intimin (eae). Hence, the serogroup is not enough to determine if a strain 
is likely to be an EHEC. 
 The pen effect can influence the prevalence and transmission of STEC between 
cattle. Animals in the same pen are more likely to shed STEC if they are in the same pen 
as an animal that is already shedding STEC (Tabe et al., 2008). Accurate analysis of 
prevalence must take into account if samples were collected from animals in the same or 
a different pen. The condition of the pen can influence the transmission and prevalence of 
STEC (Smith et al., 2005). A higher prevalence of STEC is found in pens that are dry and 
dusty or muddy compared to a condition in between these (Smith et al., 2005). 
 Wang et al. (2015) found that cattle carry bacteriophages in their gastrointestinal 
tract that are able to lyse non-O157 STEC. The specificity of these phages was restricted 
to one serogroup or exhibited activity against a broad number of serogroups (Wang et al., 
2015). These bacteriophage could drastically change the prevalence of STEC in cattle 
feces. Their use for control of non-O157 STEC in cattle has yet to be demonstrated. 
18 
 
 
 Cattle hides 
 Cattle hides are contaminated by fecal material containing STEC through direct 
interaction with feces, contact with other animals, dirt and dust particles carrying STEC, 
or other surfaces (Keen and Elder, 2002). Similar to fecal samples, seasonal variation of 
STEC O157 is observed with hide contamination more likely to occur in summer months 
compared to winter months (Barkocy-Gallagher et al., 2003). Antimicrobial washes such 
as lactic acid, hydrogen peroxide, or cetylpyridinium chloride have been used to reduce 
bacteria on cattle hides (Baird et al., 2006). Criteria have been developed to judge 
cleanliness of hides based on a 5-point scale from 1 (very clean) to 5 (very dirty) during 
processing (McEvoy et al., 2000). There was a relationship between hide cleanliness and 
reduction of total viable bacterial counts recovered on beef carcasses (McEvoy et al., 
2000). In another study, no relationship was observed between hide cleanliness and 
bacterial counts from carcasses (Van Donkersgoed et al., 1997). 
 Arthur et al. (2011) demonstrated that STEC O157 can survive on cattle hides for 
nine days. The prevalence of STEC O157 has been shown to fluctuate on cattle hides 
from 84% to 0% in only two weeks (Arthur et al., 2009). Thomas et al. (2012) recovered 
EHEC O26 and O157 from hides during beef processing. Similarly, Bonardi et al. (2015) 
recovered EHEC O26 from two of 160 and EHEC O157 from four of 160 hide samples 
from cattle at slaughter. 
 Sampling multiple locations on cattle hides gives a clearer representation of 
prevalence of STEC. The back, hock, perineum and belly were all optimal recovery sites 
for STEC O157 in different studies (Keen and Elder 2002, Stephens et al., 2007; 
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Kalchayanand et al., 2009). Keen and Elder (2002) found high isolation rates of STEC 
O157 from five different sites on cattle hides. In this study, isolation rates from the hides 
exceeded those from the feces, and visible fecal contamination did not correlate with high 
relative STEC O157 isolation (Keen and Elder, 2002). It is possible that wind and dust 
can distribute STEC over the entire hide. Hide surfaces can serve as a means for animal-
to-animal transmission of STEC. 
 
 Cattle carcasses 
 Cattle carcasses primarily become contaminated with STEC during the removal of 
STEC contaminated hides during processing (Elder et al., 2000; Arthur et al., 2002; Keen 
and Elder, 2002; Barkocy-Gallagher et al., 2003; Arthur et al., 2004; Koohmaraie et al., 
2005; Schmidt et al., 2012). Dehairing of hides, hide washes, and bacteriophage to lyse 
STEC O157 are examples of interventions to reduce hide to carcass transfer of microbial 
contamination during processing (Barkocy-Gallagher et al., 2003; Nou et al., 2003; 
Arthur et al., 2004). Similar transfer of STEC occurs during processing of sheep (Thomas 
et al., 2013). Pathogens can also be transferred onto the carcass surface by direct contact 
with contaminated equipment (knives) and hands of operators (Thomas et al., 2012). By 
sampling air next to hide removal stations during processing, Schmidt et al. (2012) found 
that hide removal introduced pathogens into the air that could then contaminate the 
carcass surface. Most studies suggest that carcasses can be contaminated with STEC, but 
the prevalence is typically <3% (Duffy et al., 2014). Carcass surfaces are treated with 
antimicrobial washes to reduce microbial contamination.  
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 As with other sample types, most of the studies have focused on the prevalence of 
STEC or EHEC O157 on carcasses. Thomas et al. (2012) found EHEC O157 on two of 
301 carcass samples. A study that sampled Danish beef carcasses found a prevalence of 
3.2% for STEC O157 (Breum and Boel, 2010). After carcass dressing and being held at 
cold storage for a week, STEC O157 was recovered from only one of 16 found positive 
(Breum and Boel, 2010). This suggests that proper dressing and chilling of carcasses may 
result in death of those organisms contaminating the carcass surface. Detection of STEC 
O157 after interventions poses a serious risk to food safety.  
 Carcasses have been sampled before and after interventions to determine if they 
were effective in reducing STEC. Final post-intervention carcass samples had a 
significantly lower prevalence of STEC O157 compared to pre-intervention carcass 
samples (Rivera-Betancourt et al., 2004). If STEC are found on carcasses after 
interventions, this would indicate ineffective controls and introduces a risk for the 
consumption of contaminated products from that carcass.   
 
 Ground beef 
 Since STEC are frequently found in cattle, beef processors are required to develop 
a hazard analysis and critical control point specific to their operation to help control for 
biological, chemical, and physical hazards (USDA, 2014a). Contamination of cattle 
carcasses from removal of STEC contaminated hides is the primary route that leads to 
beef contamination but otherwise can occur at different points during processing.  A 
multi-hurdle approach is required to eliminate contamination in the final product.  
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 Inactivation of STEC in food products is an important step in reducing foodborne 
illness. Properly cooking food products such as raw beef to a temperature of 160°F 
reduces the risk of STEC infection (Luchansky et al., 2013). Many consumers are 
unaware of the proper temperature required to inactivate bacterial pathogens, and do not 
use a thermometer to ensure that proper temperatures have been reached (Røssvoll et al., 
2014). Consumers incorrectly evaluated hamburger doneness based on the color as 
reported by Røssvoll et al. (2014). Thus, it is important for the beef industry to ensure 
elimination of adulterants before the product reaches consumers. 
 There is a tremendous economic loss to the beef industry associated with a recall 
due to EHEC-7 contamination. In 2014, 1,840,533 lbs of ground beef products were 
recalled due to EHEC-7 contamination (USDA, 2015a). High event periods are those 
events during processing where there are a higher than normal number of EHEC-7 
positive trim samples (Wang et al., 2014a). High event periods may indicate a failure to 
implement a microbial control step. Sampling techniques for STEC detection use sponges 
to swab the carcass surface or hide surface of cattle. Sampling sites of cattle have been 
chosen based on locations that are primarily used for ground beef.  
 The prevalence of STEC in commercial ground beef has been evaluated by 
multiple studies. Bosilevac and Koohmaraie (2011) surveyed 4,133 ground beef samples 
from across the U.S. and found 1,006 samples positive for stx. However, only 10 STEC 
isolates that were considered to be pathogenic were isolated from 10 different samples. In 
a different study, a convenience sample of 1,129 commercial ground beef products were 
tested for STEC, but no isolates were recovered from this study (Liao et al., 2014). In 
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another study, 18 of 51 ground beef samples were positive for at least one of the 
regulated serogroups, but no STEC isolates were detected (Magwedere et al., 2013). 
 The USDA FSIS performs testing of raw ground beef and component samples for 
EHEC-7. In 2012, 0.53% of raw ground beef tested positive for EHEC O157 and 0.91% 
tested positive for one of the EHEC-6 organisms (USDA, 2015b). Of the samples testing 
positive for non-O157 EHEC, five were EHEC O26, seven were EHEC O103, and two 
were EHEC O111 (USDA, 2015b). 
  
 Veal 
 Of the 319 beef calf hides sampled, 54% tested positive for STEC O157 (Arthur 
et al., 2009). Hide contamination may lead to contamination of veal products. Different 
processing steps may be required for veal compared to beef, and the interventions used in 
veal processing have not been extensively evaluated (Wang et al., 2014b). Due to the 
high prevalence of EHEC in veal products, USDA FSIS reports EHEC prevalence in veal 
separately from raw beef samples. In 2012, the USDA found 0.60% of veal samples were 
positive for EHEC O157 and 7.89% were positive for one of the EHEC-6 (USDA, 
2015b). A limited number of veal samples have been tested, with 166 and 38 tested for 
EHEC O157 and EHEC-6, respectively. Therefore, it is possible that the percentage of 
EHEC-6 positive veal samples is lower than expected due to the small sample size. 
 
Flies and wildlife 
 Colonization by STEC is not restricted to ruminants. A number of other animals 
have been found to carry STEC. Flies are found around cattle production environments, 
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among other places, and have been found to carry STEC (Ghosh and Zurek, 2015). Flies 
may serve as vectors for STEC, carrying strains to multiple cows and to different farms. 
Janisiewicz et al. (1999) found that flies are internally and externally contaminated with 
STEC O157. Flies can also aggregate on cattle feed. Ghosh and Zurek (2015) found that 
flies carrying fecal coliforms can contaminate steam-flaked corn used in cattle feed which 
could then lead to contaminated cattle during consumption of feed. 
 Wildlife can interact with feedlots or environments contaminated with STEC. 
Many wildlife animals are consumed as meat products and therefore could be important 
transmitters of STEC to humans. STEC were isolated from deer, wild boar and hare meat 
and some strains were EHEC O26 and O103 (Miko et al., 2009). Deer have been 
implicated in the contamination of strawberries that led to an outbreak of STEC O157 
(Laidler et al., 2013). Foxes have also been noted as carriers of STEC (Mora et al., 2012). 
Wild birds that carry STEC are of particular concern to produce farmers. STEC have 
been found in wild birds, and it has been suggested that they could transport STEC from 
feedlots and watersheds to produce fields (Cooley et al., 2013).  
 
STEC characterization and risk assessment 
 Classical typing methods for E. coli have focused on the O, H, and K antigens and 
more recently mainly the O and H antigen.  The O antigen makes up the outer most 
portion of the lipopolysaccharide and is attached to the core oligosaccharide. There are 
over 160 different O antigen structures and 53 H-types produced by E. coli (Bettelheim, 
2007). There are approximately 400 known O:H combinations (serotypes), but only 100 
of these have been associated with disease in humans (Bettelheim, 2007). Certain 
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serogroups such as EHEC-7 are more commonly associated with human illness (Brooks 
et al., 2005). Some of the biological roles that the O antigen is involved in include 
colonization of the intestine, resistance to antimicrobial peptides (Miyashita et al., 2012), 
and antiphagocytic ability of some strains of E. coli (Medearis et al., 1968). Sequencing 
of the gene that encodes for 6-phosphogluconate dehydrogenase (gnd) has also been used 
to assess the serogroup (Gilmour et al., 2007).  
 There are commercial reagents for testing of the O antigen for the most common 
serogroups in clinical disease. Serotyping is performed at reference laboratories 
commonly using antisera to test for the O antigen and restriction fragment length 
polymorphism for testing of the H-antigen (Joensen et al., 2015). H antigen 
determination has relied on the fliC gene that encodes for the flagellar filament structure 
protein. This has allowed H antigens to be typed even if the strain is non-motile. 
Serotyping can also be performed by whole-genome sequencing. Joensen et al. (2015) 
described the SerotypeFinder as a whole-genome sequencing tool for rapid identification 
of all known E. coli serotypes. Biologically, flagella allow movement of the bacteria and 
in some cases is an initial adherence factor to epithelial cells (Mahajan et al., 2009). The 
K antigen is a made up of polysaccharides or proteinaceous organelles and is a capsular 
antigen. A few of the functions of K antigens include resistance to serum-induced killing, 
interfering with complement (Johnson, 1991), and antiphagocytic abilities (Van Dijk et 
al., 1979). 
 Tracking and discrimination of strains is important for outbreak investigations. 
Multi-locus-sequence typing (MLST) is a technique that uses the sequence <10 highly 
conserved genes to compare the relatedness of strains (Sadiq et al., 2014). MLST can 
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define E. coli into sequence types, although higher discriminatory methods have been 
developed to discriminate strains within a sequence type. PFGE has been used to 
discriminate strains based on the migration of large DNA fragments under an electrical 
field (Sadiq et al., 2014). This has been the gold standard for typing STEC during 
outbreak investigations. Currently, surveillance of certain STEC outbreaks have used 
whole-genome sequencing to identify disease caused by a common strain from 
geographically dispersed outbreaks and outbreaks involving only a few patients (Dallman 
et al., 2015). The DiversiLab repetitive PCR can also be used for strain typing by 
amplifying regions of DNA between repetitive elements (Herbold et al., 2015). 
 Although classical EHEC of certain serogroups have received the most attention, 
non-classical EHEC O91, O104, O113, O128, and O146 have been isolated from clinical 
cases (Beutin and Fach, 2014). This has made predicting whether a STEC strain could be 
pathogenic to humans difficult. Molecular markers in combination with certain stx 
subtypes (stx1a and stx2a) and intimin have been associated with HC and HUS in patients 
(Scheutz et al., 2012). Based on molecular markers in O island (OI) 122, Karmali et al. 
(2003) developed the first molecular risk assessment (MRA) to assess the pathogenicity 
of STEC of different serogroups. Karmali et al. (2003) classified STEC into different 
seropathotypes. O157 was seropathotype A with a high incidence and common 
involvement in outbreaks. STEC O26, O103, O111, O121 and O145 were seropathotype 
B with moderate incidence and uncommon involvement in outbreaks. STEC O91, O104, 
O113 and others were seropathotype C with low incidence and rare involvement in 
outbreaks and multiple serotypes made up seropathotypes D and E with low and 
nonhuman incidence and rare and not applicable to involvement in outbreaks, 
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respectively. This classification scheme relies on the frequency of a serogroup to cause 
serious disease or known outbreaks, but does not fully describe the pathogenic potential 
of a strain. Coombes et al. (2008) expanded the MRA of STEC strains based on 16 genes 
from OI 36, OI 57, OI 71, in addition to OI 122. STEC strains associated with outbreaks 
strains had an average of 11.7 of 16 genes and non-outbreak strains had an average of 3.8 
of 16 genes (Coombes et al., 2008). Strains that were from patients with HUS had an 
average of 8.4 of 16 genes and non-HUS strains had an average of 3.3 of 16 genes 
(Coombes et al., 2008). 
 
Toxins 
 Shiga toxin is the main virulence factor of STEC. However, not all STEC are 
thought to be able to cause disease in humans. A myriad of other virulence factors in 
STEC have been associated with HUS and HC (Coombes et al., 2008). Factors to reduce 
the host immune response, inhibit cell death, and lyse cells to acquire nutrients all 
contribute to bacterial survival, persistence, and virulence.  
  
 Shiga toxin  
 Shiga toxin was first found in Shigella dysenteriae, which shares similarity to Stx 
found in E. coli. There are two major types of Stx termed Stx1 and Stx2. STEC strains 
can possess one or both types of the toxin. Shiga toxin genes are located on DNA from 
bacteriophage. After infecting E. coli, phage can grow lytically or undergo lysogenic 
growth by inserting into the bacterial chromosome.  Toxin production can occur during 
initial lytic growth or after a signal induces lytic growth. Serra-Moreno et al. (2007) 
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described five main insertion sites plus additional sites used by stx when they integrate 
into the E. coli chromosome. Under conditions of stress, stx can be lost from the 
chromosome (Croxen et al., 2013). The toxin has two major subunits, subunit A and 
subunit B which make up an AB5 structure (Kaper et al., 2004). The B subunit binds to 
globotriaosylceramide (Gb3) and the A unit is the catalytically active subunit. Once the A 
subunit is cleaved from the B subunit, it can bind to the ribosome and disrupt protein 
synthesis by cleaving a specific adenine (Kaper et al., 2004). 
 After a person becomes infected with STEC, Stx can cross the intestinal 
epithelium and enter the bloodstream (Croxen et al., 2013). The route that Stx takes to 
travel from the intestinal tract to the blood stream is unclear. It was shown that Stx binds 
to neutrophils, which could facilitate toxin transport to the kidneys where Stx will bind to 
Gb3 (Brigotti et al., 2008). Gb3 is found in abundance in the kidneys and to a lesser 
extent in the lung and brain (Obrig, 2010). Then, Stx is internalized and trafficked 
through the Golgi apparatus and the endoplasmic reticulum to the cytoplasm (Croxen et 
al., 2013). Once in the cytoplasm, the A subunit removes an adenine from 28S rRNA 
which inhibits protein synthesis (Croxen et al., 2013).  
 Stx2 is more toxic than Stx1in gnotobiotic piglets (Francis et al., 1989), in mice 
(Tesh et al., 1993), and is more often found in cases of human disease with severe illness 
(Law, 2000).  Scheutz et al. (2012) developed a standardized nomenclature for Stx with 
three subtypes for stx1 (stx1a, stx1c, and stx1d) and seven subtypes of stx2 (stx2a, stx2b, stx2c, 
stx2d, stx2e, stx2f, and stx2g). Multiple variants of stx can be found in a single strain. 
Variability in subtypes is mainly in the B subunit effecting binding strength to Gb3 
(Russo et al., 2014). The subtypes stx2a, stx2c and stx2d are closely related (Scheutz et al., 
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2012) and are found in isolates from patients with HUS (Feng and Reddy, 2013). At least 
three distinct sequence types of stx2a phages have been found (Yin et al., 2015). Diversity 
within subtypes arises from SNPs and insertion sequence element location (Yin et al., 
2015). The sequence differences within subtypes may play a role in the amount of Stx 
produced (Yin et al., 2015).  Subtype stx2d is also called mucus-activatable and is very 
toxic (Feng and Reddy, 2013). In pigs, stx2e has been isolated from animals with edema 
disease, and stx2e binds to globotetraosylceramide (Gb4) preferentially over Gb3 (Persad 
and LeJeune, 2014). Gb4 is found in porcine tissue but rarely in human tissues. 
Therefore, this subtype is rarely seen in human disease. In pigeon feces, stx2f is frequently 
isolated, but is rarely thought to be pathogenic to humans (Schmidt et al., 2000). 
 Stx can be found in bacteria other than E. coli and Shigella. Stx has been 
infrequently found in extraintestinal E. coli (Martínez-Castillo and Muniesa, 2014), and 
Enterococcus (Casas et al., 2011). Free Stx phage can be found in water contaminated 
with fecal material, human, cattle, and poultry wastewater and river water (Martínez-
Castillo and Muniesa, 2014). Free Stx2 phage is more prevalent than Stx1 phage in 
extraintestinal environments (Grau-Leal et al., 2015). Stx phage can persist in the 
environment or in meat processing environment even with bacterial inactivation or 
disinfection treatments (Martínez-Castillo and Muniesa, 2014). Food processing steps to 
reduce bacterial contamination such as thermal treatment, salt, UV exposure and 
antimicrobials do not reduce the presence of Stx phage and could enhance Stx release 
from STEC (Allué-Guardia et al., 2014). 
 
 Cytolethal distending toxin (CDT) 
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 CDT is produced by some Gram-negative bacterial pathogens, including E. coli. 
CDT has three subunits, CdtA, CdtB and CdtC. CDT is a cyclomodulin, which is term 
used to describe bacterial toxins and effectors that interfere with the eukaryotic cell cycle. 
CDT blocks the cell cyle transition between G2 and M phases (Nougayréde et al., 2005). 
CdtB has DNase activity, while the other two subunits transport CdtB into the host target 
cell (Croxen et al., 2013). CdtB causes DNA damage leading to cell death, which has 
been demonstrated in multiple cell lines (Jinadasa et al., 2011). All three subunits of CDT 
in E. coli are thought to be required for cell death (Taieb et al., 2015). Five types of CDT 
are known, termed CDT-I through CDT-V. CDT-V was associated with strains causing 
diarrhea in humans (Croxen et al., 2013). 
 
 Cytotoxic necrotizing factor 1(CNF1) 
 CNF1 and its isoform CNF2 are AB-type cytotoxins. CNF is a cyclomodulin that 
promotes eukaryotic cell proliferation by activating DNA replication and the transition 
from G1 to S phase of the cell cycle (Nougayréde et al., 2005). Although CNF1 is mainly 
found in uropathogenic E. coli and E. coli causing neonatal meningitis, it has also been 
found in STEC (Kaper et al., 2004). The C-terminal portion of CNF1 is involved in the 
deamination of a glutamine residue of Rho GTPases which causes reorganization of the 
cytoskeleton (Kaper et al., 2004). Reorganization of the cytoskeleton by CNF1 causes 
impairment of epithelial barrier function (Hopkins et al., 2003). CNF1 may also play a 
role in modifying the morphology of mitochondria to increase ATP-producing capacity 
for greater cell proliferation (Travaglione et al., 2014). 
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 Enteroaggregative heat-stabile toxin (EAST1) 
 EAST1 is a heat-stable enterotoxin encoded by the astA gene found in ETEC, 
EPEC, and STEC. Both STEC O157 and non-O157 STEC tested positive for astA (Law, 
2000). The role of EAST1 in pathogenesis remains unclear. It has been suggested that 
EAST1 contributes to the initial diarrhea seen in patients, because fluid secretion is 
stimulated in the rabbit model by EAST1 (Law, 2000). EAST1 and K88 fimbria were 
cloned and a constructed E. coli strain that lacked other toxins was used to assess the 
effect of EAST1 in K88 receptor-positive gnotobiotic piglets (Ruan et al., 2012). 
Gnotobiotic piglets did not develop diarrhea and showed no signs of dehydration after 
being challenged with 10
9
 CFU of this strain (Ruan et al., 2012). This suggests that 
EAST1 alone does not play a role in diarrhea. 
 
 Subtilase 
 Subtilase (SubAB) is an AB5 cytotoxin that causes apoptosis in human cortical 
renal tubular epithelial cells (Márquez et al., 2014). SubAB is located on a 165-kb 
plasmid first found in STEC O113 (Paton et al., 2004), but may also be found on the 
chromosome of some strains. There are variants of subtilase and a single strain can have 
multiple variants. The possession of at least two subtilase variants occurred in about half 
of the STEC strains isolated from sheep and wild ruminants (Nüesch-Inderbinen et al., 
2015). The A subunit cleaves a chaperone of the endoplasmic reticulum. This leads to 
accumulation of unfolded proteins in the endoplasmic reticulum, which leads to stress-
induced cell death (Croxen et al., 2013). 
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Plasmids 
 Plasmids are covalently-closed, circular DNA molecules that replicate 
independently from the chromosome and commonly carry virulence and antibiotic 
resistance genes. Plasmids can also integrate into the chromosome. Most STEC carry a 
plasmid known as pO157 that is 75-100 kb, and additionally have other plasmids. 
Plasmid pO157 is made up of prophage, parts of other plasmids, and other mobile genetic 
elements (Caprioli et al., 2005). Due to the number of mobile elements, genes are 
unevenly distributed among STEC strains (Ishii et al., 2007). It is thought that pO157 
was acquired from Yersinia pestis due to the similarity found between pO157 in EHEC 
strains and pCD1 found in Y. pestis along with similarities to pO157 and sequences in Y. 
pestis chromosome (Johnson and Nolan, 2009). The large plasmid carries genes for 
EHEC-hemolysin (ehxA), catalase peroxidase (katP), serine protease autotransporter 
(espP), a type II secretion system (etpC-O), a zinc metalloprotease (stcE), and an 
adherence factor (toxB; Yan et al., 2012). The toxB gene shows considerable similarity to 
another adherence factor (efa1), which is found on the chromosome (Caprioli et al., 
2005). Based on the nucleotide sequence, pO157 encodes for 35 proteins in total, 
including a type II secretion system, but not all of the functions are known (Burland et 
al., 1998).   
 The biological role of pO157 is not fully understood. In a Caenorhabditis elegans 
model of infection, pO157 was needed for full pathogenicity and killing of C. elegans 
(Youn et al., 2013). Its role in colonization of cattle is not well understood, and there are 
conflicting reports using cell lines (Law, 2000). Interestingly, in an inoculation 
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experiment involving cattle, strains without pO157 were not able to persist as well as 
wild type strains (Sheng et al., 2006).  
 A 121-kb plasmid (pSFO157) is found in sorbitol fermenting EHEC O157. 
Plasmid pSFO157 shares high similarity to pO157 and is predicted based on complete 
DNA sequence analysis to share a hypothetical ancestral plasmid (Rump et al., 2012). 
The major differences observed between pSFO157 and pO157 include the absence of 
espP, katP, and toxB in pSFO157. Also, pSFO157 has a sfp fimbria gene cluster that is 
absent from pO157 and accounts for most of the additional size (Brunder et al., 2006). 
Induction of this fimbria increased under conditions mimicking the colonic environment 
and facilitated adhesion to Caco-2 and HCT-8 cells (McWilliams and Torres, 2014). 
 A smaller 3.3-kb plasmid, termed pSP70 by Sharma and Stanton (2008) is also 
present in some EHEC strains. In EHEC O157, a 3.3-kb plasmid was found in 6.5% 
(Meng et al., 1995) and 8% (Haarmann et al., 1998) of strains tested. Haarmann et al. 
(1998) found sequence similarity between pSP70 and the antibiotic resistance plasmids 
NTP1 which confers ampicillin resistance and NTP16 which confers kanamycin 
resistance found in Salmonella typhimurium strains. It is unclear if pSP70 has any role in 
virulence. 
 In some LEE-negative STEC strains, a plasmid, pO113, named after STEC 
O113:H21 is found (Croxen et al., 2013). Plasmid pO113 has a size of 165-kb plasmid 
and contains many of the same genes found in pO157. By sequencing, Newton et al. 
(2009) found that pO113 encodes for known virulence factors ehxA, espP, saa, and 
subAB. A large transfer region accounted for most of the increase in size compared to 
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pO157 (Newton et al., 2009). Thus, plasmids in STEC contain genes for toxins, 
adherence factors, secretions systems, and other proteins with unknown functions. 
 
Adherence factors 
 The LEE is a 35-kb pathogenicity island in EHEC and EPEC that encodes for 
intimin, Tir, and the type III secretion system (Jores et al., 2004). The LEE is arranged 
into five polycistronic operons, LEE1 through LEE5, and is required for A/E lesions 
(Kaper et al., 2004). Elliott et al. (1999) cloned the LEE from a STEC O157 strain into 
an E. coli K-12 strain, but the K-12 strain was not able to produce A/E lesions or secrete 
E. coli secreted proteins (Esp). The Tir-cytoskeleton factor protein (TccP) was found 
outside the LEE and required for A/E lesion formation (Garmendia et al., 2004). An A/E 
lesion is described by intimate attachment of bacteria to the host cell, effacement of 
microvilli, and polymerization of actin filaments underneath attached bacteria resulting in 
“pedestal” formation (Kaper et al., 2004). In addition to E. coli, the LEE is found in 
members of C. freundii and H. alvei (McDaniel et al., 1995). The LEE is speculated to be 
acquired by horizontal gene transfer because it has a lower GC content compared to that 
of the E. coli chromosome (Elliott et al., 1998). The LEE is optimally expressed at 37°C, 
while in the exponential growth phase (Rosenshine et al., 1996), and induced in cell 
culture media (Roe et al., 2003). The LEE encoded regulator is a master regulator of LEE 
transcription and activates transcription of each LEE operon. 
  
 Intimin 
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 Intimin is a 95-kDa protein and serves as the major adherence factor for EHEC 
(Kaper et al., 2014). The 280 amino acids on the C-terminal end of the protein serve as 
the binding region to Tir (Frankel et al., 1995). A study involving human volunteers 
established the importance of intimin for the development of diarrhea (Donnenberg et al., 
1993). Volunteers ingested 2 x 10
10
 CFU of an EPEC strain or an isogenic eae deletion 
mutant. All 11 volunteers who received the intimin-positive wild-type strain developed 
diarrhea, while only four of 11 who received the intimin-negative mutant strain 
developed diarrhea (Donnenberg et al., 1993). Different growth media has an influence 
on expression of intimin. Knutton et al. (1997) reported greater expression of intimin in 
cell culture media (DMEM) compared to Luria-Bertani broth. 
 Intimin types β, ε, γ1 and γ2 were found to be preferentially associated with 
certain serotypes of STEC. Adu-Bobie et al. (1998) found that E. coli O26:H11 was 
associated with eae-β, and E. coli O157:H7 with eae-γ. In total, 27 intimin types are 
known (Ito et al., 2007). In part, the intimin type determines the tissue specificity of a 
strain. Strains expressing eae-α and eae-β have similar tissue specificity in human in vitro 
organ cultures (Mundy et al., 2007). In gnotobiotic pigs, strains expressing eae-α 
produced A/E lesions in the small and large intestine, while those expressing eae-γ 
produced lesions only in the large intestine (Tzipori et al., 1995). Phillips and Frankel 
(2000) investigated tissue tropism of intimin using human intestinal organ cultures. 
Complementation of an eae-α mutant EPEC strain, resulted in colonization of the small 
intestine, but complementation with eae-γ, resulted in colonization of Peyer’s patches 
(Phillips and Frankel, 2000). Intimin can also adhere to cell culture without Tir, and thus, 
can use host cell surface receptors to adhere (Farfan and Torres, 2012). 
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 Fimbrial adhesins 
 Intimin is the primary adhesin in STEC, but fimbriae also contribute to adhesion. 
There are 16 fimbrial loci in E. coli O157:H7 (Gonyar and Kendall, 2014) and at least 
two others in non-O157 STEC (Wurpel et al., 2013). Long polar fimbria (Lpf), curli, E. 
coli common pilus (ECP) and hemorrhagic E. coli pilus (HCP) are the best characterized 
fimbrial proteins. 
 Lpf were found in STEC O157 strains to increase adherence to HeLa and MDCK 
cells (Torres et al., 2002). Two fimbrial loci, lpf1 and lpf2, encode Lpf. They display 
long, fine structures based on transmission electron microscopy (McWilliams and Torres, 
2014). In sheep and pigs inoculated with lpf1/lpf2 double mutants, a significantly lower 
recovery rate was reported (Jordan et al., 2004). Lpf are most likely important for initial 
adhesion before intimate attachment is established (Farfan and Torres, 2012) 
 STEC have specialized fimbria that allow them to colonize plant leaves such as 
those of lettuce and spinach.  E. coli K-12 strains fail to bind the plant, but successful 
attachment occurred when Jeter and Mattysse (2005) introduced curli into K-12 strains. 
Curli is an adhesin found in STEC and EPEC that binds to fibronectin to mediate 
attachment to animal cells, but has a dual role in binding plant surfaces when outside the 
host (Farfan and Torres, 2012).  
 ECP is found in most E. coli including STEC. In one study, expression of ECP 
was found in 121 of 169 E. coli strains covering diarrheagenic and extraintestinal strains 
(Rendón et al., 2007). High levels of expression for ECP are observed between 20°C to 
26°C and a lack of expression is observed at 37°C (McWilliams and Torres, 2014). Using 
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Purified ECP, Saldaña et al., 2009 found ECO bound to HeLa cells, and anti-ECP 
antibodies blocked binding. This confirmed ECP role as an adhesin in STEC. 
 HCP was shown to be involved in binding to human intestinal and non-intestinal 
cell lines (McWilliams and Torres, 2014). HCP is a multipurpose fimbria involved in 
attachment, binding to extracellular matrix proteins, invasion of epithelial cells, 
interbacterial connections, hemagglutination of rabbit erythrocytes, and twitching 
motility (Xicohtencatl-Cortes et al., 2009b). Multiple functions of HCP contribute to 
virulence, survival, and transmission.  
 
 Non-fimbrial adhesins 
 Other adhesins contribute to intestinal colonization by STEC. EHEC factor for 
adherence (Efa-1) is a 365-kDa protein found in STEC and is known as lymphostatin 
(LifA) in EPEC (Farfan and Torres, 2012). Efa-1 is found on the chromosome and its 
homologue designated ToxB is found on pO157. ToxB is 28% identical to Efa-1 by 
amino acid identity (Tatsuno et al., 2001). Using transposon mutagenesis, Efa-1 was first 
identified as an important adhesin in EHEC O111, but was not required for A/E lesion 
formation (Nicholls et al., 2000). Efa-1 has been associated with inducing secretion of 
T3SS effectors, cell adherence and lymphostatin activity (Farfan and Torres, 2012). 
 Autotransporters are outer membrane proteins that facilitate their own transport 
across the bacterial cell membrane. A number of autotransporters have been identified in 
STEC. Three common autotransporters involved in adhesion are EHEC autotransporters 
(Eha), EhaA, EhaB, and EhaJ. EhaA and EhaB are more prevalent in STEC strains 
compared to EhaJ (Farfan and Torres, 2012).  EhaA is involved in adherence to mucosal 
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epithelium of the bovine terminal rectum, which makes it a key target for reducing 
shedding of STEC in cattle (Farfan and Torres, 2012). EhaB and EhaJ bind extracellular 
matrix proteins (Wells et al., 2009; Easton et al., 2011). 
 Two other autotransporters, EspP and STEC autoagglutinating adhesion (saa), are 
important adherence factors. The gene for expression of EspP (espP) is carried on pO157. 
EspP forms structures called “ropes” that mediate adherence to epithelial cells 
(McWilliams and Torres, 2014). Deletion of espP in STEC O157 demonstrated reduced 
adherence to T84 intestinal epithelial cells (Puttamreddy et al., 2010) and primary bovine 
rectal cells (Dziva et al., 2007) compared to the wild-type strain. LEE-negative STEC 
need adhesion factors to be able to colonize the gastrointestinal tract. The adhesin, saa, is 
an autotransporter found in O113 STEC. It increased adherence 10-fold when introduced 
into a saa-negative strain (Paton et al., 2001). 
 
Additional virulence factors 
 Catalase peroxidase (KatP) 
 KatP is an 82-kDa protein, encoded by a gene (katP) carried on pO157; KatP has 
a dual role of catalase and peroxidase (Croxen et al., 2013). It is thought to be involved in 
recovery from heat stress and protection from macrophage oxidative burst (Law, 2000). 
The distribution of this gene in STEC even among STEC of the same serogroup is 
variable (Bosilevac and Koohmaraie, 2011) and its role in causing disease is unclear. 
 
 EHEC-hemolysin 
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 EHEC-hemolysin is a member of the repeats-in toxin (RTX) family and encoded 
by a gene (ehxA) on pO157 (Kaper et al., 2004). EHEC-hemolysin is released in its free 
form upon lysis of bacterial cells or in outer membrane vesicles (Bielaszewska et al., 
2014).  It produces thin rings of hemolysis after 18 to 24 h of incubation on blood agar 
unlike the better described alpha-hemolysin of UPEC strains, which produces large zones 
of clearing after 4 h of incubation on blood agar (Beutin and Fach, 2014). Most eae-
positive STEC possess ehxA, but some eae-negative STEC may lack the gene (Verstraete 
et al., 2013). EHEC-hemolysin forms a pore in the cell membrane of erythrocytes and 
other eukaryotic cells. It was found to elicit a proinflammatory response by releasing 
interleukin-1β from human macrophages, which may amplify the effect of LPS and Stx 
(Zhang et al., 2012). In patients with HUS, antibodies are produced against the toxin 
(Schmidt et al., 1995).  
 
 Mitochondrial associated protein (Map) 
 Map is expressed by EPEC and EHEC and functions to stimulate filopodia 
formation and acts on mitochondria function (Kenny et al., 2002). Additionally, Map was 
shown to be coordinately regulated with Tir such that Map signaling inhibited pedestal 
formation (Kenny et al., 2002).  Therefore, Map may act on filopodia before intimate 
adherence occurs. 
 
Type III secretion system 
 The type III secretion system (T3SS) structural components were thought to have 
evolved from flagella, and based on structure comparison has similar structures to 
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flagella (Blocker et al., 2003).  E. coli, in addition to other pathogens, such as Chlamydia, 
Salmonella, Shigella, and Yersinia use a T3SS to attach to host cells, inject virulence 
proteins, and/or invade into cells. The T3SS is includes proteins that form ring-like 
structures in the inner and outer cell membrane of the Gram-negative bacterium, and a 
channel to the exterior of the bacterial cell. In addition, this channel is continuous with 
other T3SS proteins that form a needle-like structure on the bacterial surface that is 
inserted into and through the host cell membrane.  This allows for secretion of proteins 
from the bacterial cytoplasm directly into the host cell cytoplasm. The T3SS is a needle 
structure made up of the needle filament protein EspA and pore proteins EspD and EspB 
that allow effector proteins to be injected and secreted through the pore (Connolly et al., 
2015).  
 Jarvis and Kaper (1996) demonstrated that EHEC secrete proteins by a T3SS, are 
recognized by antiserum raised against proteins secreted by EPEC, and suggested that 
they are similar to secreted proteins of EPEC. Translocators are proteins that help 
translocate proteins into the host cell cytoplasm. Translocators are typically conserved 
among different pathogens (Connolly et al., 2015). Those proteins injected into the host 
cytoplasm are known as effectors, since they effect changes in the host cells. Effectors act 
to inhibit immune system to avoid pathogen detection and inhibit cell death 
(Vossenkämper et al., 2011). 
 STEC strains not only use the T3SS to adhere and alter the host cell, the T3SS can 
induce epithelial barrier disruption, which can contribute to diarrhea (Coburn et al., 
2007). To block the effects of the T3SS small molecule inhibitors have been designed to 
block secretion of effector proteins (Gu et al., 2015). This would be an attractive strategy 
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to treat infections caused by a broad range of Gram-negative pathogens that used the 
T3SS. 
 
Pre-harvest interventions 
 Pre-harvest interventions are designed to reduce the carriage of STEC in live 
cattle and the environment. Interventions have addressed cleaning of equipment such as 
feed and water troughs, bedding, livestock trailers, reducing animal density, removal of 
cattle shedding high numbers of STEC O157, bacteriophage, direct-fed microbial (DFM), 
probiotics, and vaccines. 
 
 Direct fed microbials and prebiotics 
 Bacteria produce antimicrobial compounds called bacteriocins for the purpose of 
inhibiting the growth of other competing bacteria. Direct-fed microbials (DFM) are 
compounds that are fed to animals with the intended main purpose of reducing intestinal 
colonization by pathogenic bacteria, and probiotics are non-pathogenic bacteria added to 
the feed used for the same purpose. Lactobacillus, Bacillus and Bifidobacterium are 
common genera of probiotics (Uyeno et al., 2015).   
Tabe et al. (2008) evaluated the effect of DFM on fecal shedding of STEC O157 
in 138 feedlot cows.  They found that cows treated with a DFM had a lower prevalence of 
STEC O157 compared to an untreated control group. Lactobacillus acidophilus has been 
shown to reduce intestinal epithelial colonization in vitro (Medellin-Peña and Griffiths, 
2009) and in live cattle (Uyeno et al., 2015).   
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 Vaccines 
 The use of vaccines against STEC O157:H7 have shown promising results for 
reducing STEC shedding in cattle (Smith, 2014b). Since STEC rarely cause recognizable 
disease in cattle, vaccines against STEC would be used primarily for public health 
purposes. Vaccines against STEC O157 have yet to be adopted by cattle producers, and 
most likely will not be adopted until their direct benefit to the producer is found to 
outweigh the cost. Most vaccines are serotype specific, which results in poor cross-
protection of other serotypes (Cernicchiaro et al., 2014). Vaccines targeting various T3SS 
components including intimin, Tir, EspA, and EspB/EspD have had mixed results, but 
some formulations of the T3SS vaccines were effective in challenge studies and field 
studies (Smith, 2014b). The length of immunity with vaccines against STEC O157 is 
unknown, because most field studies only last 60 to 100 days (Smith, 2014b). 
 Models have shown a reduction in fecal shedding in summer months down to that 
of winter months with the use of a T3SS protein vaccine (Vogstad et al., 2014).  
Additional models have demonstrated the potential usefulness of vaccines against STEC 
O157 in cattle, which would reduce STEC O157 infections in humans (Smith, 2014b). 
Although vaccines can help to reduce shedding of STEC, it is unlikely that they will 
completely eradicate these organisms from cattle (Vande Walle et al., 2013). 
 
Models for STEC infection 
 Animal and cell culture models have provided insight into the pathogenesis and 
virulence of STEC. Human derived cell lines, Caco-2, Hep-2, T84 cells, have been used 
to study adherence (Farfan and Torres, 2012). Currently, there are no bovine intestinal 
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epithelial cell lines that can be used to study STEC adherence. Human and cattle in vitro 
organ culture provide a more suitable environment to mimic host infection, but these 
tissue quickly undergo postmortem autolysis (Baehler and Moxley, 2000). Baboons, 
Caenorhabditis elegans, chickens, ferrets, greyhounds, monkeys, and rats have been used 
a limited number of times, but mice, pigs, and rabbits are the most commonly used 
animal models (Ritchie, 2014). Mice are resistant to colonization, but renal damage 
occurs with inoculation of Stx into the bloodstream (Tesh et al., 1993). Differences in 
renal damage between mice and humans due to Stx render this model of questionable 
relevance (Ritchie, 2014).  The mouse pathogen Citrobacter rodentium shares many 
virulence factors including intimin with EHEC strains and has been used as a model 
system to study in vivo colonization. An approach using C. rodentium, which naturally 
colonizes mice, has been developed to study attachment in the mouse model. This has 
been further developed by Mallick et al. (2012) to include a C. rodentium strain that 
expresses Stx. Construction of human and bovine intestinal xenograft models in mice 
have improved standard models (Golan et al., 2011). When a STEC strain was injected 
into the lumen of intestinal xenografts, tissue damage in the colon but not small intestine 
was observed, consistent with previous findings that the colon is the main site of 
attachment (Kaper et al., 2004). A lack of normal food passage or peristalsis, and a lack 
of natural microflora are limitations of this model (Ritchie, 2014). 
 Rabbits vary in their susceptibility and usefulness as a model for STEC infection. 
When inoculated with STEC O157 young New Zealand White rabbits developed 
diarrhea, but diarrhea was not observed in rabbits older than 20 days (Farmer et al., 
1983). Inoculation of STEC O157 did not result in signs of HUS likely due to a lack of 
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Gb3in the renal tubular epithelial cells, but deletion of eae in the same strain did result in 
reduced colonization supporting the importance of intimin for attachment (Ritchie et al., 
2003). 
 Gnotobiotic piglets are delivered via cesarean secretion and raised in incubators 
as germ-free animals. They can be used to study the influence of a single organism 
without the influence of the normal microflora. In addition to intestinal colonization, A/E 
lesions, they developed central nervous system disease with evidence of vascular damage 
in the brain identical to what is seen in humans (Ritchie, 2014). This model has been 
helpful to study STEC pathogenesis (Francis et al., 1986; Tzipori et al., 1986).  
  
Detection of STEC 
 STEC detection is important for diagnosis of clinical infections, outbreak 
investigations, environmental monitoring, and food safety. In order to know that STEC 
contamination has been prevented, e.g., through interventions or other process controls, 
effective methods must be established to detect these organisms. Due to these and other 
concerns, which include meeting regulatory requirements, a number of test methods have 
been developed to detect STEC. The USDA FSIS developed standardized methods for 
detection of EHEC-7 in meat products (USDA, 2014b). This relies on the screening of 
enriched samples by PCR for O-groups, stx, and eae. Potential positive samples are 
plated on chromogenic agar, and individual colonies are tested by PCR, latex 
agglutination, and biochemical testing is performed.  These methods are laborious, 
expensive, and time consuming. A number of commercial products have been developed 
to reduce the time and cost for screening for STEC. Some products have received a letter 
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of no objection by the USDA FSIS, which means they can be used in place of the 
standard USDA FSIS protocol.  
  
 Enrichment 
 Enrichment of a sample is often needed to improve detection because STEC is 
found in such low numbers (Wang et al., 2013). Factors of an enrichment procedure are 
the base enrichment broth, added selective components, time of enrichment, and 
temperature. Generally the sample is diluted 1:10 in enrichment media to reduce 
inhibitors of STEC growth (Paddock et al., 2012). Evans et al. (2011) found an increased 
recovery of E. coli isolates from 1 g fecal samples enriched in 20 ml compared to 10 g of 
the same sample enriched in 225 ml, which indicates sample size in addition to dilution 
factor is important. Samples are typically enriched at 37°C to 42°C for 6 to 24 h. To 
enhance recovery, pre-enrichment media can be used before an enrichment step to enable 
growth of stressed bacterial cells (Wang et al., 2013). Buffered peptone water has been 
used as a pre-enrichment broth and optimized by supplementation with 8-
hydroxyquinoline and sodium deoxycholate for E. coli growth in minced meat (Margot et 
al., 2015).  
 Selective components added to enrichment media are used to inhibit growth of 
background flora without reducing the growth of STEC. Acriflavin, bile salts, cefixime, 
cefsulodin, novobiocin, potassium tellurite, and vancomycin are commonly used alone or 
in combination as selective components (Hussein and Bollinger, 2008). Cefixime has 
been used to inhibit swarming growth of Proteus on agar plates. Proteus is found in feces 
and the swarming phenotype inhibits isolation of organisms (Chapman et al., 1991). 
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Cefsulodin inhibits Aeromonas spp., Pseudomonas aeruginosa, and Vibrio cholerae 
(Hussein and Bollinger, 2008). Novobiocin is known to inhibit Gram-positive organisms, 
but some STEC may grow poorly under concentrations of novobiocin commonly used in 
enrichment media (Baylis, 2008). Acriflavin, bile salts, and vancomycin are additional 
components that are selective against Gram-positive organisms (Hussein and Bollinger, 
2008; Savoye et al., 2011). Potassium tellurite inhibits both Gram-positive and -negative 
organisms. Resistance to potassium tellurite is variable among STEC strains and eae-
positive strains are more likely to grow in the presence of potassium tellurite (Fukushima 
et al., 2000).  
 Concentrations of antimicrobials are based on minimum inhibitory concentrations 
of strains, field studies, and inoculation experiments. Tellurite resistance is variable 
among EHEC-7 strains. In one study, the majority of EHEC-7 strains had a MIC above 
50 mg/liter (Fukushima et al., 2000). However, they did not test any E. coli O45 strains. 
The absence of bile salts and novobiocin and the presence of yeast extract in TSB related 
to higher detection of STEC O26 and O157 in raw ewe’s milk (Caro et al., 2011). Possé 
et al. (2008a) used TSB with 8.0 mg/liter of novobiocin, 16 mg/liter vancomycin, 2.0 
mg/liter rifampicin, 1.5 mg/liter bile salts, and 1.0 mg/liter potassium tellurite to enrich 
inoculated cattle feces. This selective enrichment procedure did not recover all strains 
from inoculated cattle feces, which indicates that some strains may be inhibited at these 
concentrations. Most STEC O157 strains were recovered, but after selective enrichment 
there was poor recovery for non-O157 STEC (Possé et al., 2008a).  
 An enrichment time that is long enough to grow STEC to a detectable 
concentration is needed for recovery of STEC in complex matrices. Typical enrichment 
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times have been from 6 to 24 h depending on sample type, convenience, or follow-up 
analysis. When the follow-up analysis includes plating on agar media, longer enrichment 
times may cause overgrowth by other background organisms (Vimont et al., 2006). A 
short enrichment time (6 h) was compared to a longer enrichment time (24 h) for the 
recovery of EHEC-7 from inoculated cattle feces (Verstraete et al., 2010). The 6 h 
enrichment time compared to 24 h did not influence the recovery of EHEC-7, but two 
enrichment times with direct plating and immunomagnetic separation (IMS) may result in 
improved recovery. Improved recovery of EHEC O157 was observed with the inclusion 
of IMS, but recovery was not improved for other EHEC serogroups (Verstraete et al., 
2010). Similarly, Paddock et al. (2012) found better detection limits when inoculated 
bovine feces were enriched for 6 h compared to 24 h. The use of multiple enrichment 
times and plating schemes increases the labor required per sample.  Similarly, Durso and 
Keen (2007) investigated the effect of enrichment on recovery of STEC O157 from 116 
naturally contaminated fecal samples. For STEC O157, 6 h enrichment improved 
detection. Enrichment tubes are typically incubated statically, but no studies have 
compared growth or detection of STEC in fecal samples incubated statically versus 
agitated. Using a metagenomics approach for STEC detection in spinach samples, 
Leonard et al. (2015) found that STEC were detected more robustly in statically enriched 
samples compared to samples that had been shaken during enrichment. 
 Simultaneous enrichment and detection is an appealing strategy to reduce the time 
to result for pathogen testing. This would reduce the time that foods are held before they 
can be sold to the consumer. This has been developed for STEC O157 using a biochip 
with antibodies specific for E. coli O157:H7 (Mondani et al., 2014).  In contrast, the use 
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of multiple enrichment broths has resulted in improved recovery of STEC O157 in 
naturally contaminated fecal samples (Vidovic et al., 2007). The time and cost saved 
using one enrichment media for multiple pathogens compared to multiple enrichment 
media for one pathogen needs to be considered. A universal enrichment media that is 
selective for all STEC serogroups is unlikely due to the diversity observed between 
STEC strains. 
 IMS is a method that uses treatment of a culture with paramagnetic beats coated 
with antibodies directed against the O antigen of interest. Bacteria bound to beads are 
separated from the broth by the use of an external or intrasolution magnet and wash steps 
are used to reduce non-specific binding. The PickPen is an intrasolution magnetic particle 
transfer device that showed improved recovery of E. coli O157 from naturally 
contaminated carcass, hide, and fecal samples compared to an external magnet (Nou et 
al., 2006). IMS has improved the detection of STEC O157 in fecal samples (Chapman et 
al., 1994). Bead size and buffers have been optimized for the recovery of STEC O157 
(Parham et al., 2003). Multiple IMS technologies are available for E. coli O157. Lau et 
al. (2012) compared the Pathatrix Auto and KingFisher Flex for recovery of E. coli O157 
from inoculated food. After 24 h of enrichment, 100% recovery of E. coli O157 was 
achieved from ground beef, sprouts, and green onions by both platforms.  IMS has been 
shown to improve recovery of STEC O26, O111 and O157 in inoculated foods, such as 
cabbage, carrots, lettuce, potatoes, and radishes (Safaríková and Safarík, 2001). 
 Simultaneous IMS for multiple serogroups would reduce the processing time and 
cost per sample. Kanki et al. (2014) evaluated the use of simultaneous IMS for O26, 
O111, and O157 added to enriched food samples. They found comparable results for 
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isolation of STEC O26 and O111, and similar but weaker results were observed for 
isolation of STEC O157 (Kanki et al., 2014). Currently there are commercial antibodies 
and IMS reagents for EHEC-7 serogroups (Medina et al., 2012). However, antibodies for 
some serogroups lack specificity to the O-groups targeted, and may target other 
conserved areas on the LPS antigen (Stromberg et al., 2015b). After IMS, the culture may 
undergo PCR, or plated on agar media for the isolation of STEC. Type of IMS bead may 
influence the recovery of organisms. Low affinities for O111 and O145 were observed by 
Verstraete et al. (2010) using Dynabeads. 
  
 Agar media 
 Agar media provides isolated colonies for follow-up detection tests, further 
investigation of virulence, and comparison to other isolates for outbreaks investigations. 
A distinct fermentation pattern belonging to STEC O157 has allowed for the 
development of agar media designed to screen for its unique phenotype. STEC O157 
does not ferment sorbitol within 24 h, while other E. coli are sorbitol fermenters (Doyle 
and Schoeni, 1984). This led to replacing lactose in MacConkey agar with sorbitol 
(SMAC). STEC O157 cannot cleave 4-methylumbelliferyl-β-D-glucuronide (MUG), 
which produces a fluorescent product under UV light. MUG negative colonies are thus 
typical of STEC O157, while most non-O157 STEC are MUG positive (Thompson et al., 
1990). 
 Commercial agar media are typically faster to prepare or come pre-poured, which 
reduces the labor needed. The USDA FSIS has implemented a modification of Rainbow 
Agar O157 in their testing of STEC in enriched beef samples. On this media, STEC O157 
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produce grey to black colonies, STEC O26 produce purple to magenta, STEC O111 are 
grey-green, and other non-O157 STEC are blue, purple, white, violet, or red (Verhaegen 
et al., 2015). The wide ranges of phenotypes exhibited within a STEC serogroup and 
within EHEC-7 make this agar difficult for use in screening.  CHROMagar STEC is 
another commercial chromogenic agar for the detection of STEC. On CHROMagar 
STEC, all STEC strains are screened based on one phenotype, mauve (Verhaegen et al., 
2015). STEC O157 colonies appear non-fluorescent under UV light while non-O157 
STEC may be fluorescent or non-fluorescent.  Some STEC are inhibited on this agar, and 
therefore, using it could give false-negative results (Verhaegen et al., 2015).  Gouali et al. 
(2013) evaluated the performance of CHROMagar STEC for detection of STEC in 
human stool samples, and found that 82% of the Stx-positive stools based on PCR 
recovered a STEC isolate on CHROMagar STEC. 
 Most STEC O26 strains cannot ferment rhamnose and thus lactose in MacConkey 
agar was replaced with rhamnose in rhamnose-MacConkey agar (RMAC; Hiramatsu et 
al., 2002).  Some strains of Enterobacter cloacae, Shigella flexneri, and Shigella sonnei 
mimicked the phenotype of STEC O26 on RMAC, which suggested a need for selective 
components to reduce background organisms. RMAC supplemented with potassium 
tellurite and cefixime at concentrations of 2.5 and 0.05 mg/liter, respectively (CT-
RMAC), selected for STEC O26.  CT-RMAC had improved recovery for STEC O26 in 
inoculated human stool samples when compared to RMAC (Hiramatsu et al., 2002). 
 In general, non-O157 STEC do not have biochemical features that distinguish 
them from generic E. coli. Most non-O157 STEC ferment sorbitol which means that 
SMAC developed for STEC O157 will not be useful for detection of non-O157 STEC. 
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The development of agar for isolation of non-O157 STEC has been more difficult and 
relied on a combination of carbohydrates, utilization of X-gal, and resistance to 
antimicrobials. A standardized method for isolation of non-O157 STEC from cattle 
matrices has not been developed. Possé et al. (2008b) formulated a chromogenic agar 
media for non-O157 STEC of serogroups O26, O103, O111, and O145 based on the 
fermentation of sucrose and sorbose, β-galactosidase activity and selective components. 
After plating on this agar, a second agar was used to identify each serogroup (Possé et al., 
2008b). A limited number of strains within these four serogroups were tested, and a 
larger number of strains and serogroups would help evaluate the usefulness of this agar. 
Variations in use of chromogenic agar, such as incubation time and temperature may 
cause slight differences in typical colony color. Due to the lack of media to detect non-
O157 STEC, current data largely underestimates the true incidence of STEC infection in 
humans (Gill et al., 2014; Verhaegen et al., 2015).  
 Agar media have been designed for detection of STEC based on the expression of 
their virulence factors. STEC heart infusion washed blood agar with mitomycin-C 
(SHIBAM) screens for STEC colonies based on the lysis of red blood cells by EHEC-
hemolysin (Feng et al., 2011). Mitomycin C enhances the production of EHEC-
hemolysin (Sugiyama et al., 2001). Screening for Stx by immunoblots on colony lifts 
from agar plates has also been used to detect STEC in culture (Hull et al., 1993), but may 
require screening a large number of colonies. Currently agar media developed for non-
O157 STEC have not been completely investigated for their effectiveness in isolating 
non-O157 STEC from food or cattle matrices including fecal samples. The lack of 
standardized methods for detection of non-O157 STEC has led to few studies using the 
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same methodologies, which complicates comparing the ecology of these organisms 
across studies. 
 Acid treatment has been used to reduce background organisms before plating 
procedures (Tillman et al., 2012). Most E. coli strains are resistant to pH as low as 2.0, 
which enable them to survive the acidic environment of the stomach (Hong et al., 2012). 
Treatment of pure cultures found a reduction in growth for Enterobacter cloacae, 
Citrobacter freundii, Klebsiella pneumoniae, but not STEC  O26, O45, O103, O111, 
O121 or O145 strains from pH 5.0 to 2.0 (Tillman et al., 2012). Tillman et al. (2012) also 
found improved recovery of STEC strains after acid treatment in inoculated ground beef 
samples. 
 A limitation of culture is the number of colonies that can be screened. Isolation of 
STEC and E. coli O157 from enriched carcass swabs on CT-SMAC, BCMO157 agar, and 
CHROMagar O157 found a lower number of samples positive compared to PCR for stx 
and a gene representing the O157 antigen (Ohtsuka et al., 2010). Culture routinely detects 
a lower number of positive samples compared to molecular tests (Wang et al., 2014b; 
Noll et al., 2015). 
 Multiple methods rely on the isolation of colonies on agar plates. A light 
scattering sensor, called Bacterial Rapid Detection using Optical scattering Technology 
(BARDOT) based on the scatter pattern generated by the colony characteristics such as 
O-antigen, peptidoglycan, or metabolites has been developed for detection of STEC-7 
(Tang et al., 2014). The BARDOT relies on a library of scatter profiles and is limited to 
the existing library. It also relies on a defined growth time, because as colonies grow for a 
longer time their characteristics change (Tang et al., 2014). A rapid method for 
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identification of STEC-7 serogroups termed the EHEC colony check assay is a cloth-
based hybridization array that test isolated colonies from agar media (Blais et al., 2014). 
Although these assays directly test colonies from agar plates, a single agar media for 
detection of all STEC has not been developed.  It has been recommended that two agar 
media be used for screening STEC (Gill et al., 2014), one agar that is highly selective and 
one agar that is less selective. 
  
 PCR detection  
 After colonies have been isolated or if testing from enriched samples, further 
testing is may be required to determine if a STEC strain is present. Cytotoxic, 
immunological, DNA-based, and culture-based assays have been used for STEC 
detection (Beutin and Fach, 2014).  PCR is a common nucleic acid detection assay for 
multiple pathogens. PCR can be performed directly from isolated colonies or colonies 
that have been lysed causing DNA to be released from cells. There is not a standard 
procedure for the number of colonies tested from an individual agar plate, and it can vary 
from one to hundreds depending on the study. The number of colonies tested is 
commonly based on cost and convenience. On enriched samples, a DNA purification step 
is included to extract DNA and remove potential PCR inhibitors, which are particularly 
problematic in fecal samples (Paddock et al., 2012). Multiplex PCR (mPCR) allows for 
the detection of multiple genes in a single assay. This technique allows for detection of 
multiple pathogens or multiple genes from a single pathogen or a combination of both.  
Despite the advantage of sensitivity and high-throughput capabilities, PCR cannot 
determine if genes representing an O-group, eae, and stx are being contributed from one 
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or multiple organisms. Detection of all three genes, commonly by PCR, in one organism 
is required by the USDA FSIS to identify meat contaminated with an EHEC-7 organism. 
 Bai et al. (2010) developed a mPCR to detect six genes in EHEC O157:H7. This 
mPCR assay had a sensitivity of 10
4
 CFU/g in unenriched cattle fecal samples. Paddock 
et al. (2012) designed a mPCR assay to detect EHEC-7 serogroups and found a 
sensitivity of 4 x 10
5
 CFU/g in unenriched fecal samples. These two multiplex reactions 
were further developed and modified into an 11-plex PCR that detected EHEC-7 
serogroups, stx1, stx2, eae and ehxA (Bai et al., 2012). 
Real-time PCR developed from traditional PCR is a method to detect genes 
during amplification, but also allows for quantification of gene sequences. Real-time 
PCR assays have been developed for detection of O157 (rbfE), stx1 and stx2 to estimate 
the prevalence of O157 from different cattle matrices. By a DNA-based real-time PCR, 
17.5% of carcasses were potentially contaminated with STEC O157 (Breum and Boel, 
2010).  
 Gene targets other than stx and eae have been used solely or in combination with 
stx and eae to detect EHEC. The E. coli attaching and effacing gene-positive conserved 
fragment (ecf1) is found on pO157 of EHEC. It has shown promising results as a single 
target for EHEC detection in beef (Livezey et al., 2015). However, ecf1 is also found on 
EPEC strains lacking bfp; these may have been strains that were EHEC but lost the Stx 
phage. Using ecf1 could result in an overestimation of EHEC positive samples. Non-LEE 
effector genes in combination with eae have been used to further discriminate between 
EPEC and EHEC (Beutin and Fach, 2014). Clustered regularly interspaced short 
palindromic repeat (CRISPR) regions of STEC have been used for serogroup specific 
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detection of STEC (Delannoy et al., 2012). However, Delannoy et al. (2012) found some 
STEC of different serogroups with the same H-type exhibited cross-activity. Recent 
advances in whole genome sequencing have led to the use of sequencing for outbreak 
investigations (Dallman et al., 2015). This allows for better resolution and determines if 
strains from different products or in different locations have a common source. 
 
 Commercial assays 
 To ensure that food and other products sold to consumers are safe, commercial 
assays have been developed for the detection of STEC. The goals for these assays are to 
be rapid, easy to use, and cheap. They have primarily been developed for detection of 
STEC in food matrices (Wang et al., 2013).  Assays may be validated by an external 
laboratory for use in a particular matrix (Livezey et al., 2015).  
PCR based commercial assays for detection of STEC in foods have been 
developed. The BioControl Assurance Genetic Detection System MPX Top 7 STEC, 
Qualicon BAX System STEC Suite, and GeneDisc array were compared for detection of 
STEC in inoculated beef trim enrichments (Wheeler et al., 2015). The Pall GeneDisc 
array is a microarray based system that identifies 12 O-groups, seven H-types, and 15 
virulence genes. The NeoSEEK STEC Detection and Identification (NS) is a PCR/mass 
spectrometry based system and is similar to the GeneDisc array in that it identifies 
multiple targets. NS detects EHEC-7 based on the identification of over 80 targets. The 
primers or targets that are used for detection of STEC are typically not known for 
commercial assays, which make them difficult to evaluate.  
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Wasilenko et al. (2014) used the BAX system to test retail ground beef for 
EHEC-7 and confirmation was done by plating on modified Rainbow Agar O157. By 
BAX, 3.9% of samples were potentially positive. Culture could confirm only four of 14 
that were predicted to be positive by BAX (Wasilenko et al., 2014). This disparity leaves 
questions on the reliability of culture and molecular tests for EHEC. Attempted 
verification of commercial molecular screens can be done by follow-up culture isolation, 
but may yield a sample positive by only one method. In veal calf hide samples, 93.9% 
were positive by NS analysis and by culture 53.0% of samples isolated an EHEC (Wang 
et al., 2014b). 
  
Quantification of STEC 
 High concentrations of STEC in the feces and on hides pose a greater risk for 
carcass contamination during processing. Cattle shedding levels above 10
4
 CFU/g of 
STEC (“super-shedders”) account for the majority of contamination of hides and in turn 
pose the greatest risk to carcass contamination. It has been suggested that cattle shedding 
high levels of STEC should be separated or not sent to processing (Arthur et al., 2009). 
The concentration that STEC are shed could be due to the concentration of organisms 
ingested, virulence and adherence genes, growth rate of strain, or host factors (Chase-
Topping et al., 2008). Williams et al. (2015) proposed that animals shedding >10
4
 CFU/g 
be termed “super-shedding events” not “supper-shedding animals”, because based on 
their findings super-shedding was transiently detected as opposed to a subset of animals 
shedding high levels continually. 
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  Quantification of EHEC remains challenging due to the high numbers of 
background organisms present in fecal and hide samples. Direct plating of samples for 
quantification allows for the quantification of viable organisms. Ten-fold serial dilutions 
of fecal samples and spread plating on agar media was used to quantify EHEC O157 
(Omisakin et al., 2003). Omisakin et al. (2003) found that 44 of 579 cattle fecal samples 
were positive for EHEC O157, and of those, 17 of 44 were quantifiable. These results are 
consistent with others reporting that the majority of cattle shed EHEC O157 at <10
2
 
CFU/g (Lahti et al., 2003; Pearce et al., 2004). In addition to direct plating, spiral plating 
has been used to reduce the number of dilutions needed. The spiral plate method uses a 
known volume dispensed in an Archimedean spiral on an agar plate. Spiral plating has 
been used to quantify EHEC O157 (Robinson et al., 2004), but not for non-O157 EHEC. 
In this study, the limit of quantification for spiral plating was 500 CFU/g.  Spiral plate 
quantification for EHEC O157 in veal hide samples was plated on CHROMagar O157, 
but no hides samples were found quantifiable for EHEC O157 (Wang et al., 2014b). 
Although this study tested for non-O157 EHEC, they did not attempt to quantify by 
culture or a molecular assay. 
 Nalidixic acid-resistant EHEC O157 strains have been used to assess the 
sensitivity of quantification methods. Antimicrobial resistant strains are easily selected by 
inhibiting background organisms with the use of high levels of antimicrobials that only 
the target strain can tolerate. Using a nalidixic acid-resistant EHEC O157 strain, LeJeune 
et al. (2006) determined that direct plating methods could quantify concentrations >100 
CFU/g in cattle feces. 
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 The most-probable number (MPN) is a technique where samples are diluted and 
the most dilute sample that gives a positive result is used to determine the concentration. 
MPN has been used with multiplex PCR and IMS to determine concentration of EHEC 
O157 in inoculated cattle feces (Guy et al., 2014). This approach quantified samples 
inoculated with 10
2
 to 10
4
 CFU/g. MPN could theoretically allow for the quantification of 
as low as one CFU/g of feces. Although this technique allows for the quantification of 
low numbers of bacteria, it requires an enrichment time and many dilution tubes, which 
can be time consuming, labor intensive, and expensive. 
 Quantitative PCR (qPCR) is a rapid method that can quantify multiple genes in a 
single reaction. This method is high-throughput and methods have been developed to 
quantify specific serogroups and virulence gene from complex samples. Typically, DNA 
must be extracted from cattle samples (fecal, hide, carcass) due to potential PCR 
inhibitors present in the sample (Paddock et al., 2012; Noll et al., 2015). qPCR cannot 
rule out the possibility that multiple genes or the same gene came from multiple strains. 
To avoid this problem, Luedtke et al. (2014) developed a qPCR assay based on ecf1. This 
method quantifies total EHEC present in a sample and is not limited to an induvial 
serogroup. Luedtke and Bosilevac (2015) used this method to quantify EHEC from veal 
hides and carcasses. They found that the assay enumerated 32% of hide samples and 17% 
of carcass samples for EHEC, and found moderate agreement for enumeration between 
the qPCR assay and an MPN assay. However, no relation was observed between the 
qPCR assay and an MPN assay for enumeration of EHEC on carcass samples (Luedtke 
and Bosilevac, 2015). The low concentration of EHEC on carcass samples may not have 
allowed for a relationship to be observed between the qPCR and MPN assays. 
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 Digital PCR (dPCR) is a method used to quantify nucleic acids by separating a 
sample into partitions. Each partition is read by a flow cytometer to determine the 
number of positive partitions. This allows for the detection of targets that are infrequently 
found in a sample. It has an advantage to other PCR methods in that it does not require a 
standard curve and is relatively insensitive to PCR inhibitors. Using dPCR, Luedtke and 
Bosilevac (2015) found that EHEC could be quantified from 10
3
 to 10
7
 CFU/ml. EHEC 
concentration had a higher estimated concentration in hide and carcass samples 
previously tested by qPCR and MPN assays. 
 
Hypotheses derived from existing literature 
 Detection methods such as culture-based and PCR methods for STEC typically 
require an enrichment step. There is no defined enrichment media for all STEC, and it 
may be different depending on the matrix type. Enrichment media for STEC O157 have 
been supplemented with antibiotics to decrease background flora, or have been optimized 
for detection of multiple foodborne pathogens alongside STEC O157 (Suo and Wang, 
2014). Vimont et al. (2006) reviewed enrichment broths for STEC over a wide range of 
matrices and found that trypticase soy broth (TSB) and E. coli EC broth were the most 
common. Paddock et al. (2012) showed that after enrichment in EC broth, PCR detected 
more E. coli serogroups and virulence genes in cattle fecal samples compared to TSB. 
Vimont et al. (2007) found the use of EC broth reduced the false negative results for 
detection of non-O157 STEC in cattle fecal samples. EC broth contains bile salts and 
lactose compared to the absence of bile salts and glucose potentially making EC more 
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selective. Thus, we hypothesize that that EC broth would yield greater growth of STEC 
compared to TSB. 
 The prevalence of EHEC-7 in cattle is poorly understood. Although many studies 
have estimated the prevalence of EHEC O157 on cattle hides and carcasses (Elder et al., 
2000; Arthur et al., 2002; Barkocy-Gallagher et al., 2003; Nou et al., 2003; Rivera-
Betancourt et al., 2004; Woerner et al., 2006; Brichta-Harhay et al., 2008), few studies 
have estimated the prevalence of EHEC-7 (Monaghan et al., 2012; Thomas et al., 2012). 
Based on data from the CDC, seven serogroups of EHEC are the most predominant in 
clinical infections (Brooks et al., 2005), which led us to hypothesize that these seven 
EHEC would be found on the hides and to a lesser extent, carcasses of feedlot cattle at 
harvest. 
 Production type and environment may influence the prevalence of STEC 
(Sargeant et al., 2004; Smith, 2014a). The age of cattle may also influence the status of 
STEC carriage in cattle (Mir et al., 2015). Older animals may be immunosuppressed, 
which would make them more likely to carry STEC (Hancock et al., 1994), and dairy 
cattle tend to be older than feedlot cattle at harvest on a percentage basis. We 
hypothesized that dairy cattle will be heavy colonized with EHEC-7. 
 Isolation of non-O157 STEC remains challenging on current agar media. Possé et 
al. (2008b) developed a media for screening four serogroups of STEC. Novobiocin and 
potassium tellurite are selective components of this agar, but some strains do not grow at 
higher concentrations of these antibiotics (Hussein and Bollinger, 2008). We 
hypothesized that reduction of novobiocin and potassium tellurite in this agar medium 
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would allow for a greater number of STEC-7 positive fecal samples detected compared to 
the original formulation. 
 Baehler and Moxley (2000, 2002) showed that EHEC O157 produces A/E lesions 
on colonic mucosal explants from cattle. Girard et al. (2007) found that some, but not all 
EHEC strains adhere to bovine colonic explants. We hypothesized that STEC-6 with 
different intimin subtypes (eae-β1, eae-ε, eae-γ1, and eae-γ2) and STEC O104:H4 would 
adhere, and strains with intimin would produce A/E lesions on cattle and human colonic 
epithelial cells. 
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Abstract 
 Detection of Shiga toxin-producing Escherichia coli (STEC) in complex sample 
matrices remains challenging. In an attempt to improve detection, nonselective and 
selective enrichment broths were compared as follows: (1) trypticase soy broth (TSB) 
was compared with TSB plus novobiocin, vancomycin, rifampicin, bile salts, and 
potassium tellurite (TSB-NVRBT) for supporting growth of STEC in pure culture; (2) E. 
coli broth (EC), TSB, and TSB plus bile salts (mTSB) were compared for enrichment of 
STEC O26, O45, O103, O104, O111, O121, O145, and O157 (STEC-8) in inoculated 
cattle fecal samples; (3) EC, TSB, and mTSB were compared for the detection of STEC-8 
in inoculated cattle fecal samples. Fecal samples were inoculated with wild-type STEC-8 
or nalidixic acid- or rifampicin-resistant derivatives of the same strains at 100, 1000, or 
10,000 colony-forming units per gram (CFU/g) of feces. In pure culture, the mean STEC 
CFU/mL following enrichment in TSB was 1.17 log10 greater than that in TSB-NVRBT 
(P < 0.05). In inoculated fecal samples, EC enrichment yielded growth of STEC-8 (6.42 
log10 CFU/g) that was significantly greater than in TSB (6.23 log10 CFU/g; P < 0.05), and 
numerically but not significantly greater than in mTSB (6.37 log10 CFU/g; P = 0.60). 
Wild-type STEC strains were detected in 43.8 % (21/48) of the samples enriched in EC 
and mTSB compared to 27.1 % (13/48) of the samples enriched in TSB (P = 0.15). 
Overall, STEC grew significantly better when enriched in EC compared to TSB. 
Modification of TSB by the addition of bile salts improved the growth and detection of 
STEC compared to TSB alone. 
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Introduction 
 Shiga toxin-producing Escherichia coli (STEC) are the major cause of 
hemorrhagic colitis and hemolytic-uremic syndrome in human patients (Kaper et al., 
2004; Brooks et al., 2005; Bettelheim, 2007) and commonly colonize the large intestines 
of cattle, sheep, and other ruminants, which serve as reservoirs (Bettelheim, 
2007; Sánchez et al., 2009). These organisms are shed in ruminant feces, often in 
relatively low numbers, in conjunction with high numbers of commensal flora including 
nonpathogenic E. coli (Fegan et al., 2004; Bettelheim, 2007). The infectious dose of 
STEC O157:H7 in humans is very low, estimated to be <50 bacterial cells (Tilden et al., 
1996). Due to the frequent presence of STEC at low concentrations in different sample 
matrices and given their low infectious dose, enrichment is usually necessary for 
detection (Tilden et al., 1996; Fegan et al., 2004; Barkocy-Gallagher et al., 2005). 
 The majority of illnesses due to STEC in the U.S. are caused by serogroups O26, 
O45, O103, O111, O121, O145, and O157 (STEC-7; Brooks et al., 2005); further, most 
of these STEC-7 organisms are intimin (eae)-positive and hence classified as 
enterohemorrhagic E. coli (EHEC) (Kaper et al., 2004). Additionally, the O104:H4 
outbreak associated with fenugreek sprouts (Bucholz et al., 2011) has raised concern 
about STEC contaminating other food sources, and therefore, STEC-7 and STEC 
O104:H4 (collectively referred to herein as STEC-8) were addressed in this study. 
 Many culture-based and -independent methods for the detection of STEC in food 
and environmental samples include an enrichment step to enhance detection (Wang et al., 
2013). However, a medium that gives optimal enrichment, collectively, for all STEC-7 or 
-8 has yet to be determined. Trypticase soy broth (TSB) and E. coli broth (EC) have been 
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used most commonly for enrichment in support of detection of STEC O157:H7 and non-
O157 in studies spanning across all sample matrix types (Vimont et al., 2006). Strains 
enriched in TSB were more likely to yield false-negative results compared to strains 
enriched in EC (Vimont et al., 2007). Enrichment media have been modified by the 
addition of antibiotics and selective components depending on the matrix (Hussein and 
Bollinger, 2008). The addition of novobiocin (Vimont et al., 2007; Hussein et al., 2008) 
or a combination of vancomycin, cefsulodin, and cefixime (Baylis, 2008) has been 
reported to inhibit growth of some STEC. The inclusion of bile salts as a selective 
measure in media has previously been shown to delay the Jameson effect and was 
therefore interpreted to potentially promote STEC growth (Vimont et al., 2007). 
Enrichment time is another important consideration that increases STEC to a detectable 
level. An enrichment time of 24 h did not enhance the recovery of STEC compared to 6 h 
(Verstraete et al., 2010). 
 The objectives of this study were to (i) compare the growth of STEC-7 in pure 
culture using TSB and TSB plus novobiocin (8.0 mg/L), vancomycin (16.0 mg/L), 
rifampicin (2.0 mg/L), bile salts No. 3 (1.5 g/L), and potassium (K) tellurite (1.0 mg/L; 
TSB-NVRBT); (ii) evaluate the growth of STEC-8 in cattle fecal samples enriched in EC, 
TSB, and TSB with 1.5 g/L of bile salts No. 3 (modified TSB; mTSB) using spontaneous 
antibiotic-resistant mutant derivative strains; and (iii) compare EC, TSB, and mTSB for 
the detection of STEC-8 in inoculated cattle fecal samples using wild-type (WT) strains. 
 
Materials and Methods 
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 Bacterial strains, preparation of inoculum, and inoculation of fecal 
samples. All strains used in this study were STEC. Strains used for Experiment 1 were 
obtained from Dr. Shannon Manning (Michigan State University STEC Center) and Dr. 
David G. Renter (Kansas State University), or from our laboratory collection (Table 1). 
Spontaneous nalidixic acid-resistant mutant (Nal
R
), spontaneous rifampicin-resistant 
(Rif
R
) mutant, and WT parent strains used for Experiments 2 and 3 were obtained from 
Dr. John B. Luchansky (USDA, Agricultural Research Service, Eastern Regional 
Research Center) or were from our laboratory collection (Table 2). 
 Frozen (−80 °C) stock cultures of strains were streaked onto Luria–Bertani broth, 
Miller (LB; BD, Sparks, MD) agar plates without antibiotics or with 40 mg/L nalidixic 
acid (Fisher) or 100 mg/L rifampicin (Sigma-Aldrich) when appropriate and incubated at 
37 °C for 24 h. A single colony was inoculated in LB with corresponding antibiotics for 
24 h at 37 °C in a stationary culture. 
 Fresh feces were collected from beef cattle housed one per pen at the University 
of Nebraska–Lincoln. One gram (g) of cattle feces was suspended in 9 mL of EC (Oxoid 
Ltd., Hampshire, UK), TSB (BD, Sparks, MD) or mTSB and vortexed for 2 min. Serial 
tenfold dilutions of the inoculum were prepared in buffered peptone water (BPW) and 
used to inoculate fecal samples at a concentration of 100, 1000, or 10,000 colony-forming 
units per gram (CFU/g) of feces, with BPW used as a mock inoculation. Following 20 s 
of vortexing, samples were enriched for 6 h at 40 °C in a stationary culture, as described 
by Paddock et al. (2012). 
 Experiment 1: Comparison of TSB and TSB-NVRBT.  Frozen stock 
cultures were streaked onto TSB agar and used to inoculate 5 mL of TSB. Stationary 
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cultures were incubated 24 h at 37 °C. The medium, TSB-NVRBT, was prepared 
according to Possé et al. (2008a). Duplicate stationary cultures of each strain were 
prepared in TSB and TSB-NVRBT. Following incubation for 18 h at 42 °C, serial tenfold 
dilutions in BPW were made from each culture and plated on TSB agar. Plates containing 
TSB agar were incubated for 18 h at 37 °C, and aerobic plate counts (APC) were 
performed according to the FDA Bacteriological Analytical Manual (BAM) (Maturin and 
Peeler, 2001).  
 Experiment 2: Evaluating growth of STEC-8 using Nal
R
and Rif
R
 strains. 
Cattle fecal samples were inoculated with Nal
R
 or Rif
R
 STEC-8 strains at concentrations 
of 100, 1000, or 10,000 CFU/g to evaluate the effect of different enrichment broths on 
STEC growth in two independent experiments. After enrichment, samples were serially 
diluted and spread plated onto Possé differential agar (Possé et al., 2008b) modified by 
supplementation with nalidixic acid (40 mg/L) or rifampicin (100 mg/L) with reduced 
bile salts No. 3 (1.5 g/L) and containing no novobiocin or K tellurite (mPossé1); these 
plates were incubated 18 h at 37 °C. Plates were counted by standard methods (Maturin 
and Peeler, 2001), growth was determined as CFU/g, and these values were 
log10 transformed prior to statistical analysis. Colonies were confirmed to be the 
respective inoculum strain by PCR (Paddock et al., 2012). 
 Experiment 3: Detection of STEC-8 using WT strains. Cattle fecal samples 
inoculated with WT STEC at 100, 1000, and 10,000 CFU/g were subjected to 
immunomagnetic separation (IMS) for the corresponding O-antigen using a KingFisher™ 
Flex Magnetic Particle Processor (Thermo Scientific, Waltham, MA). Anti-O157 
Dynabeads
®
 (Invitrogen, Carlsbad, CA), and IMS beads for E. coli O26, O45, O103, 
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O104, O111, O121, and O145 (Abraxis LLC, Warminster, PA) were used for IMS. After 
IMS, samples were diluted and spread plated onto CHROMagar™ STEC (DRG 
International, Mountainside, NJ), Possé differential agar (Possé et al., 2008b), and Possé 
differential agar modified by having reduced concentrations of novobiocin (5 mg/L) and 
K tellurite (0.5 mg/L; mPossé2). Colonies were tested by PCR (Paddock et al., 2012) and 
recorded as detection or no detection. Two independent experiments were conducted for 
all STEC-8 WT strains. 
 Detection by PCR. Five colonies were picked from countable plates according 
to the methods described in the FDA BAM (Maturin and Peeler, 2001), put into 50 μL of 
ultrapure water, and heated at 95 °C for 10 min for use as DNA template. From these, a 
single colony was selected at random and tested by multiplex PCR for inoculum-specific 
O-type and Shiga toxin (stx) type as described by Paddock et al. (2012) to confirm that 
colonies on agar plates were that of the respective inoculum strain. 
 Statistical analysis. A paired t test was used to compare the growth of STEC in 
TSB to that in TSB-NVRBT (SAS 9.2, PROC GLIMMIX). The restricted maximum 
likelihood method was used to compare the growth of antibiotic-resistant STEC in 
inoculated fecal samples, and a χ 2analysis was used to compare the detection of WT 
STEC in inoculated fecal samples (SAS 9.2, PROC MIXED, PROC GLIMMIX). 
 
Results and Discussion 
 Antimicrobials have the potential to inhibit background organisms and allow 
STEC to grow to high numbers; however, it has been reported that some antimicrobials, 
e.g., novobiocin and K tellurite, can restrict the growth of some STEC (Vimont et al., 
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2006; Vimont et al., 2007; Baylis, 2008; Kanki et al., 2011). In order to assess whether 
antimicrobials in an enrichment medium designed for STEC (Possé et al., 2008a) were 
actually selective against STEC growth, TSB was compared to TSB-NVRBT on a 
relatively large number of STEC-7 strains. There was a mean CFU/mL log10 reduction of 
1.17 for strains grown in TSB-NVRBT compared to TSB and, in both media, strains 
within and among serogroups varied in their growth (Table 1). Overall, strains grown in 
TSB had significantly greater growth than strains grown in TSB-NVRBT (P < 0.05); this 
was true for all non-O157 STEC and STEC O157:H7, and growth of STEC O26, O103, 
and O121 strains was particularly reduced. The ranking of STEC serogroups in 
descending order of tolerance of the enrichment conditions were O45, O111, O145, 
O157, O121, O103, and O26. Two strains (one O26 and one O157:H7) exhibited poor 
growth in TSB with a minimal further reduction in growth in TSB-NVRBT. Since 
supplementation of TSB with NVRBT resulted in a significant reduction in growth of 
STEC, we did not test it further and chose instead to focus on TSB and EC for further 
experiments in bovine fecal samples. EC and TSB without additional antimicrobials (e.g., 
novobiocin) had been shown in previous studies to be less inhibitory to growth, and EC 
reportedly most suitable for supporting detection of non-O157 STEC in bovine feces, but 
these results were based on very few strains or strains of unidentified serogroups, and did 
not test the effects of bile salts per se (Vimont et al., 2007; Paddock et al., 2012). Since 
EC and TSB vary, respectively, by the presence of lactose versus glucose, and bile salts 
versus none, we sought to determine whether the addition of bile salts to TSB might 
make it comparable to EC in performance. 
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 Strains that were Nal
R
 or Rif
R
 were used to accurately assess growth in a complex 
matrix since these antibiotics effectively eliminated the background microflora in fecal 
samples. All strains had detectable growth in all enrichment media. The APCs resulting 
from enrichment of fecal samples inoculated at different CFU/g concentrations were 
significantly different (P < 0.05); samples inoculated with 10,000 CFU had the highest 
APC, 1000 CFU the next highest, and 100 CFU the lowest. This indicated that the 
cultures had not become saturated by 6 h of enrichment. A longer enrichment time may 
increase the concentration of STEC in low abundance. Conversely, when the background 
microflora reaches its maximum level, STEC growth will stop (Vimont et al., 2007), and 
an extended time may not increase STEC in low abundance. 
 Strains in inoculated samples grew to 6.42 log10 CFU/g in EC, 6.23 log10 CFU/g 
in TSB, and 6.37 log10 CFU/g in mTSB. Although growth of STEC-8 in EC appeared 
only slightly higher compared to that in TSB, a significant difference was observed 
(P < 0.05), and means were numerically but not significantly greater in mTSB compared 
to TSB (Table 3). All strains isolated from the feces were confirmed to be that of the 
inoculum by PCR, and no STEC were isolated in non-inoculated samples. Higher growth 
of the STEC inoculum strains in EC suggests that lactose provided a selective advantage 
for these organisms, as expected, in contrast to glucose. Also, as expected, the bile salts 
in EC and mTSB suppressed growth of background microflora and allowed the STEC to 
grow to a higher level. 
 Cattle fecal samples were inoculated with WT STEC strains to compare the 
detected number of STEC positive samples enriched in EC, TSB, and mTSB. Strains 
inoculated at 10,000 CFU were detected more frequently than strains at 1000 and 
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100 CFU (P < 0.05). One STEC-8 WT strain was detected in 21 of 48 samples enriched 
in EC and mTSB and in 13 of 48 samples enriched in TSB (Table 4). Although STEC-8 
WT strains were detected more frequently in samples enriched in EC and mTSB 
compared to TSB, a significant difference for broth type was not observed (P = 0.15). 
Increased growth of STEC in EC and mTSB may have led to more frequent detection 
compared to TSB. In a study comparing four enrichment broths for detection of non-
O157 STEC in inoculated radish sprouts and beef, modified EC with novobiocin 
demonstrated a lower recovery rate compared to modified TSB with bile salts with or 
without novobiocin and universal pre-enrichment broth (Kanki et al., 2011). These 
findings suggest that modification of EC by adding novobiocin may be inhibitory to 
STEC detection in food compared to other enrichment broths.  
 There have been extensive improvements for enrichment of STEC O157:H7 in 
cattle feces (Sanderson et al., 1995; Fegan et al., 2004; Barkocy-Gallagher et al., 2005), 
but methods to improve enrichment of non-O157 STEC have yielded inconsistent results 
(Fukushima and Gomyoda, 1999; Vimont et al., 2006; Vimont et al., 2007; Hussein et 
al., 2008; Possé et al., 2008a, Verstraete et al., 2010; Kanki et al., 2011; Paddock et al., 
2012; Wang et al., 2013). Our work suggests that lactose and bile salts in EC provide a 
more suitable environment compared to the presence of glucose and absence of bile salts 
as found in TSB for the enrichment of STEC-8. 
 
Conclusion 
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 The addition of several selective antimicrobials to TSB was found to inhibit 
growth of STEC in pure culture compared to TSB. EC broth yielded significantly greater 
STEC growth compared to TSB but not TSB plus bile salts in cattle fecal samples. 
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Table 1.  Comparison of growth for Shiga toxin-producing Escherichia coli strains under 
pure culture conditions. 
Strain Serotype Source stx1 stx2 eae Mean log10 CFU/ml 
TSB
 
TSB-NVRBT
 
DEC10B O26:H11 Human + - + 8.64 7.46 
97-3250 O26:H11 Human + + + 8.62 7.79 
MT#10 O26:NT Human + - + 7.30 7.11 
TB352A O26:NM Human + - + 8.63 7.30 
DA-10 O26:NM Human + - + 9.28 7.41 
16272 O26:NT Cattle + - + 10.30 7.34 
1577-88 O26:H11 Cattle + - + 8.85 7.68 
M103-19 O45:H2 Human + - + 8.79 7.90 
MI01-88 O45:H2 Human + - + 9.04 7.87 
MI05-14 O45:H2 Human + - + 9.00 8.30 
DA-21 O45:H2 Human + - + 9.00 8.20 
B8026-C1 O45:H2 Cattle + - + 9.15 8.18 
B8227-C8 O45:H2 Cattle + - + 9.04 8.30 
MT#80 O103:H2 Human + - + 9.20 7.72 
TB154A O103:H2 Human + - + 8.82 7.54 
8419 O103:H25 Human + - + 9.08 7.62 
PT91-24 O103:NM Human + - + 8.92 7.60 
6:38 O103:NM Human + - + 8.83 7.67 
3720 O103:H2 Water + - + 8.90 7.62 
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15612 O103:H11 Cattle + - + 8.85 7.11 
6708-87 O103:H2 Goat + - + 9.11 7.91 
RD8 O111:H10 Human - + - 9.15 7.63 
3215-99 O111:H8 Human + + + 9.15 8.37 
0201 9611 O111:H8 Human + - + 8.93 7.81 
3007-85 O111:H8 Human + + + 9.18 8.04 
95-3208 O111:NM Human + + + 8.92 8.08 
7726 O111:NT Cattle + + + 9.36 8.18 
8266 O111:NT Cattle + + + 9.34 8.26 
10049 O111:H11 Cattle + - + 8.97 7.68 
MT#2 O121:H19 Human - + + 8.81 6.98 
MT#18 O121:NT Human - + + 8.95 7.85 
DA-5 O121:H19 Human - + + 8.91 7.85 
DA-37 O121:H19 Human - + + 8.59 7.63 
3377-85 O121:H19 Human - + + 8.85 8.02 
1553 O121:H7 Cattle + - - 8.97 7.02 
4190 O121:NT Cattle + - - 9.15 7.96 
DEC10I O145:H16 Human + - + 8.92 7.38 
4865/96 O145:H28 Human - + + 8.93 7.76 
GS G5578620 O145:H28 Human + - + 9.08 7.83 
IH 16 O145:NM Human - + + 8.81 7.82 
75-83 O145:NM Human - + + 9.11 7.98 
1234 O145:H28 Cattle + + + 9.11 8.15 
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7744 O145:NT Cattle + - + 9.08 8.08 
933 O157:H7 Beef + + + 8.60 7.68 
86-24 O157:H7 Human - + + 8.97 7.89 
S2006 #1 O157:H7 Cattle + + + 8.93 7.72 
S2006 #2 O157:H7 Cattle + + + 8.95 7.77 
S2006 #3 O157:H7 Cattle + + + 8.93 7.72 
S2006 #4 O157:H7 Cattle + + + 8.00 7.82 
S2006 #5 O157:H7 Cattle + + + 9.34 7.87 
S2006 #6 O157:H7 Cattle + + + 9.00 7.99 
Strains were incubated in enrichment broth as stationary cultures for 18 h at 42°C. 
NT not typed, TSB trypticase soy broth, TSB-NVRBT trypticase soy broth plus 
novobiocin, vancomycin, rifampicin, bile salts, and K tellurite. 
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Table 2. Shiga toxin-producing Escherichia coli strains used for inoculation  
of cattle fecal samples. 
Strain Serotype
 
Source stx1 stx2 eae Resistance
 
DA-10 O26:NM Human + - + N
 
H30 O26:H11 Human + - + WT, R 
B8227-C8 O45:H2 Cattle + - + N 
CDC 96-3285 O45:H2 Human + - + WT, R 
TB154A O103:H2 Human + - + N 
CDC 90-3128 O103:H2 Human + - + WT, R 
TY-2482 O104:H4 Human - + - WT, R 
0201 9611 O111:H8 Human + - + N 
JB1-95 O111:NM Human + + + WT, R 
KDHE 55 O121:NT Human - + + N 
CDC 97-3068 O121:H19 Human - + + WT, R 
IH 16 O145:NM Human - + + N 
83-75 O145:NM Human - + + WT, R 
933 O157:H7 Beef + + + WT, N 
USDA FSIS 380-94 O157:H7 Salami + + + R 
NT not typed, WT wild-type, N nalidixic acid-resistant, R rifampicin-resistant. 
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Table 3. Growth of antibiotic-resistant Shiga toxin-producing 
 Escherichia coli in inoculated cattle fecal samples. 
Enrichment broth
 
Mean log10 CFU/g 
EC 6.42 
TSB 6.23 
mTSB 6.37 
Means with different letters are significantly different (P < 0.05). 
EC E. coli broth, TSB trypticase soy broth, mTSB trypticase soy broth 
plus bile salts. 
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Table 4. Number of samples (%) detected positive for Shiga toxin-producing  
Escherichia coli in 48 inoculated cattle fecal samples 
Enrichment broth
 
Agar media Total 
CHROMagar™ STEC Possé mPossé2 
EC 8 (16.7) 15 (31.3) 16 (33.3) 21 (43.8) 
TSB 5 (10.4) 8 (16.7) 8 (16.7) 13 (27.1) 
mTSB 9 (18.8) 13 (27.1) 15 (31.3) 21 (43.8) 
EC E. coli broth, TSB trypticase soy broth, mTSB trypticase soy broth plus bile salts. 
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Abstract 
 Cattle hides are a main source of enterohemorrhagic Escherichia coli (EHEC) 
contamination of beef carcasses. The objectives of this study were to (1) determine the 
prevalence of “top 6” non-O157 plus O157:H7 EHEC (EHEC-7) on feedlot cattle hides 
and their matched preintervention carcasses; (2) assess the agreement among detection 
methods for these matrices; and (3) conduct a molecular risk assessment of EHEC-7 
isolates. Samples from 576 feedlot cattle were obtained at a commercial harvest facility 
and tested for EHEC-7 by a culture-based method and the polymerase chain 
reaction/mass spectrometry–based NeoSEEK™ STEC Detection and Identification test 
(NS). Prevalence data were analyzed with generalized linear mixed models. The 
cumulative prevalence of EHEC-7 in hide samples as detected by NS was 80.7%, with a 
distribution of 49.9%, O145; 37.1%, O45; 12.5%, O103; 11.0%, O157; 2.2%, O111; 
2.0%, O121; and 0.2%, O26. In contrast, the cumulative prevalence of EHEC-7 in hide 
samples by culture was 1.2%, with a distribution of 0.6%, O157; 0.4%, O26; 0.2%, 
O145; and 0%, O45, O103, O111, and O121. The cumulative prevalence of EHEC-7 on 
matched preintervention carcasses as detected by NS was 6.0%, with a distribution of 
2.8%, O157; 1.6%, O145; 1.2%, O103; 1.1%, O45; 0.2%, O26; and 0.0%, O111 and 
O121. Although the culture-based method detected fewer positive hide samples than NS, 
it detected EHEC in five hide samples that tested negative for the respective organism by 
NS. McNemar's chi-square tests indicated significant (p<0.05) disagreement between 
methods. All EHEC-7 isolates recovered from hides were seropathotype A or B, with 
compatible virulence gene content. This study indicates that “top 6” and O157:H7 EHEC 
are present on hides, and to a lesser extent, preintervention carcasses of feedlot cattle at 
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harvest. However, continued improvement in non-O157 detection methods is needed for 
accurate estimation of prevalence, given the discordant results across protocols. 
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Introduction 
 Shiga toxin (Stx)-producing Escherichia coli (STEC) are major pathogens of 
humans and most commonly acquired through the consumption of contaminated food or 
water (Cole et al., 2014; Luna-Gierke et al., 2014). E. coli O157:H7 is the prototype of 
STEC further classified as enterohemorrhagic E. coli (EHEC), which by definition 
contain genes for Stx (stx) and products encoded on the locus of enterocyte effacement 
pathogenicity island, most notably intimin (eae) (Kaper et al., 2004). All STEC not of the 
O157 O-antigen type are commonly called non-O157 (Bettelheim, 2007). From 1983 to 
2002, 6 serogroups (viz., O26, O45, O103, O111, O121, and O145) accounted for 71% of 
the reported non-O157 STEC cases in the United States (Brooks et al., 2005); STEC 
belonging to these serogroups have become known as the “top 6” (Hegde et al., 2012; 
Conrad et al., 2014). A total of 84% of the “top 6” isolates in the cases reported by 
Brooks et al. (2005) were EHEC. 
 Collectively, the “top 6” non-O157 plus O157:H7 (hereafter referred to as EHEC-
7) were responsible for 92.3% of the human cases of STEC infection in the United States 
from 2000 to 2010 (Gould et al., 2013). E. coli O157:H7 was declared an adulterant in 
raw ground beef in 1994 and in raw, nonintact beef in 1999 by the United States 
Department of Agriculture (USDA), Food Safety and Inspection Service (FSIS). The “top 
6” non-O157 STEC were declared adulterants in raw, nonintact beef by the USDA-FSIS 
in 2011. Based on the requirement for stx and eae detection in a “top 6” isolate for 
qualification as an adulterant (USDA, 2014b), these organisms are also by definition 
EHEC. 
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 STEC mainly contaminate beef through transfer from fecally contaminated hides 
to carcass surfaces during slaughter (Elder et al., 2000; Arthur et al., 2002; Keen and 
Elder, 2002; Barkocy-Gallagher et al., 2003; Arthur et al., 2004; Koohmaraie et 
al., 2005; Schmidt et al., 2012). The prevalence of O157 and non-O157 STEC on de-
hided carcass surfaces has been reported, but little information is available on the “top 6.” 
The objectives of this study were to (1) determine the prevalence of EHEC-7 on matched 
hides and de-hided preintervention carcass surface samples obtained from commercial 
feedlot cattle at harvest; (2) compare the performance capability and agreement of a 
culture-based method with that of a polymerase chain reaction (PCR)/mass spectrometry–
based method for detection of EHEC-7 in enriched hide and carcass sponge samples, and 
a PCR/mass spectrometry–based method to a commercial immunomagnetic/PCR–based 
method for enriched carcass sponge samples; and (3) conduct a molecular risk assessment 
(MRA) of EHEC-7 isolates obtained from hides. 
 
Materials and Methods 
 Study design and sample collection. Cattle from a commercial beef feedlot in 
the central United States were followed through harvest using a repeated cross-sectional 
study design. Matched samples from the hides and carcass surfaces of 576 cattle (24 
pens, 24 cattle/pen, 2 pens/wk for 12 wks, from June to August 2013) were obtained at a 
processing plant using a modified protocol for E. coliO157:H7 sampling (USDA FSIS, 
2005). While in lairage, cattle were sprayed with a commercial bacteriophage solution 
(Finalyse
®
; Elanco Animal Health, Greenfield, IN) that is lytic for O157:H7 
(Sillankorva et al., 2012). Stunned animals were sprayed with a high-pressure ambient 
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water rinse, shackled, and placed onto the overhead rail for exsanguination. Afterward, 
the hides were sampled immediately before the carcasses entered the first hide-on wash 
cabinet. 
 Hide samples were collected using 11.5×23.0-cm sponges (Speci-Sponge
®
; 
Nasco, Fort Atkinson, WI) premoistened with 35 mL of buffered peptone water (BPW). 
Sponges were used to sample an area of 1000 cm2, 15 cm from the midline at the level of 
the diaphragm. 
 From each de-hided carcass, two surface samples were collected before the first 
carcass cabinet wash occurred. The first covered a 1000-cm
2
 area in the brisket–short 
plate region using a Speci-Sponge
®
 with 15 mL of BPW, following the procedure used 
for hides. The second was from a 3000-cm
2
 area in the lateral hock and round-rump 
regions. These 2 sponges and their buffer volumes (representing a combined 
4000 cm2 area per carcass) were combined into a single Whirl-Pak® bag. Samples were 
shipped overnight on ice to the laboratories. 
 Culture of hide and carcass samples. Hide and carcass sponge samples were 
processed and analyzed within 24 h after collection. Ninety milliliters of E. coli broth 
(EC; Oxoid Ltd., Hampshire, UK) was added to each hide sponge sample, and these were 
incubated at 40°C for 6 h. After incubation, separate broth aliquots were subjected to 
immunomagnetic separation (IMS) using a KingFisher
™
Flex Magnetic Particle Processor 
(Thermo Scientific, Waltham, MA) with anti-O157 Dynabeads
®
 (Invitrogen, Carlsbad, 
CA), and IMS beads for E. coli O26, O45, O103, O111, O121, and O145 (Abraxis LLC, 
Warminster, PA). Washed IMS beads were spread onto Possé differential agar (Possé et 
al., 2008b) modified (mPossé) by reducing the concentration of novobiocin and 
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potassium tellurite to 5.0 and 0.5 mg/L, respectively. mPossé plates were each spread-
inoculated with 1 IMS treatment and incubated for 18 h at 37°C. Six or fewer colonies 
per mPossé plate were picked; on plates inoculated with O26, O45, O103, O111, or O157 
IMS-treated cultures, red- or blue-purple colonies were picked and for O121 or O145 
IMS-treated cultures, red- or blue-purple, and green colonies were picked. Colonies were 
streaked for isolation on 5% sheep blood agar (Remel, Lenexa, KS), and incubated for 
15 h at 37°C. Isolated colonies were picked, suspended in 50 μL of ultrapure water, and 
boiled for 10 min for use as DNA template in PCR assays. 
 Eighty milliliters of EC broth was added to each carcass sponge sample, and 
incubated at 42°C for 8 h. Following incubation, a 1-mL aliquot of each enrichment broth 
sample was tested using the Biocontrol Assurance GDS
™
 MPX Top 7 STEC system 
(GDS) (Biocontrol Systems, Inc., Bellevue, WA) following the manufacturer's protocol. 
The GDS system consists of a proprietary IMS that targets the EHEC-7 serogroups (i.e., 
the seven O-group antigens) followed by PCR for detection of eae, stx1, and stx2, with 
EHEC-6 and EHEC O157 presumptive positive or negative results generated. An 
additional 1-mL aliquot of each enrichment broth sample was placed into 1.5-mL 
centrifuge tubes and stored at −80°C for later shipment to GeneSeek® Inc. (Lincoln, NE) 
for NeoSEEK™ analysis. Enrichment broths that tested negative by GDS were not 
cultured further. Those that tested presumptive positive by GDS were subjected to IMS 
and plated on mPossé agar as described above for the hide samples, with the exception 
that IMS was done manually. From each mPossé plate, ≤6 isolated red- or blue-purple, 
and green colonies were picked and subcultured onto trypticase soy agar (TSA) to ensure 
isolation. TSA-isolated colonies representing those from each mPossé plate were picked, 
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pooled, and tested by GDS. Any pools testing positive for EHEC-6 or EHEC O157 by 
GDS were to be tested by 11-plex PCR as described below for the hide samples. 
 Detection and characterization of EHEC isolates from hide samples. From 
each hide sample culture, ≤6 colonies from mPossé plates were pooled and tested by 
multiplex PCR for EHEC-7 serogroups. Isolates in positive pools were tested individually 
by 11-plex PCR for genes representing each of the EHEC-7 serogroups (wzx, 
wbq, or rfbE), plus stx1, stx2, eae, and EHEC-hemolysin (ehxA) using methods previously 
described (Bai et al., 2010; Paddock et al., 2012). H-antigen typing (fliC) was conducted 
using the methods of Wang et al. (2003). Serogroups for EHEC-7-positive isolates were 
confirmed by latex agglutination tests (Abraxis LLC, Warminster, PA). Isolates were 
further characterized by MRA PCR for nleA, nleB, nleB2, nleC, nleD, nleE, nleF, nleG, 
nleG2-1, nleG2-3, nleG5-2, nleG6-2, nleG9, nleH1-1, nleH1-2, and ent genes, using 
primers and conditions as previously described (Coombes et al., 2008). In addition, 
isolates were tested for eae subtypes and putative virulence factor genes, viz., Z4321 
(Salmonella enterica serovar Typhimurium [pagC]), Z4326 (Shigella flexneri enterotoxin 
2 [sen]), and Z4332 and Z4333 (EHEC factor for adherence [efa1]) as previously 
described (Karmali et al., 2003; Blanco et al., 2004). In the respective PCR assays, water 
was used as a negative control. E. coli strain 933 (O157:H7) was used as a positive 
control for nle, pagC, sen, efa1, and fliC. For the 11-plex PCR, the following strains were 
used for the respective O group: DEC10B (O26:H11); B8227-C8 (O45:H2); 15612 
(O103:H11); 7726 (O111:NT); 4190 (O121:NT); 1234 (O145:H28); and 86-24 
(O157:H7). 
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 Detection of EHEC by the NeoSEEK
™
 STEC Detection and Identification 
(NS) test. Enriched hide and carcass sponge sample aliquots stored at −80°C were 
shipped overnight or directly delivered for EHEC-7 testing by the NS (Neogen
®
 Corp., 
Lansing, MI) test, a PCR/mass spectrometry–based analytical method at GeneSeek® Inc. 
NS results were reported by the company as confirmed positive or negative. Based on NS 
data, a positive result for EHEC was inferred by the concurrent detection of stx, targeted 
O-group single nucleotide polymorphism, specific eae subtypes, and several other 
virulence markers using a total of 70 independent markers. Identifying combinations 
of eae subtypes and EHEC-7 O group markers were as follows: eae-β with O26; eae-ɛ 
with O45, O103, or O121; eae-γ2 with O111; and eae-γ1 with O145 or O157. 
 Statistical analysis. Adjusted sample-level prevalence estimates for each EHEC 
serogroup, using the definitions for a positive test result described above, were obtained 
from model intercepts for each detection protocol (i.e., culture and NS for hide, and GDS 
and NS for carcass samples). Generalized linear mixed models were fitted using 
restricted pseudo-likelihood estimation, Newton-Raphson and Ridging optimization, 
binary distribution, logit link, and Kenward-Rogers degrees of freedom (PROC 
GLIMMIX, SAS 9.3, SAS Institute Inc., Cary, NC). Random effects of pens nested 
within sampling week were used to adjust prevalence estimates for the lack of 
independence resulting from collecting multiple samples from each study pen across 
multiple sampling weeks. 
 The overall agreement on detection of EHEC groups between the culture-based 
method and NS on hide samples, and between GDS and NS on carcasses, beyond that 
due to chance, was determined by computing the Cohen's κ coefficient and the 
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McNemar's chi-square test (Dohoo et al., 2009). The degree of agreement was interpreted 
based on the scale proposed by Landis and Koch (1977). In addition, a test of 
proportions, based on Z tests, was used to compare the proportion of EHEC-7 positives 
obtained from hide and carcass surface samples based on NS. 
 
Results 
 Detection of EHEC in hide sponge samples by culture-based and multiplex 
PCR assays. Of the 576 hide sponge samples cultured, 476 were tested by multiplex 
PCR, whereas 100 were not tested due to inadequate DNA concentration. At least 1 
targeted O-group positive organism (which included both STEC and non-STEC) was 
isolated from 248 of the 476 hide samples (52.1%) as tested by 11-plex PCR on 
individual colonies. In descending order, the proportion of hide samples testing positive 
for the 7 targeted O-group genes (which included both STEC and non-STEC) by PCR 
following enrichment broth culture was 138/476 (29.0%), O103; 124/476 (26.1%), O157; 
52/476 (10.9%), O26; 18/476 (3.8%), O45; 8/476 (1.7%), O111; and 3/476 (0.6%) each, 
O121 and O145. The proportion of hide samples in which the targeted virulence genes 
were identified by PCR in these cultures was 25/476 (5.3%), stx; 19/476 (4.0%), eae; and 
51/476 (10.7%), ehxA (Table 1). Eight EHEC-7 isolates were recovered by the culture-
based protocol from 6/476 (1.3%) of the samples. These isolates included 2 O26:[H11], 1 
O145:[H28], and 5 O157:H7 (Table 2). No EHEC-6 or EHEC O157 isolates were 
obtained from the carcass samples by the culture-based method. 
 Characterization of EHEC-7 hide isolates. The results of molecularly 
serotyping and testing for virulence genes and eae subtype in EHEC-7 isolates from hides 
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are shown in Table 2. All EHEC O157:H7 isolates were positive for 15 or 16 nle genes in 
the MRA, whereas EHEC non-O157 isolates were positive for 7–15 of these genes. 
 Detection of EHEC on hides and carcasses by NS. The proportion of hide 
sponge samples testing positive for EHEC-7 by NS was 451/576 (78.3%, Table 3). In 
descending order, the proportions of these samples testing positive for the different 
EHEC were 282/576 (49.0%), O145; 227/576 (39.4%), O45; 107/576 (18.6%), O103; 
83/576 (14.4%), O157; 14/576 (2.4%), O121; 13/576 (2.3%), O111; and 3/576 (0.5%), 
O26. Although the NS test detected a higher proportion of positive samples than the 
culture-based method, five hide samples from which EHEC isolates were obtained by 
culture tested negative for the respective serogroup by NS. NS detected EHEC O145 
from the remaining hide sample from which an EHEC O145 organism was isolated 
(Table 2). By interpreting in-parallel the combined results of NS and the culture-based 
method, 78.5% of the hide samples (452/576) were positive for EHEC-7. 
 The proportion of preintervention de-hided carcass sponge samples testing 
positive by NS for EHEC-7 was 36/576 (6.3%, Table 4). In descending order, the 
proportions of these samples testing positive for the different EHEC serogroups was 
16/576 (2.8%), O157; 11/576 (1.9%), O145; 10/576 (1.7%), O103; 8/576 (1.4%), O45; 
2/576 (0.3%), O26; 0/576 (0.0%) each, for O111 and O121. Based on GDS, 165/576 
(28.6%) and 86/576 (14.9%) of the carcass samples were presumptive positive for the 
“top 6” EHEC and EHEC O157, respectively. Based on NS, the proportion of EHEC-7 
positives in hide sponge samples was significantly higher (p<0.05) than in carcass surface 
samples. 
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 Model-adjusted cumulative prevalence estimates of EHEC on hides and 
carcasses. The model-adjusted cumulative prevalence estimates of EHEC-7 in hide 
sponge samples based on the culture-based method and NS are shown in Table 3. The 
model-adjusted cumulative prevalence estimate of EHEC-7 in hide sponge samples as 
detected by NS was 80.7%, with a distribution of 49.9%, O145; 37.1%, O45; 12.5%, 
O103; 11.0%, O157; 2.2%, O111; 2.0%, O121; and 0.2%, O26. In contrast, the model-
adjusted cumulative prevalence estimate of EHEC-7 in hide samples based on culture 
was 1.2%, with a distribution of 0.6%, O157; 0.4%, O26; 0.2%, O145; and 0% for the 
remaining serogroups.  
 The model-adjusted cumulative prevalence estimate of EHEC-6 and EHEC O157 
in carcass sponge samples based on GDS was 24.8% and 13.1%, respectively (Table 4). 
In contrast, the model-adjusted cumulative prevalence estimates of EHEC-6 and EHEC-7 
in carcass sponge samples as detected by NS were 4.0% and 6.0%, respectively, with a 
distribution of 2.8%, O157; 1.6%, O145; 1.2%, O103; 1.1%, O45; 0.2%, O26; and 0.0%, 
O111 and O121. 
 Comparison of culture-based method versus NS for EHEC-7 detection in 
hide samples and GDS versus NS for carcass samples. The McNemar's chi-square 
tests comparing the culture-based method and NS results on hide samples were 
statistically significant (p<0.05) for all EHEC groups, indicating a serious disagreement 
between the tests, except for EHEC O26. The κ coefficient for the comparison of the 
culture-based method and NS for EHEC O26 (κ=−0.005; 95% CI=−0.0099, −0.0003) 
indicated a poor agreement between the tests. The McNemar's chi-square tests comparing 
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GDS and NS on carcass samples for detection of EHEC O157 and EHEC-6 were 
statistically significant (p<0.05), indicating disagreement between the tests. 
 
Discussion 
 Although the results of this study were derived from only one plant, one feedlot, 
and one period, they suggest that EHEC-7, as detected by NS, are ubiquitous on hides of 
commercial feedlot cattle harvested in the summer (>80% positive), with EHEC O145, 
O45, O103, and O157, in descending order, the most prevalent. The results also suggest 
that at least 6 per 100 carcasses, prior to evisceration and interventions, are contaminated 
with EHEC-7, based on NS, with EHEC O157, O145, O103, and O45, in descending 
order, also the most prevalent. 
 Few studies have estimated the prevalence specifically of EHEC-6 and EHEC-7 
on hides and carcasses, as compared to that for E. coli O157:H7 and non-O157 STEC. In 
one recent study, hide and carcass surface samples were cultured for EHEC-6 and −7, but 
no isolates were obtained from the hides; in addition, it was unclear whether carcass 
isolates were EHEC-7 (Svoboda et al., 2013), and the methods yielded only presumptive 
positive results. In our study, GDS yielded a higher proportion of presumptive positives 
for EHEC-6 on carcasses than the proportion of confirmed positive samples obtained 
using NS, and no isolates were obtained from these samples. Prevalence estimates made 
solely on the detection of O-group plus stx and eae in an enrichment broth sample 
(presumptive positive) will likely be higher due to false-positive results generated by 
background organisms containing some, but not all of the gene targets. NS results are 
reported as confirmed positive or negative; however, recovery of fully characterized 
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bacterial isolates provides the most definitive evidence of a true positive sample. In the 
present study, GDS testing was not conducted on the hide samples due to the 
unavailability of the test system in the lab handling these samples. 
 In contrast to non-O157 EHEC, a relatively large number of studies have reported 
on the prevalence of EHEC O157:H7 on hides and pre-evisceration beef carcass surfaces. 
A summarization of the results from these studies is provided in Table 5. Varying 
methods, media, geographical locations, and seasons undoubtedly contribute to 
differences in reported prevalence. In the present study, only 6 colonies per plate for each 
of the 7 IMS serogroups (i.e., 42 colonies per sample) were picked, but the chromogenic 
phenotype was shared by many of the background flora; hence this protocol is relatively 
insensitive. Interestingly, the culture-based protocol used in the study by Arthur et 
al. (2002) yielded similar reported EHEC-6 prevalence levels. 
 E. coli O157:H7 was isolated from fewer hide samples in this study than in 
previous ones (Elder et al., 2000; Brichta-Harhay et al., 2008). This may have been the 
result of using mPossé agar, which in its original formulation was intended for detection 
of E. coli O26, O103, O111, and O145, but not O157:H7 (Possé et al., 2008b). We chose 
this medium because we had found in preliminary experiments with pure cultures that all 
seven EHEC serogroups could be screened for in three colony colors. A potential 
contributing factor to the lower proportion of EHEC O157 detected could have been the 
prior treatment of cattle with a commercial bacteriophage solution that is lytic for E. 
coli O157:H7. Improvements in culture-based methods are likely needed for isolation of 
EHEC, given the disparities we found between detection protocols. However, it should be 
noted that our culture method detected EHEC-7 in five hide samples that were negative 
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for the respective organism by NS. In these samples, the signals targeted in the NS test 
were below the level of detection (E. Hosking, personal communication). In addition to 
providing backup for more sensitive methods, culture-based tests remain important for 
trace-back of contaminated foods, the identification of novel genes, and other uses as 
they produce isolates that can be further confirmed and characterized. 
 Using the MRA developed by Coombes et al. (2008), all EHEC isolates from hide 
samples in the present study were seropathotype A or B, and had the virulence gene 
content (e.g., nle and other) expected for this classification. One isolate (serotype 
O145:[H28]) would have been less likely to cause a disease outbreak, since it lacked 
complete O-Islands 36, 57, 71, and 122, and contained only 7 of the 16 genes tested for in 
the MRA. In general, the MRA tests for genes on these four O-Islands that encode 
effectors that reduce pro-inflammatory signaling (viz., NleB, NleC, NleD, NleH1, and 
NleH2) and sustain colonization by preventing bacterial detachment and death of infected 
host epithelial cells (viz., NleD, NleH1, and NleH2; Vossenkämper et al., 2011). In 
addition, we tested for three other genes on O-Island 122 (efa1, sen, and pagC; 
Karmali et al., 2003). Since all isolates had efa1 and sen, and all O157:H7, but none of 
the non-O157 isolates had pagC, we hypothesize that isolates expressing the products of 
these genes might have increased virulence through enhancement of intestinal 
colonization (Efa1), water loss (Sen), and enhanced survival in macrophages (PagC; 
Karmali et al., 2003; Kitagawa et al., 2010). 
 
Conclusions 
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 The prevalence of enterohemorrhagic E. coli (EHEC) O26, O45, O103, O111, 
O121, O145, and O157 (EHEC-7) on hides and preintervention de-hided carcasses was 
estimated from a population of commercial feedlot cattle at harvest. The prevalence of 
EHEC-7 was 1.2% on hides based on culture, but 80.7% on hides and 6.0% on carcasses 
based on the NeoSEEK
™
 STEC Detection and Identification Test (NS). The prevalence 
of EHEC-7 on hides was significantly greater than that on carcasses, based on these NS 
results. This study provides evidence that “top 6” non-O157 and O157:H7 EHEC are 
present on the hides and carcasses of commercial feedlot cattle at harvest; however, 
continued improvement of methods is needed for accurate detection and estimation of 
non-O157 EHEC prevalence, given the discordant results across protocols. 
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Table 1. Detection of enterohemorrhagic Escherichia coli (EHEC) O26, O45, O103, 
O111, O121, O145, and O157 in cattle hide samples by a culture-based protocol and 
NeoSEEK
TM
 STEC Detection and Identification Test (NS) 
 No. (%) of samples 
Detection 
method Total
a 
O-group 
positive
b
 
stx 
positive
c
 
eae 
positive 
ehxA 
positive 
EHEC-7 
positive 
Culture 476 (100) 
248 
(52.1) 
25 (5.3) 19 (4.0) 51 (10.7) 6 (1.3) 
NS 576 (100) 576 (100) 574 (99.7) 
576 
(100) 
NA 
451 
(78.3) 
a
A total of 100 hide samples had inadequate DNA concentration for 11-plex polymerase 
chain reaction; hence, the culture-based protocol could only be completed on 476 
samples. 
b
Samples that isolated one or more O-group positive colonies from serogroups O26, O45, 
O103, O111, O121, O145 and O157. 
c
Samples positive for stx1 and/or stx2. 
NA, not applicable. 
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Table 2. Molecular risk assessment of enterohemorrhagic Escherichia coli (EHEC) hide 
isolates by polymerase chain reaction assay 
Isolate 
Sample 
no. Serotype stx
a
 eae
b
 
No. of 
detected  
nle genes
c
 pagC
d
 sen
e
 efa1
f
 
3-O157-3 3 O157:[H7] 2 γ1 16 + + + 
1379D 293 O157:[H7] 2 γ1 16 + + + 
1568B 320 O157:[H7] 2 γ1 16 + + + 
1379B 293 O157:[H7] 2 γ1 15 + + + 
3-8G 320 O157:[H7] 2 γ1 15 + + + 
1394E 296 O26:[H11] 1 β1 15 - + + 
400D 154 O26:[H11] 1 β1 12 - + + 
860B 219 O145:[H28] 2 γ1 7 - + + 
a
Shiga toxin type. 
b
Intimin type and subtype. 
c
Nonlocus of enterocyte effacement genes. 
d
Detection of putative virulence gene Z4321, homologue of Salmonella enterica serovar 
Typhimurium (pagC), originally reported on pathogenicity island OI-122 of EHEC 
O157:H7 strain EDL 933. 
e
Detection of putative virulence gene Z4326, homologue of Shigella flexneri enterotoxin 
2 (sen), originally reported on pathogenicity island OI-122 of EHEC O157:H7 strain 
EDL 933. 
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f
Detection of putative virulence genes Z4332 and Z4333 (EHEC factor for adherence 
[efa1]), originally reported on pathogenicity island OI-122 of EHEC O157:H7 strain EDL 
933. 
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Table 3. Crude proportions and model-adjusted cumulative prevalence estimates 
of enterohemorrhagic Escherichia coli (EHEC) O26, O45, O103, O111, O121, O145, and 
O157 in cattle hide samples as detected by culture-based protocol and NeoSEEK
TM 
STEC 
Detection and Identification Test (NS) 
 Culture NS 
 Total n = 476
a 
Total n = 576 
Serogroup 
 No. 
 samples  
positive (%) 
Mean 
prevalence, 
% 95% CI 
No.  
samples 
 positive (%) 
Mean 
prevalence, 
% 95% CI 
EHEC O26 2 (0.42) 0.42 0.11-1.66 3 (0.52) 0.21 0.03-1.48 
EHEC O45 0 (0.00) 0.00 0.00-0.00 227 (39.41) 37.09 25.24-50.73 
EHEC O103 0 (0.00) 0.00 0.00-0.00 107 (18.58) 12.48 6.87-21.59 
EHEC O111 0 (0.00) 0.00 0.00-0.00 13 (2.26) 2.23 1.43-3.45 
EHEC O121 0 (0.00) 0.00 0.00-0.00 14 (2.43) 1.98 0.98-3.99 
EHEC O145 1 (0.21) 0.21 0.03-1.48 282 (48.96) 49.88 38.39-61.39 
EHEC O157 3 (0.63) 0.63 0.20-1.94 83 (14.41) 11.02 6.73-17.52 
EHEC-6 3 (0.63) 0.63 0.20-1.93 429 (74.48) 77.53 68.47-84.58 
EHEC-7 6 (1.26) 1.24 0.54-2.84 451 (78.30) 80.71 73.27-86.46 
a
A total of 100 hide samples had inadequate DNA concentration for 11-plex polymerase 
chain reaction; hence, the culture-based protocol could be completed on only 476 
samples. 
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Table 4. Crude proportions and model-adjusted cumulative prevalence estimates of 
enterohemorrhagic Escherichia coli (EHEC) O26, O45, O103, O111, O121, O145, and 
O157 in preintervention carcass samples by Biocontrol Assurance GDS
TM
 MPX Top 7 
STEC System (GDS) and NeoSEEK
TM 
STEC Detection and Identification Test (NS) 
 GDS NS 
 Total n = 576 Total n = 576 
Serogroup 
or virulence 
gene 
No.  
samples  
positive (%) 
Mean 
prevalence, 
% 95% CI 
No.  
samples  
positive (%) 
Mean 
prevalence, 
% 95% CI 
EHEC O26 NA NA NA 2 (0.35) 0.21 0.03-1.40 
EHEC O45 NA NA NA 8 (1.39) 1.13 0.47-2.71 
EHEC O103 NA NA NA 10 (1.74) 1.23 0.50-2.99 
EHEC O111 NA NA NA 0.00 0.00 0.00-0.00 
EHEC O121 NA NA NA 0.00 0.00 0.00-0.00 
EHEC O145 NA NA NA 11 (1.91) 1.58 0.74-3.36 
EHEC O157 86 (14.93) 13.13 9.02-18.73 16 (2.78) 2.78 1.71-4.49 
EHEC-6 165 (28.65) 24.83 16.72-35.21 24 (4.17) 3.96 2.46-6.31 
EHEC-7 NA NA NA 36 (6.25) 5.98 4.02-8.80 
stx NA NA NA 349 (60.59) 66.37 43.14-83.70 
stx1 118 (20.49) 15.69 9.55-24.71 
NA NA NA 
stx2 138 (23.96) 21.89 15.91-29.33 
eae 385 (66.84) 71.69 58.02-82.27 398 (69.10) 74.52 60.17-84-99 
NA, not applicable; STEC, Shiga toxin–producing Escherichia coli.
  
 
9
9 
Table 5. Previous studies on the prevalence of enterohemorrhagic Escherichia coli O157:H7 and “Top 6” non-O157 on hides and de-
hided pre-evisceration carcasses as detected by culture-based methods 
Prevalence
 
    
  
 
O157 % 
“Top 6” non-
O157 % Season Sample area 
Sample 
type Enrichment
 
Immunomagnetic 
separation Plating
 
Reference 
13.0 NA Summer 450 cm
2
 Hide 2% BGB, 37°C 6 h O157 CT-SMAC
 
Elder et al., 
2000 43.4 NA Summer 4000 cm
2
 Carcass 2% BGB, 37°C 10 h O157 CT-SMAC and BCM 
NA 1.2 Summer 4000 cm
2
 Carcass 2% BGB, 37°C 10 h No TSA, colony hybridization 
for stx followed by SMAC 
Arthur et al., 
2002 
60.6 ND Year-
round 
1700 cm
2
 Hide TSB, 25°C 2 h, 42°C 6 h O157 CT-SMAC and NT-Rainbow Barkocy-
Gallagher et al., 
2003 73.8 ND Spring 1700 cm
2
 Hide TSB, 25°C 2 h, 42°C 6 h O157 CT-SMAC and NT-Rainbow 
73.5 ND Summer 1700 cm
2
 Hide TSB, 25°C 2 h, 42°C 6 h O157 CT-SMAC and NT-Rainbow 
67.2 ND Fall 1700 cm
2
 Hide TSB, 25°C 2 h, 42°C 6 h O157 CT-SMAC and NT-Rainbow 
29.4 ND Winter 1700 cm
2
 Hide TSB, 25°C 2 h, 42°C 6 h O157 CT-SMAC and NT-Rainbow 
26.7 ND Year-
round 
Unknown Carcass TSB, 25°C 2 h, 42°C 6 h O157 CT-SMAC and NT-Rainbow 
  
 
1
00
 
30.3 ND Spring Unknown Carcass TSB, 25°C 2 h, 42°C 6 h O157 CT-SMAC and NT-Rainbow 
31.9 ND Summer Unknown Carcass TSB, 25°C 2 h, 42°C 6 h O157 CT-SMAC and NT-Rainbow 
33.0 ND Fall Unknown Carcass TSB, 25°C 2 h, 42°C 6 h O157 CT-SMAC and NT-Rainbow 
32.9 ND Winter Unknown Carcass TSB, 25°C 2 h, 42°C 6 h O157 CT-SMAC and NT-Rainbow 
88.3 NA Summer 2000 cm
2
 Hide TSB, 25°C 3 h, 42°C 6 h O157 CT-SMAC and N-Rainbow Nou et al., 2003 
50.0 NA Summer 8000 cm
2
 Carcass TSB, 25°C 3 h, 42°C 6 h O157 CT-SMAC and N-Rainbow 
75.7 NA Fall 100 cm
2
 Hide TSB, 25°C 2 h, 42°C 6 h O157 CT-SMAC and NT-Rainbow Arthur et al., 
2004 14.7 NA Fall 8000 cm
2
 Carcass TSB, 25°C 2 h, 42°C 6 h O157 CT-SMAC and NT-Rainbow 
61.9 NA Spring to 
Fall 
1700 cm
2
 Hide TSB, 25°C 2-3 h, 42°C 6 
h 
O157 CT-SMAC and NT-Rainbow Rivera-
Betancourt et 
al., 2004 7.0 NA Spring to 
Fall 
4000 cm
2
 Carcass TSB, 25°C 2-3 h, 42°C 6 
h 
O157 CT-SMAC and NT-Rainbow 
14.7 NA Unknown 300 cm
2
 Hide BGB, 37°C 6 h O157 CT-SMAC and T-CO157 Woerner et al., 
2006 10.1 NA Unknown 300 cm
2
 Carcass BGB, 37°C 6 h O157 CT-SMAC and T-CO157 
46.9  ND Year-
round 
1000 cm
2
 Hide TSB, 25°C 2 h, 42°C 6h O157 CT-SMAC and NT-CO157 Brichta-Harhay 
et al., 2008 
43.2 ND Spring 1000 cm
2
 Hide TSB, 25°C 2 h, 42°C 6h O157 CT-SMAC and NT-CO157 
55.7 ND Summer 1000 cm
2
 Hide TSB, 25°C 2 h, 42°C 6h O157 CT-SMAC and NT-CO157 
  
 
1
01
 
38.7 ND Fall 1000 cm
2
 Hide TSB, 25°C 2 h, 42°C 6h O157 CT-SMAC and NT-CO157 
50.4 ND Winter 1000 cm
2
 Hide TSB, 25°C 2 h, 42°C 6h O157 CT-SMAC and NT-CO157 
16.7 ND Year-
round 
8000 cm
2
 Carcass TSB, 25°C 2 h, 42°C 6h O157 CT-SMAC and NT-CO157 
14.2 ND Spring 8000 cm
2
 Carcass TSB, 25°C 2 h, 42°C 6h O157 CT-SMAC and NT-CO157 
18.3 ND Summer 8000 cm
2
 Carcass TSB, 25°C 2 h, 42°C 6h O157 CT-SMAC and NT-CO157 
14.9 ND Fall 8000 cm
2
 Carcass TSB, 25°C 2 h, 42°C 6h O157 CT-SMAC and NT-CO157 
19.5 ND Winter 8000 cm
2
 Carcass TSB, 25°C 2 h, 42°C 6h O157 CT-SMAC and NT-CO157 
NA 0.0 Year-
round 
400 cm
2
 Hide mTSB+N,
 
41.5°C 24 h O157 CT-SMAC Wieczorek et 
al., 2011 
NA 0.0 Year-
round 
400 cm
2
 Carcass mTSB+N,
 
41.5°C 24 h O157 CT-SMAC 
NA 0.0  
Year-
round 
100 cm
2
 Hide TSB+V, 37°C overnight No TBX+SS Monaghan et 
al., 2012 
NA 0.4  
Year-
round 
Whole 
carcass 
Carcass TSB+V, 37°C overnight No TBX+SS 
  
 
1
02
 
17.9 0.2  
Year-
round 
100 cm
2
 Hide mTSB+CV, 37°C 6 h O157, O26, 
O103, O111 and 
O145 
CT-SMAC and C-CCV, 
followed by EMB agar 
Thomas et al., 
2012 
0.7 0.0  
Year-
round 
100 cm
2
 Carcass mTSB, 37°C 6 h O157, O26, 
O103, O111 and 
O145 
CT-SMAC and C-CCV, 
followed by EMB agar 
 
BGB, brilliant green bile broth; TSB, trypticase soy broth; mTSB, trypticase soy broth modified with the addition of bile salts No. 3; 
N, novobiocin; V, vancomycin; C, cefixime; NA, not applicable; ND, not determined; CT-SMAC, MacConkey agar with sorbitol, 
cefixime and potassium tellurite; BCM, Biosynth chromogenic media; TSA, trypticase soy agar; SMAC, MacConkey agar with 
sorbitol; NT-Rainbow, Rainbow agar with novobiocin and potassium tellurite; N-Rainbow, Rainbow agar with novobiocin; T-CO157, 
CHROMagar O157 with potassium tellurite; NT-CO157, CHROMagar O157 with novobiocin and potassium tellurite; 
TBX + SS, tryptone bile x-glucuronide agar with streptomycin sulphate and sulfamethazine; C-CCV, Chromocult coliform agar with 
cefixime, cefsulodin sodium salt, and vancomycin; EMB, eosin methylene blue agar. 
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Abstract 
 The primary objective of this study was to determine the prevalence and 
concentration of enterohemorrhagic Escherichia coli (EHEC) O26, O45, O103, O111, 
O121, O145, and O157 in fecal, hide, and pre-intervention carcass surface samples from 
culled dairy cows. Matched samples (n = 300) were collected from 100 cows at harvest 
and tested by a culture-based method and 2 molecular-based methods, NeoSEEK STEC 
(NS), and Atlas STEC EG2 Combo (Atlas). Both culture and NS tested for presence of 
each of the 7 EHEC types, from which the cumulative (EHEC-7) prevalence was 
inferred, whereas Atlas only tested for presence of non-O157 EHEC without 
discrimination of serogroup and EHEC O157.  The EHEC-7 prevalence in samples of 
feces, hides, and carcass surface, respectively, was 6.5%, 15.6%, and 1.0% by culture, 
and 25.9%, 64.9%, and 7.0% by NS. By Atlas, the prevalence of non-O157 EHEC was 
29.1%, 38.3%, and 28.0% and that of EHEC O157 was 29.1%, 57.0%, and 3.0% for 
feces, hides, and carcasses, respectively. Only 2 samples originating from different cows, 
a hide and fecal sample contained quantifiable EHEC. In both samples these were EHEC 
O157, with 6.0 log colony-forming units (CFU)/1,000 cm
2
 in the hide and 3.9 log CFU/g 
in the fecal sample. Moderate agreement was observed between culture and NS for 
detection of EHEC O26 (Kappa = 0.58, P < 0.001), EHEC O121 (Kappa = 0.50, P < 
0.001), and EHEC O157 (Kappa = 0.40, P < 0.001). No significant agreement was 
observed between NS and Atlas or between culture and Atlas. Detection of an EHEC 
serogroup in fecal samples was significantly associated with detection of the same EHEC 
serogroup in hide samples for EHEC O26 (P = 0.001), EHEC O111 (P = 0.002), EHEC 
O121 (P < 0.001), and EHEC-6 (P = 0.029) based on NS detection and for EHEC O121 
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(P < 0.001) based on detection by culture. This study provides evidence that non-O157 
EHEC are ubiquitous on hides of culled dairy cattle, and feces are an important source of 
non-O157 EHEC hide contamination. 
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Introduction 
Shiga toxin (Stx)-producing Escherichia coli (STEC) cause severe illness in 
humans, including hemorrhagic colitis and hemolytic uremic syndrome (HUS) (Croxen et 
al., 2013). These organisms are naturally found in the intestines of ruminants, shed in the 
feces, and transmitted to humans through the ingestion of contaminated food or water, or 
by direct contact (Gyles, 2007; Cole et al., 2014; Luna-Gierke et al., 2014). 
Enterohemorrhagic E. coli (EHEC) is a subset of STEC and generally defined as E. coli 
that contain genes for Stx (stx) and locus of enterocyte effacement (LEE) proteins, e.g., 
intimin (eae), but may also include LEE-negative stx-positive E. coli strains that cause 
hemorrhagic colitis and HUS in human patients (Croxen et al., 2013).  EHEC of the 
serogroups O26, O45, O103, O111, O121, and O145 (EHEC-6) caused 71% of the 
human STEC cases in the U.S. from 1983 to 2002 (Brooks et al., 2005). Cumulatively, 
EHEC-6 with EHEC O157:H7 (hereafter referred to as EHEC-7) caused >90% of the 
human STEC cases in the U.S. from 2000-2010 (Gould et al., 2013). Thus, the United 
States Department of Agriculture Food Safety and Inspection Service (USDA-FSIS) 
declared EHEC-7 as adulterants in raw, non-intact beef (USDA, 2014a).  
 The clonality and rather unique biochemical features of EHEC O157:H7 allowed 
for the development of sensitive and specific culture methods for this organism (Moxley, 
2003; Beutin and Fach, 2014); in contrast, culture methods for non-O157 EHEC 
adulterants developed to date have lacked sensitivity and specificity due to the 
multiplicity of organisms needing to be targeted, the lack of clonality of these organisms, 
and, other than having Stx and intimin, these organisms lack characteristics that 
distinguish them from generic E. coli (Wang et al., 2013; Gill et al., 2014; Kase et al., 
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2015; Stromberg et al., 2015a).  USDA-FSIS methods for detection and isolation of 
EHEC from meat products, which involve PCR screening, immunomagnetic separation, 
cultural isolation with the use of a chromogenic agar, and confirmatory PCR and 
agglutination have been improved through a number of modifications, but are still not 
optimal (Wang et al., 2013; USDA, 2014b). Molecular methods that detect nucleic acids 
from EHEC organisms have been used in place of culture-based methods or as an initial 
screen before culture-based detection of EHEC in foods, but also lack specificity because 
gene targets can be contributed by background organisms leading to false positive results 
(Wang et al., 2013). In an attempt to increase sensitivity and specificity, the NeoSEEK 
STEC Detection and Identification test (NS; Neogen, Lansing, MI) and Atlas STEC EG2 
Combo Detection Assay (Atlas; Roka Bioscience, Warren, NJ) have been used. The NS 
test includes a proprietary set of genetic markers, is approved by the USDA-FSIS as a 
confirmation test for detection of EHEC adulterants in beef trim, and has been used to 
detect EHEC in veal calf hide samples (Wang et al., 2014a) and feedlot cattle hide and 
carcass samples (Stromberg et al., 2015a). In addition, the Atlas test has been used on 
cattle fecal samples (Bosilevac et al., 2013).   
 EHEC pose a threat to food safety as they contaminate carcass surfaces during the 
removal of hides (Elder et al., 2000; Arthur et al., 2002; Keen and Elder, 2002; Barkocy-
Gallagher et al., 2003; Koohmaraie et al., 2005; Arthur et al., 2007; Brichta-Harhay et 
al., 2008; Schmidt et al., 2012), and the predictive virulence of EHEC isolates is a 
question of major importance. In one study, based on NS test results, the prevalence of 
EHEC-7 in beef feedlot cattle was 80.7% on hides and 6.0% on pre-intervention carcass 
surfaces (Stromberg et al., 2015a).  In addition to feedlot cattle, culled dairy cows are a 
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significant source of beef.  In 2014, 9.5% of cattle slaughtered were classified as dairy 
cows (USDA, 2015c). In fecal samples from dairy cows tested by culture-based methods, 
the prevalence of EHEC O157:H7 ranged from 0.2% to 48.8% and that of non-O157 
STEC ranged from 0.4% to 74.0% (Hussein and Sakuma, 2005). Coombes et al. (2008) 
developed a molecular risk assessment (MRA) protocol for assessing the predictive 
virulence or public health risk of non-O157 STEC strains based on the detection of 
specific virulence genes. The identification of more highly virulent strains is important 
since these are the ones most likely to cause outbreaks of disease and case progression to 
HUS (Karmali et al., 2003; Coombes et al., 2008). 
 Many factors have been implicated in the intestinal colonization of cattle with 
EHEC, including management practices (Renter et al., 2005, Smith, 2014a; Smith, 
2014b).  Production systems vary between beef feedlot cattle and dairy cattle, which may 
cause differences in EHEC prevalence. Culled dairy cows (6-8 years old) are typically 
older than feedlot steers and heifers (<2 years old).  Cray and Moon (1995) reported that 
pre-weaned (3- to 14-week-old) calves were more susceptible to infection with STEC 
O157:H7 following experimental inoculation than adult (1- to 3-year-old) cattle; 
however, Mir et al. (2015) reported that cows (≥2 years old) had a higher natural 
prevalence of STEC compared to heifers (1-2 years old).    
 In addition to prevalence, concentration is an important contributor to risk of 
EHEC infection (Ekong et al., 2015). Concentrations of E. coli O157:H7 >10
4
 CFU/g are 
associated with hide contamination (Arthur et al., 2009), and even higher concentrations 
in the environment may lead to more human exposure (Chase-Topping et al., 2008). The 
objectives of this cross-sectional study were to: (1) determine the prevalence and 
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concentration of EHEC-7 in fecal, hide, and pre-intervention carcass surface samples 
from culled dairy cows at a commercial processing plant; (2) conduct a MRA on 
recovered EHEC isolates; (3) compare the applicability of a culture-based method, NS, 
Atlas for detection of EHEC; and (4) determine the association between detection of an 
EHEC serogroup in fecal samples with that on hides. 
 
Materials and Methods 
 Study design and sample collection. Matched fecal, hide, and carcass surface 
samples (n = 300) were collected from 100 dairy cows (10-30 cows/week for 5 weeks) at 
a small (60 animals/h) western U.S. commercial processing plant from June to July 2014 
using a modified protocol for E. coli O157:H7 sampling (USDA, 2005). Samples of 
rectal lumen contents (as a surrogate for and hereafter referred to as feces) were obtained 
at the viscera table after the cattle were slaughtered and eviscerated. Hides were rinsed 
with water by plant employees as part of the routine process before the research team 
collected samples. Hide and carcass surface samples were collected using wet (35 ml 
buffered peptone water) Speci-sponges (Nasco, Ft Atkinson WI) according to methods 
previously described (Stromberg et al., 2015a). Hide samples were collected by sampling 
an area of approximately 1,000 cm
2
 (32 cm ˟ 32 cm), 15 cm from the ventral midline near 
the diaphragm. Two carcass surface samples per animal were collected: the first was 
obtained from an area of approximately 1,000 cm
2
 in the brisket-short plate region, and 
the second was from an area of approximately 3,000 cm
2
 in the lateral hock and round-
rump regions.  The 2 carcass sponges and their buffer volumes, representing a combined 
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4,000 cm
2
 area per carcass, were combined into a single Whirl-Pak
®
 bag.  Samples were 
shipped overnight on ice to the laboratory. 
 Isolation and confirmation of EHEC using culture and PCR.  Fecal, hide, and 
carcass samples (n = 300) were processed within 24 h after collection (Fig. 1). One g of 
feces was suspended in 9 ml of E. coli broth (EC; Oxoid Ltd., Basingstoke, UK) and 
vortexed for 1 min. Ninety ml of EC at room temperature (RT) was added to each hide 
sponge sample and 80 ml of EC at RT was added to each carcass sponge sample, and all 
samples were incubated at 40°C for 6 h. Following incubation, broth culture was 
inoculated onto a CHROMagar STEC plate (DRG Int., Springfield, NJ) for isolation, and 
incubated overnight at 37°C. Four or fewer pink to mauve colonies (2 with and 2 without 
UV fluorescing halos when present) were picked and inoculated into 500 µl trypticase 
soy broth and incubated overnight at 37°C. Genomic DNA was prepared from overnight 
cultures by centrifuging a 200-μl aliquot at 2,000 ˟  g for 20 min, replacing the media 
with 200 μl PBS, vortexing to resuspend the cells, incubating at 95°C for 20 min, 
centrifuging again at 2,000 ˟  g for 20 min, and collecting the supernatant. One μl of 
DNA was used in a 20-µl PCR reaction containing 1.3 ˟ final concentration Bullseye HS 
Taq Buffer II (with balanced ammonium/potassium), 29.5 mM MgCl2, 10 mM each 
dNTPs, 1.5 U Bullseye HS Taq (MidSci, St Louis, MO), and primers shown in Table 1. 
PCR amplification was performed as previously described (Paton and Paton, 1998).  
 Primers for the amplification of the type III secreted effector EspK (espK) were 
generated from the E. coli O157:H7 EDL933 genome (GenBank accession no. 
AE005174). The espK (Z1829) sequence was loaded into Geneious version 7.1.8 and 
Primer 3 software to design PCR primers with acceptable Tm and that generated a 200-bp 
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product. Primers EspK_F1 and EspK_R1 were validated against 86 espK-positive STEC 
strains. This included the U.S. Meat Animal Research Center E. coli O157:H7 molecular 
diversity panel, a set of 50 unique E. coli O157:H7 isolated from across North America, 
each with an individual pulsed-field gel electrophoresis restriction digest pattern, and 6 
STEC strains each of the O26, O45, O103, O111, O121, and O145 serogroups. Negative 
controls for espK included the 72 commensal E. coli that make up the E. coli collection of 
reference (ECOR) strains (Ochman and Selander, 1984). 
 Additionally after enrichment, 3 separate 490-µl broth aliquots were diluted with 
490 µl of PBS with 0.05% Tween-20 (PBS-Tween) and each aliquot was subjected to 1 of 
3 immunomagnetic separation (IMS) treatments using a KingFisher Flex Magnetic 
Particle Processor (Thermo Scientific, Waltham, MA) (Fig. 1): i) 20 µl of anti-O157 
Dynabeads (Invitrogen, Carlsbad, CA); ii) a pool of 20 µl of IMS beads (6.3 μl each) for 
E. coli O26, O45, and O121 (Abraxis LLC, Warminster, PA); and iii) a pool of 20 µl of 
IMS beads (6.3 μl each) for E. coli O103, O111, and O145 (Abraxis). Fifty µl of 
recovered beads from the E. coli O157 IMS treatment were spread onto CHROMagar 
O157 (DRG Int.) with cefixime trihydrate (0.025 mg/liter), cefsulodin (5.0 mg/liter), and 
potassium tellurite (2.5 mg/liter; CCT-CHROMagar O157) and incubated for 18 h at 
37°C. Fifty µl of recovered beads from the remaining 2 IMS treatments were spread onto 
STEC heart infusion washed blood agar with mitomycin C (0.5 µg/ml; SHIBAM) and 
incubated for 18 h at 37°C. SHIBAM was prepared with 4% defibrinated sheep blood 
(Quad Five, Ryegate, MT), according to the methods of Feng et al. (2011). Five or fewer 
mauve colonies per CCT-CHROMagar O157 plate were picked and ≤20 enterohemolytic 
phenotype colonies per SHIBAM plate were picked. All colonies picked from CCT-
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CHROMagar O157 and SHIBAM plates were streaked for isolation on 5% sheep blood 
agar (Remel, Lenexa, KS) and incubated for 15 h at 37°C. Isolated colonies were picked 
from blood agar, suspended in 50 μl of ultrapure water, and heated at 95°C for 10 min for 
use as DNA template in PCR assays. Individual DNA preparations from isolated colonies 
(n = 6) were pooled and the pooled DNA was tested by single-plex PCR for stx (Monday 
et al., 2007). If a pool was positive for stx, the DNA preparations from each of the isolate 
making up the pool were individually tested by 11-plex PCR.  The 11-plex PCR included 
genes representing each of the EHEC-7 serogroups (wzx, wbq, or rfbE), plus stx1, stx2, 
and EHEC-hemolysin (ehxA) (Bai et al., 2012) which was modified by the use of primers 
for eae as described by Blanco et al. (2004), and primers for the wzx gene of O111 as 
described by Noll et al. (2015). 
 Additional aliquots of broth enrichment culture of each fecal, hide and carcass 
surface sample were obtained and held at 4°C (24-96 h) until molecular screening assays 
(Atlas and NS) were completed (Fig. 1). Broths identified as positive for E. coli O157:H7 
by Atlas testing were subjected to O157 IMS by adding 20 µl of beads (Pickpen
®
 IMS, 
BioControl, Bellevue, WA) to broth culture, shaking at 900 rpm on a bench top plate 
shaker and then separated using a KingFisher (Thermo Scientific). The IMS steps 
included 2 wash steps in PBS-Tween, and the final captured beads from the IMS-broth 
treatment were suspended in 200 µl PBS-Tween. The concentrated beads (50 µl and 1 µl) 
were spread plated onto 2 CHROMagar O157 plates supplemented with novobiocin (5.0 
mg/liter) and potassium tellurite (1.0 mg/liter). Plates were incubated overnight at 37ºC 
and mauve colonies were picked and tested for E. coli O157:H7 by multiplex PCR as 
described by Hu et al. (1999).  
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 A broth culture was suspected of containing an EHEC-6 if it was found positive 
for non-O157 EHEC by Atlas and/or NS.  Based on those results, IMS for each particular 
suspect-positive serogroup was conducted; hence an enrichment broth culture was 
subjected to 1-6 IMS treatments depending on the screening results.  One ml of each 
EHEC-6 suspect broth culture was subjected to IMS using individual specific O group 
IMS beads (Romer Laboratories, Union, MO) with captured beads from an IMS-broth 
treatment diluted 1:10 and 1:100 and spiral-plated using an Autoplate 4000 (Advanced 
Instruments Inc, Norwood, MA) onto STEC differentiation agar (SDA) (Kalchayanand et 
al., 2013) and washed blood agar with 0.5 µg/ml mitomycin C (WBAM) (Sugiyama et 
al., 2001), respectively. Plates were incubated overnight at 37°C. Suspect colonies on 
SDA plates were O-group specific shades of green and blue and on WBAM presented 
with an enterohemolytic phenotype. Four or fewer colonies per plate were picked and 
screened by multiplex PCR for stx, eae, espK, non-locus of enterocyte effacement genes 
(nleB and nleF), and subtilase (subA; Table 1). All E. coli isolates from SDA and WBAM 
that were positive for both stx and eae were serogrouped using multiplex PCR that 
identified all EHEC-6 serogroups (Bosilevac and Koohmaraie, 2011; Fig. 1).  
 Detection of EHEC by NS. Enriched sample aliquots were tested for EHEC-7 by 
NS (Neogen Corp., Lansing, MI), a PCR coupled with mass spectrometry-based 
analytical method. Based on NS data, a positive result for EHEC was defined by the 
concurrent detection of stx, targeted O-group single nucleotide polymorphisms, and 
specific eae subtype in conjunction with the O group marker. Identifying combinations of 
eae subtypes and EHEC-7 O group markers were as follows: eae-β with O26; eae-ε with 
O45, O103, or O121; eae-γ2 with O111; and eae-γ1 with O145 or O157. 
114 
 
 
 
 Detection of EHEC by Atlas. Enriched sample aliquots were tested for EHEC 
O157 and non-O157 EHEC by Atlas (Roka Bioscience, Warren, NJ). After enrichment, 
1.2 ml was transferred to a Roka Bioscience G2 RT lysis tube and placed in the Atlas 
System instrument for analysis using the STEC EG2 Combo Detection Assay (Roka 
Bioscience). Atlas identified samples suspected to be positive for EHEC O157 or non-
O157 EHEC.   
 Quantification of EHEC-7. Pre-enriched 1 ml sample aliquots were frozen in 
500 µl of brain heart infusion broth with 50% glycerol at -80°C. Samples to be quantified 
were identified based on NS or culture positive results from post-enriched samples. Pre-
enriched samples were removed from -80°C and allowed to recover at room temperature 
for 2 h. Using an Eddy Jet 2 spiral plater (IUL Instruments, Königswinter, Germany), 50 
µl was spiral plated on Possé agar modified by reducing novobiocin (5.0 mg/liter) and 
potassium tellurite (0.5 mg/liter; mPossé) as previously described (Stromberg et al., 
2015) and incubated at 37°C for 18 h.  Based on NS results, blue-purple and red-purple 
colonies were counted for samples positive for EHEC O26, O45, O103, O111, or O157 
and blue-purple, red-purple, and green colonies were counted for those positive for 
EHEC O121 or O145. Additionally, EHEC O157 culture positive samples were spiral-
plated on CCT-CHROMagar O157 and mauve colonies were enumerated. Up to 10 target 
colonies were picked per plate and heated at 95°C in 50 µl of water for use as DNA 
template. Colonies were tested by an 11-plex PCR as described above (Blanco et al., 
2004; Bai et al., 2012; Noll et al., 2015). Those colonies positive for one of the EHEC-7 
serogroup genes, plus stx and eae were confirmed as an EHEC-7 and counted as positive. 
115 
 
 
 
Concentration was determined based on the proportion of target colonies on an individual 
plate that were confirmed EHEC-7 positive by the 11-plex PCR assay. 
 Characterization of EHEC isolates. H-antigen typing (fliC) for H2, H7, H8, 
H11, and H28 was done as previously described (Luedtke et al., 2014). All other H-
antigen typing was done at the Pennsylvania State E. coli Reference Center (Machado et 
al., 2000) or using the methods of Wang et al. (2003). Serogroups for EHEC-7 positive 
isolates were confirmed by latex agglutination tests (Abraxis LLC, Warminster, PA).  If 
EHEC isolates were not an EHEC-7 serogroup, they were O:H serotyped at the 
Pennsylvania State University E. coli Reference Center using the methods of Ørskov et 
al. (1977), and Machado et al. (2000), or O-serogrouped by agglutination testing with 
pooled and specific Statens Serum Institute antisera (Cedarlane Labs, Burlington, NC) 
according to the manufacturer’s instructions. Isolates were tested by MRA PCR for genes 
associated with HUS and foodborne outbreaks. The MRA PCR tested for the presence of 
nleA, nleB, nleB2, nleC, nleD, nleE, nleF, nleG, nleG2-1, nleG2-3, nleG5-2, nleG6-2, 
nleG9, nleH1-1, nleH1-2, and ent, using primers and conditions as previously described 
(Coombes et al., 2008). In addition, isolates were tested for putative virulence factor 
genes (pagC, sen, and efa1) and eae subtyped as previously described (Karmali et al., 
2003; Blanco et al., 2004). The FDA E. coli identification array (FDA-ECID) (Jackson et 
al., 2011) was used to determine if isolates from different sample types of the same 
animal were the same strain. 
 Statistical analysis. The overall agreement on detection of EHEC groups, beyond 
that due to chance, between the culture-based method, NS, and Atlas, independent of 
sample type was determined by computing the Cohen’s κ coefficient and the McNemar’s 
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Chi-square test (Dohoo et al., 2009).  The κ coefficient was interpreted on the scale of <0, 
0 to 0.2, 0.21 to 0.4, 0.41 to 0.6, 0.61 to 0.8 or 0.81 to 1.0 as poor, slight, fair, moderate, 
substantial, or almost perfect agreement, respectively (Landis and Koch, 1977).  
 Associations between the detection of an EHEC serogroup or virulence gene 
(presence or absence of a gene) in fecal samples (explanatory variables) with the 
presence of an EHEC serogroup or virulence genes on hide samples (dependent 
variables) were evaluated, using generalized linear mixed models (GLMMs) in SAS 
(SAS 9.3, SAS Institute Inc., Cary, NC). Similar models were fitted to estimate 
associations between EHEC serogroup or virulence gene detected in hide samples with 
their presence in carcass surface samples. An independent model was fitted for each 
EHEC serogroup and detection method. Mixed models were fitted using a residual 
pseudo-likelihood estimation, binary distribution, logit link, Kenward-Roger degrees of 
freedom approximation, and a random intercept for sampling date to account for the 
clustering effect of samples nested within date of sample collection. Mean probability 
estimates and 95% confidence intervals were computed.  P-values <0.05 were deemed 
significant.  
 Model-adjusted sample-level prevalence estimates and their 95% confidence 
intervals were computed for all EHEC serogroup and virulence genes, based on each 
detection protocol, using GLMMs.  Prevalence estimates were calculated from model 
intercepts using the following formulae: 𝑒𝛽°/ (1 + 𝑒𝛽°), where 𝛽° is the coefficient of the 
model intercept. 
 
Results 
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 Detection of EHEC in fecal, hide, and carcass samples by culture-based 
methods, NS, and Atlas. One hundred matched fecal, hide, and carcass samples were 
tested for EHEC by culture, NS, and Atlas. By culture, stx-positive isolates were detected 
in 20%, eae-positive isolates in 31%, and EHEC-7 in 7% of the fecal samples. EHEC-7 
were detected in 26% of the fecal samples by NS. In descending order, the proportions of 
fecal samples testing positive for the different EHEC serogroups by NS were 11%, O45; 
7%, O103; 7%, O111; 7%, O145; 4%, O157; 1%, O26; and 0%, O121. By Atlas, 29% of 
fecal samples tested positive for non-O157 EHEC and 29% tested positive for EHEC 
O157 (Table 2). 
 By culture, stx-positive isolates were detected in 24%, eae-positive isolates in 
38%, and EHEC-7 in 16% of the hide samples. EHEC-7 were detected in 65% of the hide 
samples by NS. In descending order, the proportions of these samples testing positive for 
the different EHEC serogroups were 36%, O45; 23%, O145; 15%, O111; 10%, O103; 
7%, O26; 7%, O157; and 3%, O121. By Atlas, 46% of the hide samples tested positive 
for non-O157 EHEC and 51% tested positive for EHEC O157 (Table 3). 
 By culture, stx-positive isolates were detected in 3%, eae-positive isolates in 12%, 
and EHEC-7 in 1% of the carcass samples. EHEC-7 were detected in 7% of the carcass 
samples by NS. In descending order, the proportions of these samples testing positive by 
NS for the different EHEC serogroups were 4%, O103; 3%, O26; 2%, O145; 1%, O157; 
and 0%, O45, O111 and O121. By Atlas, 28% of the carcass samples tested positive for 
non-O157 EHEC and 3% were EHEC O157 positive (Table 4). 
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 Model-adjusted prevalence estimates of EHEC in fecal, hide, and carcass 
samples. The model-adjusted prevalence estimates for EHEC serogroups and virulence 
genes as detected by culture, NS, and Atlas are shown in Tables 2-4. 
 Quantification of EHEC-7. Pre-enriched aliquots from 26 fecal, 67 hide, and 7 
carcass samples that were NS- or culture-positive were spiral-plated on mPossé to 
quantify EHEC-7, and 6 fecal, 9 hide, and 1 carcass samples were spiral-plated on CCT-
CHROMagar O157 to quantify EHEC O157. No EHEC-7 were quantifiable from the 
carcass samples. One hide sample was positive for EHEC O26 and 1 fecal sample and 1 
hide sample were positive for EHEC O157 as detected by spiral plating, and of these, the 
EHEC O157 samples were quantifiable. EHEC O157 was estimated to be 3.9 log CFU/g 
in 1 fecal sample and 5.0 log CFU/100 cm
2
 on 1 hide sample. EHEC isolates that were of 
a serogroup other than EHEC-7 were quantified in 1 fecal and 3 hide samples. O-non-
typeable EHEC were estimated to be 4.2 log CFU/g in 1 fecal sample. In hide samples, 2 
EHEC O177 isolates were quantified at 5.0 log CFU/100 cm
2
 and 4.1 log CFU/100 cm
2
, 
and 1 EHEC O101 was quantified at 4.9 log CFU/100 cm
2
. 
 Characterization of EHEC-7 isolates. The results of molecular serotyping and 
testing for virulence genes in EHEC isolates are shown in Table 5. EHEC O157 isolates 
tested positive for all 16 genes in the MRA, while non-O157 EHEC isolates tested 
positive for 6 to 13 out of 16 genes. Only EHEC-7 isolates tested positive for the EHEC 
factor for adherence (efa1). 
 Comparison of methods for the detection of EHEC-7. The McNemar’s Chi-
squared tests comparing the culture-based method and NS results, independent of sample 
type were statistically significant (P < 0.05) or not applicable (at least one of the tests did 
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not detect any positives). For EHEC O45, O103, O111, and O145 the McNemar’s Chi-
squared test was not applicable because at least 1 of the tests did not detect any 
positives.  The κ coefficient was calculated for the comparison of the culture-based 
method and NS for EHEC O26 (Kappa = 0.58, P < 0.001), EHEC O121 (Kappa = 0.50, P 
< 0.001), and EHEC O157 (Kappa = 0.40, P < 0.001) indicating fair to moderate 
agreement (Table 6). The McNemar’s Chi-squared test indicated disagreement (P < 0.05) 
between NS and Atlas or between culture and Atlas and no significant agreements were 
observed. 
 Associations of EHEC detection. Two EHEC O98 isolates from 1 fecal sample 
and 1 carcass sample of the same animal were inferred to be the same strain by the FDA-
ECID. Similarly, 2 EHEC O157 isolates from 1 fecal sample and 1 carcass sample of the 
same animal were inferred to be the same strain. Detection of an EHEC serogroup in 
fecal samples was significantly associated with the detection of the corresponding EHEC 
serogroup on hide samples for EHEC O26 (P < 0.001), EHEC O111 (P = 0.002), EHEC 
O121 (P < 0.001), and EHEC-6 (P = 0.029) based on NS detection, and for EHEC O121 
(P < 0.001) based on detection by culture (Table 7). No significant associations were 
found between detection of an EHEC serogroup on hide samples with the detection of an 
EHEC serogroup on carcass samples.  
 
Discussion 
 Management practices and cattle type may play a role in the prevalence of STEC 
in animals and their production environments (Hancock et al., 1994; Cobbold et al., 
2004; Callaway, 2010; Besser et al., 2014; Smith, 2014a; Smith, 2014b; USDA, 2014a).  
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In one study, a lower prevalence of STEC was detected in feedlot cattle compared to 
dairy and range cattle (Cobbold et al., 2004). In the present study, 65% of culled dairy 
cattle hides were positive for EHEC-7 by NS, compared to a previous study which found 
>80% of feedlot cattle hides positive by the same method (Stromberg et al., 2015a). 
Interventions such as high pressure water washes containing sanitizing agents (e.g., 1% 
cetylpyridinium chloride) that reduce bacterial concentrations on hides have been 
effective in reducing transfer of E. coli O157 onto carcasses during processing (Arthur et 
al., 2002; Bosilevac et al., 2004; Moxley and Acuff, 2014). EHEC-7 prevalence on pre-
intervention carcasses surfaces of culled dairy cows was 7% by NS, which was similar to 
that of feedlot beef cattle (Stromberg et al., 2015a). However, these studies were done in 
different locations and different years making it difficult to make reliable comparisons.   
 Other than our recent publication in beef feedlot cattle at harvest (Stromberg et 
al., 2015a), we are aware of only 4 other publications that reported EHEC-6 data on cattle 
hides and carcasses based on culture-based protocols. In those 4 studies, prevalence 
estimates were based on proportion of samples positive instead of model-adjusted 
estimates.  Two studies conducted at a beef export abattoir in Ireland, neither indicating 
the source of the cattle (i.e., beef or dairy) and both sampling 100 cm
2
 of hides and 
carcasses, detected very low EHEC-6 prevalence. One of the studies, which did not 
include IMS in their protocol, detected only EHEC O26, and that in only 2 of 450 (0.4%) 
of carcasses and 0 of 450 hides (0.0%) (Monaghan et al., 2012).  The other study from 
Ireland used IMS for O26, O103, O111, and O145 and of 402 hides and carcasses 
cultured, detected 1 of 402 hides positive for O26 (0.2%) and no other EHEC-6 
serogroup on hides or carcasses (Thomas et al., 2012).  One study conducted on cattle at 
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an abattoir in Poland, not specifying whether of beef or dairy origin, sampling 400 cm
2
 of 
hide and carcass surface area and not including non-O157 IMS, did not isolate any 
EHEC-6 from any sample (Wieczorek et al., 2011).  However, Arthur et al. (2002), who 
cultured samples from 4,000 cm
2
 of carcass surface from beef feedlot cattle in the 
Midwest U.S. and used a protocol that involved enrichment followed by a colony blot 
screen for stx on agar plates, detected EHEC-6 in 4 of 334 carcass samples (1.2%).  
These isolates included EHEC of serogroups O103, O121 and O145.  These results 
suggest that based on culture, EHEC-6 is relatively low in prevalence, but increased 
sampling area and use of a protocol that includes serogroup-specific IMS increases the 
prevalence estimates. 
  In addition to adequate sampling area and IMS, many other factors, such as 
variability in carbohydrate source for fermentation and resistance to antimicrobials affect 
the detection of non-O157 STEC or EHEC.  Based on the variability of these organisms, 
the use of multiple agar media as conducted in our study are recommended for their 
isolation (Hussein et al., 2008; Gill et al., 2014).  In the present study, EHEC O157 was 
the most common serogroup isolated by culture either because it is truly the most 
prevalent or it is more easily detected because of the greater specificity of media.  
Approximately half of the samples that tested positive for EHEC O157:H7 by NS were 
confirmed by culture, and significant agreement (P < 0.001) was observed between NS 
and culture for detection of EHEC O157:H7. However, most samples that tested positive 
for non-O157 EHEC by NS or Atlas did not test positive by culture. This finding is 
consistent with our previous observations (Stromberg et al., 2015a) in that it appears 
there is a need to improve agar media for detection of non-O157 EHEC. It is also 
122 
 
 
 
possible that the molecular screening methods result in detection of false positives in 
some samples, in which case improved specificity is needed.  Discrepancies between 
molecular- and culture-based methods for detection of EHEC-7 have been previously 
reported. Wang et al. (2014a) reported that 93.9% of veal calf hide samples were positive 
for EHEC-7 by NS, but by culture only 53.0% were positive. Wasilenko et al. (2012) 
used another molecular screen (BAX) and culture to test retail ground beef for EHEC-7.  
By BAX, 14 of 308 samples were positive for stx, eae and at least one EHEC-7 
serogroup, but culture could confirm only 4 of these (Wasilenko et al. 2012).  Since the 
NS test sample consists of a DNA extract from an aliquot of an enrichment broth culture, 
it is able to concurrently test thousands if not millions of bacterial cells, in contrast to our 
culture-based method which would have tested approximately 50 bacterial colonies from 
the same sample (Fig. 1). This would provide one explanation why the NS test might be 
more sensitive than culture. An advantage of culture, however, is the recovery of isolates, 
which may include other EHEC serogroups that may prove useful in subsequent studies.  
For example, in the present study, EHEC O84, O98, O109 and O177 were isolated by 
culture.  These EHEC serogroups have previously been isolated from cattle (Renter et al., 
2005; Mekata et al., 2014), and caused disease in humans (Bettelheim, 2007).  
 Only two samples had EHEC-7 concentrations that were quantifiable by the 
methods used.  In both samples, the organisms were EHEC O157 and in concentrations 
nearly 10,000 CFU per unit or greater. One was a fecal sample containing 7,900  CFU/g 
and one was a hide sample  100,000 CFU/100 cm
2
. EHEC-7 were not detected in most 
pre-enrichment samples suggesting they were in low concentrations in most samples, 
indicating the importance of enrichment for their detection. Current methods to quantify 
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EHEC have relied upon real-time PCR assays for eae or stx and may overestimate the 
concentration of EHEC due the contribution of these genes from multiple different 
organisms (Conrad et al., 2014). Recently, E. coli attaching and effacing gene-positive 
conserved fragment 1 (ecf1) has been used as a gene target for detection of STEC 
(Livezey et al., 2015), and ecf1 and eae have been used as targets to enumerate EHEC 
directly in cattle feces (Luedtke et al., 2014). Although this assay allows for enumeration 
of EHEC, it quantifies the total EHEC load and not specifically EHEC-7.   
 Previously, for most EHEC-7 serogroups, no significant agreement was observed 
between a culture-based method and NS (Stromberg et al., 2015a).  In this study, 
significant agreement was observed with 3 of 7 EHEC-7 serogroups between the culture-
based method and NS; however, there was no significant agreement beyond that due to 
chance between culture and Atlas or NS and Atlas. Atlas detects all EHEC compared to 
NS which only detects EHEC-7 and the culture-based method used in this study targeted 
EHEC-7 by using IMS beads directed against those 7 serogroups. Therefore, Atlas results 
only for EHEC O157 could be compared to NS and culture.   
Hides can be contaminated by multiple sources, and with feces from one animal 
or multiple animals in lairage (Arthur et al., 2007). Significant association between the 
detection of an EHEC in fecal samples with the detection of an EHEC on hide samples 
was determined for EHEC O26, O111, O121, and EHEC-6 and supports the hypothesis 
that feces are a major source of hide contamination.  Effective pre-harvest interventions 
that reduce carriage of EHEC in the intestines e.g., vaccines (Besser et al., 2014; Smith, 
2014a; Smith, 2014b) may reduce prevalence on hides. 
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 In summary, these data were collected to determine the prevalence of EHEC-7 in 
culled dairy cattle using multiple detection methods. Molecular screening assays detected 
more EHEC than the culture-based method. Although there was significant agreement for 
some EHEC-7 serogroups between the NS and culture-based method, continued 
improvement is needed for accurate detection and isolation of EHEC-7 in the matrices 
tested.  Significant associations between EHEC detection in fecal samples with EHEC 
detection on hide samples supports the need to identify effective pre-harvest interventions 
to reduce EHEC contaminated hides.  Prevalence and concentration estimates will be 
further used to populate a quantitative microbial risk assessment model. 
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Table 1. List of primers for screening enterohemorrhagic E. coli 
Gene Primer Sequence (5’→3’) 
Conc. 
(nM) 
Amplicon 
Size (bp) Reference 
nleF nleF F ATGTTACCAACAAGTGGTTCTTC 250 567 Coombes et al., 2008 
 nleF R ATCCACATTGTAAAGATCCTTTGTT 250   
subA SubHCDF TATGGCTTCCCTCATTGCC 300 556 Paton and Paton, 2005 
 SubSCDR TATAGCTGTTGCTTCTGACG 300   
eae eaeAF GACCCGGCACAAGCATAAGC 150 384 Paton and Paton, 1998 
 eaeAR CCACCTGCAGCAACAAGAGG 150   
nleB nleB F GGAAGTTTGTTTACAGAGACG 500 297 Coombes et al., 2008 
 nleB R AAAATGCCGCTTGATACC 500   
espK1 EspK_F1 ATCAAAAGCGAAATCACACC 500 200 This report 
 EspK_R1 TGTAATTTTTCACAGTTAATGACG 500   
stx
a 
Stx1/2-F TTTGTYACTGTSACAGCWGAAGCYTTACG 1,000 132 Wasilenko et al., 2012 
 Stx1/2-R CCCCAGTTCARWGTRAGRTCMACDTC 1,000   
a
Degenerate nucleotide codes: Y (C,T), W (A,T), R (A,G), M (A,C), D (A,G,T), S (C,G).  
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Table 2. Number of positive samples and model-adjusted prevalence estimates of enterohemorrhagic E.coli (EHEC) in fecal samples 
from culled dairy cows as detected by culture isolation, NeoSEEK STEC Detection and Identification test (NS), and the Atlas STEC 
EG2 Combo Detection Assay (Atlas) 
 n = 100 
Serogroup or 
virulence gene 
Culture  NS  Atlas 
No. of 
positive 
samples 
% Mean 
prevalence 
Prevalence 
95% CI  
No. of 
positive 
samples 
% Mean 
prevalence 
Prevalence 
95% CI  
No. of 
positive 
samples 
% Mean 
prevalence 
Prevalence 
95% CI 
EHEC O26 1 1.01 0.09-9.90  1 1.01 0.09-9.90  NA
a
 NA NA 
EHEC O45 0 0.00 0.00-0.00  11 11.00 6.20-18.78  NA NA NA 
EHEC O103 0 0.00 0.00-0.00  7 7.00 3.37-13.96  NA NA NA 
EHEC O111 1 1.00 0.12-7.94  7 4.90 1.20-17.96  NA NA NA 
EHEC O121 0 0.00 0.00-0.00  0 0.00 0.00-0.00  NA NA NA 
EHEC O145 0 0.00 0.00-0.00  7 6.74 2.47-17.05  NA NA NA 
EHEC O157 6 6.13 2.22-15.84  4 4.00 1.51-10.18  29 29.10 20.23-39.92 
Non-O157 EHEC NA NA NA  NA NA NA  29 29.11 18.27-43.00 
EHEC-6 2 2.10 0.45-9.26  24 23.59 13.86-37.21  NA NA NA 
EHEC-7 7 6.54 2.40-16.63  26 25.90 16.08-38.94  NA NA NA 
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stx 20 20.42 9.50-38.54  90 90.00 82.40-94.53  NA NA NA 
eae 31 31.40 22.06-42.53  83 83.00 74.34-89.16  NA NA NA 
a
NA: not applicable. 
Model-adjusted prevalence estimates for all EHEC serogroup and virulence genes for each diagnostic protocol were obtained from mixed-effects models that 
incorporated a random intercept for sampling date. 
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Table 3. Number of positive samples and model-adjusted prevalence estimates of enterohemorrhagic E. coli (EHEC) on hide samples 
from culled dairy cows as detected by culture isolation, NeoSEEK STEC Detection and Identification test (NS), and the Atlas STEC 
EG2 Combo Detection Assay (Atlas) 
 n = 100 
Serogroup or 
virulence gene 
Culture  NS  Atlas 
No. of 
positive 
samples 
% Mean 
prevalence 
Prevalence 
95% CI  
No. of 
positive 
samples 
% Mean 
prevalence 
Prevalence 
95% CI  
No. of 
positive 
samples 
% Mean 
prevalence 
Prevalence 
95% CI 
EHEC O26 5 3.19 0.50-17.59  7 1.53 0.06-28.70  NA
a
 NA NA 
EHEC O45 0 0.00 0.00-0.00  36 27.10 10.77-53.36  NA NA NA 
EHEC O103 0 0.00 0.00-0.00  10 10.00 5.47-17.60  NA NA NA 
EHEC O111 1 1.00 0.14-6.75  15 12.03 4.76-27.26  NA NA NA 
EHEC O121 1 1.01 0.09-9.90  3 1.71 0.14-17.99  NA NA NA 
EHEC O145 0 0.00 0.00-0.00  23 18.59 7.71-38.45  NA NA NA 
EHEC O157 9 6.65 1.85-21.22  7 6.04 2.05-16.51  51 57.03 32.43-78.59 
Non-O157 EHEC NA NA NA  NA NA NA  46 38.29 17.27-64.83 
EHEC-6 7 6.68 2.39-17.31  62 61.37 46.84-74.13  NA NA NA 
EHEC-7 16 15.56 8.35-27.16  65 64.94 49.44-77.83  NA NA NA 
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stx 24 24.11 16.08-34.52  98 98.00 92.36-99.50  NA NA NA 
eae 38 39.34 21.39-60.72  98 98.00 92.36-99.50  NA NA NA 
a
NA: not applicable. 
Model-adjusted prevalence estimates for all EHEC serogroup and virulence genes for each diagnostic protocol were obtained from mixed-effects models that 
incorporated a random intercept for sampling date. 
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Table 4.  Number of positive samples and model-adjusted prevalence estimates of enterohemorrhagic E. coli (EHEC) on pre-
intervention carcass surface samples from culled dairy cows as detected by culture isolation, NeoSEEK STEC Detection and 
Identification test (NS), and the Atlas STEC EG2 Combo Detection Assay (Atlas) 
 n = 100 
Serogroup or 
virulence gene 
Culture  NS  Atlas 
No. of  
positive 
samples 
% Mean 
prevalence 
Prevalence 
95% CI  
No. of  
positive 
samples 
% Mean 
prevalence 
Prevalence 
95% CI  
No. of  
positive 
samples 
% Mean 
prevalence 
Prevalence 
95% CI 
EHEC O26 0 0.00 0.00-0.00  3 1.39 0.09-17.35  NA
a 
NA NA 
EHEC O45 0 0.00 0.00-0.00  0 0.00 0.00-0.00  NA NA NA 
EHEC O103 0 0.00 0.00-0.00  4 4.00 1.51-10.18  NA NA NA 
EHEC O111 0 0.00 0.00-0.00  0 0.00 0.00  NA NA NA 
EHEC O121 0 0.00 0.00-0.00  0 0.00 0.00  NA NA NA 
EHEC O145 0 0.00 0.00-0.00  2 2.00 0.50-7.64  NA NA NA 
EHEC O157 1 1.00 0.12-7.93  1 1.00 0.14-6.75  3 3.00 0.97-8.89 
Non-O157 EHEC NA NA NA  NA NA NA  28 28.01 19.48-38.50 
EHEC-6 0 0.00 0.00-0.00  7 7.00 3.37-13.96  NA NA NA 
EHEC-7 1 1.00 0.12-7.94  7 7.00 3.37-13.96  NA NA NA 
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stx 3 2.80 0.61-11.90  45 41.61 24.78-60.65  NA NA NA 
eae 12 12.00 6.94-19.95  50 50.06 32.25-67.86  NA NA NA 
a
NA: not applicable. 
Model-adjusted prevalence estimates for all EHEC serogroup and virulence genes for each diagnostic protocol were obtained from mixed-effects models that 
incorporated a random intercept for sampling date. 
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Table 5.  Distribution of virulence genes in Enterohemorrhagic E. coli isolates recovered from post-enrichment cultures 
Serotype Virulence genes 
No. of detected  
MRA
a
 genes pagC sen efa1 
No. of isolates 
Feces Hide Carcass Total 
O26:[H11] stx1, eae-β1, ehxA 13 - + + 1 4 0 5 
O26:[H11] stx1, eae-β1, ehxA 6 - + + 0 1 0 1 
O84:[H2] stx1, eae-ζ, ehxA 6 + + - 0 0 1 1 
O98:NM stx1, eae-ζ, ehxA 8 + + - 6 0 1 7 
O109:[H10] stx2, eae-ι, ehxA 6 - - - 1 0 0 1 
O111:[H8] stx1, eae-γ2, ehxA 9 + + + 1 1 0 2 
O121:[H19] stx2, eae-ε, ehxA 7 + + + 0 1 0 1 
O157:[H7] stx2, eae-γ1, ehxA 16 + + + 5 2 0 7 
O157:[H7] stx1, stx2, eae-γ1, ehxA 16 + + + 5 23 5 33 
O177:[H25] stx2, eae-β1, ehxA 12 - + - 3 8 0 11 
a
MRA: molecular risk assessment. 
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Table 6. Cohen’s kappa coefficient and McNemar’s χ2 analysis for agreement between a 
culture-based method and NeoSEEK STEC Detection and Identification test, independent 
of sample type 
Serogroup Kappa P-value McNemar’s χ2 P-value 
EHEC O26 0.58 <0.0001 0.059 
EHEC O45 NA
a
 NA NA
 
EHEC O103 NA NA NA 
EHEC O111 0.16 <0.0001 <0.0001 
EHEC O121 0.50 <0.0001 0.157 
EHEC O145 NA NA NA 
EHEC O157 0.40 <0.0001 0.317 
a
NA: not applicable (at least one of the tests did not detect any positives). 
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Table 7.  P-values of associations between the detection of an enterohemorrhagic E. coli 
(EHEC) serogroup or virulence gene in fecal samples with the presence of an EHEC 
serogroup or virulence gene on hide samples using generalized linear mixed models 
EHEC serogroup or virulence 
gene in fecal samples 
EHEC serogroup or virulence gene on hide samples 
Detection method 
Culture P-value NS
a
 P-value Atlas
b
 P-value 
EHEC O26 0.989 <0.001 NA
c 
EHEC O45 NA 0.973 NA 
EHEC O103 NA 0.764 NA 
EHEC O111 0.989 0.002 NA 
EHEC O121 <0.001 <0.001 NA 
EHEC O145 NA 0.139 NA 
EHEC O157 0.418 0.323 0.262 
Non-O157 EHEC NA NA 0.519 
EHEC-6 0.985 0.029 NA 
EHEC-7 0.952 0.251 NA 
stx 0.625 0.998 NA 
eae 0.373 0.242 NA 
a
NS: NeoSEEK Detection and Identification test. 
b
Atlas: Atlas STEC EG2 Combo Detection Assay. 
c
NA: not applicable. 
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Fecal, hide, or 
carcass sample 
Feces + 9 ml, hide + 90 
ml, and carcass + 80 ml 
of E. coli broth enriched 
for 6 h at 40°C 
Directly streaked for 
isolation on 
CHROMagar STEC 
≤4 colonies 
subcultured 
PCR for stx, eae, 
espK1, nleB, nleF, 
and subA 
stx- and eae-
positive 
PCR for O26, O45, 
O103, O111, O121, 
and O145 
IMS treatment with 
bead pool for E. coli 
O26, O45, and O121 
50 µl plated 
on SHIBAM 
≤20 colonies 
subcultured 
Pooled DNA 
from 6 colonies 
tested for stx 
by PCR 
stx-positive 
Individual colony 
DNA tested for O26, 
O45, O103, O111, 
O121, O145, O157, 
stx1, stx2, eae and 
ehxA 
IMS treatment with 
bead pool for E. coli 
O103, O111, and 
O145 
50 µl plated 
on SHIBAM 
≤20 colonies 
subcultured 
Pooled DNA 
from 6 colonies 
tested for stx 
by PCR 
stx-positive 
Individual colony 
DNA tested for O26, 
O45, O103, O111, 
O121, O145, O157, 
stx1, stx2, eae and 
ehxA 
IMS treatment for E. 
coli O157 
50 µl plated on 
CCT-
CHROMagar 
O157 
≤5 colonies 
subcultured 
Pooled DNA 
from 6 colonies 
tested for stx 
by PCR 
stx-positive 
Individual colony 
DNA tested for O26, 
O45, O103, O111, 
O121, O145, O157, 
stx1, stx2, eae and 
ehxA 
Atlas 
EHEC O157 
positive 
IMS treatment 
for E. coli 
O157 
50 µl and 1 µl 
plated on NT-
CHROMagar 
O157 
≤4 colonies 
subcultured 
PCR for O157, 
H7, stx1, stx2, 
and eae 
Non-O157 
EHEC positive 
Serogroup-
specific IMS 
treatment 
50 µl plated 
on SDA 
≤4 colonies 
subcultured 
PCR for stx, eae, 
espK1, nleB, 
nleF, and subA 
stx- and eae-
positive 
PCR for O26, 
O45, O103, 
O111, O121, 
and O145 
50 µl plated 
on WBAM 
≤4 colonies 
subcultured 
PCR for stx, eae, 
espK1, nleB, 
nleF, and subA 
stx- and eae-
positive 
PCR for O26, 
O45, O103, 
O111, O121, 
and O145 
NS 
Non-O157 
EHEC positive 
Serogroup-
specific IMS 
treatment 
50 µl plated 
on SDA 
≤4 colonies 
subcultured 
PCR for stx, eae, 
espK1, nleB, 
nleF, and subA 
stx- and eae-
positive 
PCR for O26, 
O45, O103, 
O111, O121, 
and O145 
50 µl plated 
on WBAM 
≤4 colonies 
subcultured 
PCR for stx, eae, 
espK1, nleB, 
nleF, and subA 
stx- and eae-
positive 
PCR for O26, 
O45, O103, 
O111, O121, 
and O145 
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Figure 1. Flowchart of culture- and molecular-based methods performed for detection of enterohemorrhagic E. coli.  Atlas, Atlas 
STEC EG2 Combo Detection Assay; CCT-CHROMagar O157, CHROMagar O157 containing cefixime, cefsulodin, and potassium 
tellurite; IMS, immunomagnetic separation; NS, NeoSEEK STEC Detection and Identification; NT-CHROMagar O157, CHROMagar 
O157 containing novobiocin and potassium tellurite; SHIBAM, STEC heart infusion washed blood agar with mitomycin C; SDA, 
STEC differentiation agar; WBAM, washed blood agar with mitomycin C. 
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Abstract 
 The isolation and quantification of Shiga toxin-producing Escherichia coli 
(STEC) from cattle fecal samples remains difficult. The objective of this study was to 
compare agar media for the detection and quantification of STEC in cattle feces. 
Comparison studies were performed using CHROMagar
TM
 STEC, Possé differential agar 
(Possé), Possé modified by the reduction or addition of antimicrobials, STEC heart 
infusion washed blood agar with mitomycin C (SHIBAM), and SHIBAM modified by 
the addition of antimicrobials.  Fourteen STEC strains, two each belonging to serogroups 
O26, O45, O103, O111, O121, O145, and O157, were used to test their detection in 
inoculated fecal samples at concentrations of 10
2
 or 10
3
 colony-forming units (CFU)/g. 
One STEC strain from each of these six non-O157 serogroups was used to estimate the 
concentration of recovered STEC in feces inoculated at 10
3
, 10
4
, or 10
5
 CFU/g.  
Significantly (P < 0.05) more samples were positive for STEC when plated on Possé 
containing reduced concentrations of novobiocin and potassium tellurite compared to 
SHIBAM, but not SHIBAM modified by containing these same antimicrobials at the 
same concentrations.  Numerically, more samples were positive for STEC using this 
same form of modified Possé compared to Possé, but this difference was not statistically 
significant. More samples were positive for STEC cultured on CHROMagar STEC 
compared to Possé, (P < 0.05) and modified Possé (P = 0.05).  Most inoculated fecal 
samples below 10
4 
CFU/g of feces were underestimated for the concentration of STEC, 
or were not quantifiable using CHROMagar STEC or modified Possé. These results 
suggest that CHROMagar STEC performs better than Possé or SHIBAM for detection of 
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STEC in bovine feces, but adjustments in the concentrations of novobiocin and potassium 
tellurite in the latter two media result in significant improvements in their performance.  
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Introduction 
 Shiga toxin-producing Escherichia coli (STEC) are enteric pathogens of humans 
that cause hemorrhagic colitis and hemolytic-uremic syndrome (Thorpe, 2004). STEC are 
naturally found in the intestinal tract of ruminants and these organisms are shed in 
ruminant feces (Karmali et al., 2010). STEC are commonly transmitted to humans 
through the ingestion of contaminated food (Erickson and Doyle 2007), particularly beef 
products (Duffy et al., 2014). Thus, the U.S. Department of Agriculture Food Safety and 
Inspection Service declared seven serogroups of intimin-positive STEC that account for 
the majority of disease due to STEC in the U.S. as adulterants in raw, non-intact beef 
(USDA 2012).  
 Detection of STEC is critical for food safety, clinical diagnosis of STEC 
infection, and determination of environmental prevalence. Epidemiological studies 
(Wells et al., 1991) and clinical laboratories (March and Ratnam 1986; Krishnan et al., 
1987; Simor et al., 1990) have used sorbitol-MacConkey agar to detect sorbitol-negative 
E. coli O157:H7, which lack the ability to ferment sorbitol within 24 h. The addition of 
antimicrobials such as cefixime and potassium tellurite to agar media has further 
improved detection of E. coli O157:H7 (Sanderson et al., 1995). However, most non-
O157 STEC ferment sorbitol and have varying levels of resistance to these antimicrobials 
(Hussein et al., 2008). Therefore, sorbitol-MacConkey agar is not a suitable agar media 
to detect non-O157 STEC, and would result in undetected non-O157 STEC (Klein et al., 
2002).   
 Non-O157 STEC are estimated to account for approximately 64% of foodborne 
illness caused by STEC in the U.S. (Scallan et al., 2011), and their detection in clinical 
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patients has increased in recent years (Gould et al., 2013). STEC O26, O45, O103, O111, 
O121, and O145 (STEC-6) caused 71% of the cases of non-O157 STEC infection in the 
US from 1983 to 2002 (Brooks et al., 2005). However, detection of non-O157 STEC 
remains challenging due to their diversity (Gill et al., 2014). Agar media designed to 
detect non-O157 STEC have relied on fermentation of specific carbohydrates, β-
galactosidase activity, and resistance to antimicrobials (Possé et al., 2008; Kalchayanand 
et al., 2013). Organism isolation remains important for confirmational assays such as 
hyperspectral imaging (Windham et al., 2013), latex agglutination (Medina et al., 2012), 
PCR (Bai et al., 2012), and other nucleic acid detection methods (Blais et al., 2012). 
 Concentration estimates of STEC are important for assessing the risk of STEC in 
the food chain (Ekong et al., 2015). Concentration  has been determined by use of spiral 
plate methods for STEC O157:H7 (Robinson et al., 2004; Berry and Wells 2008) or real-
time PCR assays that quantify total STEC load or specific serogroups of STEC (Conrad 
et al., 2014; Luedtke et al., 2014; Ahmed et al., 2015). Real-time assays with multiple 
targets may detect genes contributed by multiple organisms. Since there is no single 
target for STEC-7, organism isolation by spiral plating could be used to determine if the 
O-group, Shiga toxin (stx) and intimin (eae) genes are from one organism. 
 The purpose of this study was to assess the performance of agar media for the 
detection of STEC-6 and STEC O157:H7 (STEC-7) and quantification of STEC-6 in 
cattle feces. This study compared CHROMagar
TM
 STEC, Possé differential agar (Possé; 
Possé et al., 2008), modifications of Possé, STEC heart infusion washed blood agar with 
mitomycin C (SHIBAM), and a modification of SHIBAM for the detection of STEC-7 in 
inoculated cattle fecal samples. Additionally, CHROMagar STEC and a modification of 
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Possé were used to establish a quantification method for STEC-6 in inoculated cattle 
fecal samples by spiral plating. 
 
Materials and Methods 
 Bacterial strains and preparation of inoculum. All strains used in this study 
were STEC, and were obtained either from Dr. Shannon Manning (Michigan State 
University), Dr. David Renter (Kansas State University), Dr. John Luchansky (USDA, 
Agricultural Research Service, Eastern Regional Research Center), or our laboratory 
collection. Frozen stock cultures (-80°C) of strains were streaked onto Luria-Bertani 
broth, Miller (LB; BD, Sparks, MD) agar plates without antibiotics or with 100 mg/liter 
rifampicin (Sigma) when appropriate and incubated at 37°C for 24 h. A single colony 
was inoculated in LB with corresponding antibiotics for 24 h at 37°C in a stationary 
culture. Serial ten-fold dilutions of the inoculum were prepared in buffered peptone water 
(BPW), and used to inoculate fecal samples at a concentration of 10
2
 or 10
3
 colony-
forming units (CFU)/g of feces for detection studies and 10
3
, 10
4
, or 10
5
 CFU/g of feces 
for quantification studies. BPW was used as a mock inoculation. 
 Sample collection. Fresh feces were collected from steers housed one per pen at 
the University of Nebraska-Lincoln, and processed as previously described (Stromberg et 
al., 2015a).  Briefly, one gram of cattle feces was suspended in 9 ml of E. coli broth (EC; 
Oxoid Ltd., Hampshire, UK) and vortexed for 1 min. After inoculation, samples were 
vortexed for 20 s and enriched for 6 h at 40°C in a static culture.   
 Agar media. Agar media was prepared according to the manufacturers’ 
instructions or as published with minor modifications. CHROMagar STEC (DRG Int., 
143 
 
 
 
Springfield, NJ) was prepared according to the manufacturer’s instructions and 
CHROMagar STEC with rifampicin was prepared by adding rifampicin at 100 mg/liter 
and without adding the CHROMagar STEC supplement. Possé differential medium was 
prepared according to the published instructions (Possé et al., 2008).  The first modified 
form of Possé differential medium was made by reducing the concentrations of 
novobiocin (5.0 mg/liter; Sigma) and potassium tellurite (0.15 mg/liter; Sigma) and by 
adding cefixime trihydrate (Sigma) at 0.05 mg/liter (mPossé1). A second modified form 
of Possé as described by Stromberg et al. (2015b) was made by reducing novobiocin (5.0 
mg/liter) and potassium tellurite (0.5 mg/liter; mPossé2). Modified Possé with rifampicin 
was prepared by adding rifampicin to Possé differential agar at 100 mg/liter, with reduced 
bile salts (1.5 g/liter), and containing no novobiocin or potassium tellurite. SHIBAM was 
prepared according to the FDA Bacteriological Analytical Manual (Feng et al., 2011) and 
modified by adding novobiocin at 5.0 mg/liter and potassium tellurite at 0.5 mg/liter 
(mSHIBAM).  
 Detection of STEC-7 on mPossé2 and SHIBAM. Two independent experiments 
were performed to compare mPossé2 and SHIBAM for the detection of STEC. After 
fecal samples were inoculated and enriched in EC for 6 h, 490-µl aliquots were diluted in 
490 µl of PBS with 0.05% Tween-20 and subjected to three separate immunomagnetic 
separation (IMS) treatments using a KingFisher
TM
 Flex Magnetic Particle Processor 
(Thermo Scientific, Waltham, MA). The first treatment consisted of 20 µl of anti-E. coli 
O157 IMS Dynabeads
®
 (Invitrogen, Carlsbad, CA), the second treatment used a 20-µl 
pool of O103, O111 and O145 IMS beads (Abraxis LLC, Warminster, PA), and the third 
treatment used a 20-µl pool of O26, O45 and O121 IMS beads (Abraxis). After IMS, the 
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beads were dropped into 1.0 ml of BPW. The bead suspension was serial diluted in BPW 
and 50 µl of each bead suspension diluted 100-fold was spread plated onto mPossé2 and 
SHIBAM and incubated at 37°C for 18 h. On mPossé2, ≤20 red/blue-purple and green 
colonies were picked and ≤20 enterohemolytic colonies were picked from SHIBAM. 
Colonies were suspended in 50 µl of water and heated for 10 min at 95°C for use as DNA 
template in PCR reactions. Five colonies were pooled and tested by PCR for stx 
according to Monday et al. (2007). Individual colonies from PCR positive pools were 
tested by 11-plex PCR for genes representing EHEC-7 serogroups, stx1, stx2, EHEC-
hemolysin (ehxA) (Bai et al., 2012) modified with primers for eae (Blanco et al., 2004) 
and primers for O111 as described by Noll et al. (2015) to confirm the inoculum.   
 Detection of STEC-7 on mPossé2 and mSHIBAM. Three independent 
experiments were performed to compare mPossé2 and mSHIBAM for the detection of 
STEC. Fecal samples were processed and colonies were tested as described for the 
comparison between mPossé2 and SHIBAM with a minor modification. After IMS, the 
bead suspension was dropped into 1.0 ml of BPW and serial diluted in BPW. Fifty µl of 
non-diluted or 10-fold diluted bead suspension was spread plated onto mPossé2 and 50 µl 
of 100-fold bead suspension was spread plated onto mSHIBAM and incubated at 37°C 
for 18 h. On mPossé2, ≤20 red/blue-purple and green colonies were picked and ≤20 
enterohemolytic colonies were picked from mSHIBAM. Colonies were tested by 11-plex 
PCR as described above (Blanco et al., 2004; Bai et al., 2012; Noll et al., 2015). 
 Detection of STEC-7 on CHROMagar STEC, Possé, mPossé1, and mPossé2. 
Replicate experiments were performed to compare CHROMagar STEC, Possé, mPossé1 
and mPossé2 for the detection of STEC. After enrichment, separate aliquots were 
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subjected IMS treatments with 20 µl of each IMS bead type (O26, O45, O103, O111, 
O121, O145, and O157). After IMS, the beads were dropped into 1.0 ml of BPW and 
diluted 10-fold and 100-fold in BPW. Fifty µl of each bead suspension was spread plated 
onto each agar and incubated at 37°C for 18 h. Colonies were picked from plates with 25 
to 250 colonies. On Possé, mPossé1, and mPossé2 plates inoculated with O26, O45, 
O103, O111, or O157 IMS beads, ≤six red/blue-purple colonies were picked and for 
O121 or O145 IMS beads, ≤six red/blue-purple and green colonies were picked. On 
CHROMagar STEC, ≤six mauve colonies were picked per plate. Colonies were 
suspended in 50 µl of water and heated for 10 min at 95°C for use as DNA template in 
PCR reactions.  Individual colonies were tested by 11-plex PCR as described above 
(Blanco et al., 2004; Bai et al., 2012; Noll et al., 2015).   
 Quantification of STEC-6 strains in inoculated cattle fecal samples. 
Rifampicin-resistant strains were used to estimate the concentration of STEC recovered 
on CHROMagar STEC and mPossé2 from inoculated fecal samples from one animal. 
Samples were inoculated at a concentration of approximately 10
3
, 10
4
, or 10
5
 CFU/g of 
feces in nine ml of EC broth, and 50 µl was spiral plated onto CHROMagar STEC, 
CHROMagar STEC with rifampicin, mPossé2 and mPossé with rifampicin using an Eddy 
Jet 2 spiral plater (Neu-tec, Farmingdale, NY). Red/blue-purple and green colonies were 
counted on mPossé2 and mPossé with rifampicin plates and mauve colonies were 
counted on CHROMagar STEC and CHROMagar STEC with rifampicin. A total of ≤10 
colonies per plate of the target phenotype were picked and each colony was suspended in 
50 µl of water each. The suspended colonies were heated for 10 min at 95°C and tested 
by 11-plex PCR (Blanco et al., 2004; Bai et al., 2012; Noll et al., 2015). Concentration 
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was determined by the proportion of colonies that tested positive for O-group, stx, and 
eae that matched that of the inoculum. 
 Statistical analysis. Detection of STEC on different agar media was compared 
using a binary distribution in SAS v 9.3 (PROC GLIMMIX, SAS Institute INC., Cary, 
NC). Statistically significant results were represented by P-values <0.05. 
 
Results 
Agar comparison studies using inoculated cattle fecal samples. Two independent 
experiments were performed for the comparison between mPossé2 and SHIBAM for the 
recovery of STEC in inoculated fecal samples. Of the strains tested, six of 14 were 
detected on both agars, seven of 14 were detected only on mPossé2, and one of 14 was 
not detected. STEC strains were detected in 11 of 28 on mPossé2 and two of 28 samples 
on SHIBAM when inoculated with 10
2
 CFU/g, and 17 of 28 on mPossé2 and four of 28 
samples on SHIBAM when inoculated with 10
3
 CFU/g. In total, STEC strains were 
detected in 28 of 56 when plated on mPossé2 compared to six of 56 samples when plated 
on SHIBAM (TABLE 1).  mPossé2 detected significantly (P < 0.05) more STEC positive 
samples compared to SHIBAM. 
 In three independent experiments, mPossé2 and mSHIBAM were compared for 
the recovery of STEC in inoculated fecal samples. Of the strains tested, four of 14 were 
recovered on mPossé2 alone, and 10 of 14 were not recovered on either agar. STEC 
strains were detected in two of 42 on mPossé2 and zero of 42 samples on mSHIBAM 
when inoculated with 10
2
 CFU/g, and four of 42 on mPossé2 and zero of 42 samples on 
SHIBAM when inoculated with 10
3
 CFU/g. In total, STEC strains were detected in six of 
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84 samples plated on mPossé2, however, no STEC were recovered when plated on 
mSHIBAM (TABLE 2). mPossé2 detected fewer STEC positive samples than in the 
previous comparison, and did not detect significantly more STEC compared to 
mSHIBAM. 
 In two independent experiments, CHROMagar STEC, Possé, mPossé1, and 
mPossé2 were compared for the recovery of STEC in inoculated cattle feces. No strains 
were detected on all media, three of 14 were recovered on CHROMagar STEC only, 
three of 14 were recovered on all except mPossé1, two of 14 were recovered on 
CHROMagar STEC and mPossé2 only, one of 14 were recovered on CHROMagar STEC 
and Possé only, one of 14 were recovered on all except Possé, and four of 14 were not 
recovered. STEC strains were detected in nine of 28 on CHROMagar STEC, four of 28 
on Possé, one of 28 on mPossé1, and four of 28 samples on mPossé2 when inoculated 
with 10
2
 CFU/g. When inoculated with 10
3
 CFU/g, STEC were detected in eight of 28 on 
CHROMagar STEC, two of 28 on Possé, zero of 28 on mPossé1, and five of 28 samples 
on mPossé2. In total, STEC were recovered from 17 of 56 plated on CHROMagar STEC, 
nine of 56 on mPossé2, six of 56 on Possé, and one of 56 samples on mPossé1 (TABLE 
3). Significantly (P < 0.05) more STEC positive samples were detected by plating on 
CHROMagar STEC compared to Possé and mPossé1, and approached significance (P = 
0.05) compared to mPossé2. Possé was not significantly different compared to mPossé1 
or mPossé2. However, mPossé2 detected significantly (P <0.05) more STEC positive 
samples compared to mPossé1. 
 Quantification of STEC using inoculated cattle fecal samples. Rifampicin 
resistant STEC strains were spiral plated on CHROMagar STEC and mPossé2 to 
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determine whether STEC-6 strains could be quantified on these media. CHROMagar 
STEC and mPossé2 were also supplemented with rifampicin to suppress background 
organisms and allow for optimal recovery of STEC. No strains were quantifiable in 
samples inoculated with STEC at 6.2 x 10
2
 to 1.0 x 10
3
 CFU/g. However, when 
inoculated at 6.2 x 10
3
 to 1.0 x 10
4
 CFU/g, two of six strains were quantifiable on 
CHROMagar STEC and CHROMagar STEC supplemented with rifampicin, one of six 
strains were quantifiable on mPossé2, and 0 of six strains were quantifiable on mPossé2 
with rifampicin.  When inoculated at 6.2 x 10
4
 to 1 x 10
5
 CFU/g, five of six strains were 
quantifiable on CHROMagar STEC with rifampicin and mPossé2 with rifampicin, four of 
six strains were quantifiable on CHROMagar STEC, and three of six strains were 
quantifiable on mPossé2 (TABLE 4). 
 
Discussion 
 Successful detection of STEC in a complex background requires an agar media 
that suppresses the growth of background organisms with minimal suppression of the 
growth of STEC. In addition to reducing background organisms for detection of STEC, 
other factors such as cost, time to prepare the media, shelf life, and ease of interpreting 
phenotypes are important in agar selection (Kase et al., 2015). In general, commercial 
agars are more expensive but quicker to prepare compared to published agars such as 
Possé and SHIBAM.  STEC are screened based on one phenotype on CHROMagar STEC 
and SHIBAM. STEC on CHROMagar STEC can vary in their shade of mauve from 
purple/pink to brown. For SHIBAM, it can be difficult to determine the enterohemolytic 
phenotype, and other E. coli may present as α-hemolytic, which can obscure the target 
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phenotype. On Possé and modifications of Possé, STEC are screened based on three 
phenotypes (blue-purple, red-purple, and green). It can be difficult to discriminate 
between blue-purple and red-purple on Possé and modifications of Possé in the fecal 
background. 
 The matrix is also important when evaluating an agar media. Cattle feces will 
likely have a higher concentration of non-pathogenic E. coli and other background 
organisms compared to foods. The FDA recommends using Levine’s Eosin-Methylene 
Blue and SHIBAM for isolating non-O157 STEC (Feng et al., 2011). Lin et al. (2012) 
found that SHIBAM was useful for isolating non-O157 STEC from romaine lettuce and 
tomatoes. Although SHIBAM may be suitable for food products with low numbers of 
background organisms, this study found that SHIBAM is not a suitable agar for detection 
of STEC in cattle feces. A significant difference was not found when mSHIBAM was 
compared with mPossé2 even though no STEC were detected on mSHIBAM.  A high 
number of background organisms in these fecal samples may have reduced the ability to 
recover STEC. 
 Agar media designed to detect E. coli O157 use potassium tellurite as a means to 
select against non-pathogenic E. coli and other enteric organisms (Sanderson et al., 
1995). Verhaegen et al. (2015) compared the isolation of a variety of non-O157 STEC 
including those of the O26, O45, O103, O111, and O145 serogroups on multiple agar 
media in pure culture. There was a correlation between growth of the STEC strain on 
Possé and CHROMagar STEC with the presence of the tellurite resistance gene terB 
(Verhaegen et al., 2015).The agars tested in this study had a range of potassium tellurite 
concentrations from 0.15 mg/liter to 2.50 mg/liter or an unknown concentration in 
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CHROMagar STEC. mPossé2, which had higher levels of potassium tellurite, detected 
significantly more STEC positive fecal samples compared to mPossé1. mPossé1 had 
concentrations of potassium tellurite, novobiocin, and cefixime as recommended by the 
Microbiology Laboratory Guidebook for detection and isolation of non-O157 STEC on 
modified Rainbow agar (USDA 2014). A higher level of potassium tellurite may increase 
the detection rate of STEC and suppress the growth of non-target organisms.  
 CHROMagar STEC has been evaluated on human stool samples (Gouali et al., 
2013) and in pure cultures and beef (Gill et al., 2012). In stool samples, 82% of samples 
that were found to be Shiga toxin-positive resulted in recovery of a STEC on 
CHROMagar STEC (Gouali et al., 2013). Gill et al. (2012) found lower recovery 
concentrations on CHROMagar STEC in pure culture and in inoculated beef compared to 
brain heart infusion agar. These results suggest that some STEC may be inhibited on 
CHROMagar STEC. This study found that some STEC could not be recovered from 
enriched fecal samples on CHROMagar STEC or on other agars tested. 
 CHROMagar O157 has been used in spiral plate quantification of STEC O157 
(Robinson et al., 2004; Berry and Wells, 2008), and mPossé2 has been used to quantify 
STEC in feces, hide and carcass samples (Stromberg et al., 2015c). To our knowledge 
this is the first report of the use of CHROMagar STEC for spiral plate quantification of 
STEC-6. For most samples, quantification by spiral plating underestimated the 
concentration of STEC or did not quantify STEC in the fecal sample. Even when 
rifampicin was supplemented in the agar media to reduce background organisms, STEC 
were infrequently enumerated at their true values.  Most samples could be enumerated 
when concentrations were above 10
4
 CFU/g. These results suggest that some strains can 
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be quantified by spiral plating on CHROMagar STEC or mPossé2, but their enumeration 
may be underestimated.   
 In conclusion, there is no single optimal agar media for detection of STEC-7 in 
cattle feces. Although, this study suggests that CHROMagar STEC and mPossé2 detect 
more STEC positive samples compared to other agar media tested, some STEC strains 
remained undetected when using these media. Additionally, this study established that 
CHROMagar STEC and mPossé2 could be used to quantify STEC-6 in cattle feces. 
Further studies are needed to determine the optimum antimicrobial concentrations in agar 
media for detection of STEC-7. 
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Table 1. Comparison between Possé differential agar with reduced novobiocin and potassium tellurite (mPossé2) and STEC heart 
infusion washed blood agar with mitomycin C (SHIBAM) for the detection of Shiga toxin-producing E. coli in inoculated cattle fecal 
samples 
Strain Serotype
a 
Source stx eae ehxA 
Positive samples/No. 
tested at 10
2
 CFU/g
 
Positive samples/No. 
tested at 10
3
 CFU/g
 
mPossé2
b 
SHIBAM mPossé2 SHIBAM 
DEC10B O26:H11 Human stx1 + + 1/2 1/2 1/2 0/2 
16272 O26:H11 Bovine stx1 + + 1/2 0/2 1/2 0/2 
B8227-C8 O45:H2 Bovine stx1 + - 1/2 0/2 1/2 0/2 
D88-28058 O45:NM Bovine stx1 + + 1/2 0/2 2/2 1/2 
MT#80 O103:H2 Human stx1 + + 1/2 0/2 1/2 0/2 
236-5 O103:NT Bovine stx1 and stx2 + + 1/2 0/2 1/2 1/2 
8266-1 O111:NT Bovine stx1 and stx2 + + 1/2 0/2 1/2 0/2 
10049 O111:H11 Bovine stx1 and stx2 + + 1/2 1/2 2/2 0/2 
DA-37 O121:H19 Human stx2 + + 0/2 0/2 0/2 0/2 
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8-084 O121:H19 Bovine stx2 + - 0/2 0/2 2/2 0/2 
GS G5578620 O145:H28 Human stx1 + + 1/2 0/2 1/2 1/2 
1234 O145:H28 Bovine stx1 and stx2 + - 1/2 0/2 2/2 1/2 
933 O157:H7 Beef stx1 and stx2 + + 1/2 0/2 1/2 0/2 
S2006#1 O157:H7 Bovine stx1 and stx2 + + 0/2 0/2 1/2 0/2 
Total      11/28 2/28 17/28 4/28 
a
NM, non-motile.  NT, not typed. 
b
Possé differential agar with 5.0 mg/liter novobiocin and 0.5 mg/liter potassium tellurite. 
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Table 2. Comparison between Possé differential agar with reduced novobiocin  and  potassium tellurite (mPossé2) and STEC heart 
infusion washed blood agar with mitomycin C, novobiocin and potassium tellurite (mSHIBAM) for the detection of Shiga toxin-
producing E. coli in inoculated cattle fecal samples  
Strain Serotype
a 
Source stx eae ehxA 
Positive samples/No. tested at 10
2
 
CFU/g
 
Positive samples/No. 
tested at 10
3
 CFU/g
 
mPossé2
b 
mSHIBAM
c 
mPossé2 mSHIBAM 
DEC10B O26:H11 Human stx1 + + 0/3 0/3 2/3 0/3 
16272 O26:H11 Bovine stx1 + + 0/3 0/3 1/3 0/3 
B8227-C8 O45:H2 Bovine stx1 + - 0/3 0/3 0/3 0/3 
D88-28058 O45:NM Bovine stx1 + + 0/3 0/3 0/3 0/3 
MT#80 O103:H2 Human stx1 + + 0/3 0/3 0/3 0/3 
236-5 O103:NT Bovine stx1 and stx2 + + 1/3 0/3 0/3 0/3 
8266-1 O111:NT Bovine stx1 and stx2 + + 0/3 0/3 0/3 0/3 
10049 O111:H11 Bovine stx1 and stx2 + + 0/3 0/3 0/3 0/3 
DA-37 O121:H19 Human stx2 + + 0/3 0/3 0/3 0/3 
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8-084 O121:H19 Bovine stx2 + - 0/3 0/3 0/3 0/3 
GS G5578620 O145:H28 Human stx1 + + 1/3 0/3 1/3 0/3 
1234 O145:H28 Bovine stx1 and stx2 + - 0/3 0/3 0/3 0/3 
933 O157:H7 Beef stx1 and stx2 + + 0/3 0/3 0/3 0/3 
S2006#1 O157:H7 Bovine stx1 and stx2 + + 0/3 0/3 0/3 0/3 
Total      2/42 0/42 4/42 0/42 
a
NM, non-motile. NT, not-typed. 
b
Possé differential agar with 5.0 mg/liter novobiocin and 0.5 mg/liter potassium tellurite. 
c
STEC heart infusion washed blood agar with mitomycin C, 5.0 mg/liter novobiocin and 0.5 mg/liter potassium tellurite. 
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Table 3. Comparison between CHROMagar STEC, Possé differential agar, Possé differential agar with novobiocin, cefixime 
trihydrate, and potassium tellurite (mPossé1) and Possé differential agar with reduced novobiocin  and potassium tellurite (mPossé2) 
for the detection of Shiga toxin-producing E. coli in inoculated cattle fecal samples  
Strain Serotype
a 
Source stx eae 
Positive samples/No. tested at 10
2
 CFU/g
 
Positive samples/No. tested at 10
3
 CFU/g
 
CHROMagar 
STEC Possé mPossé1
b 
mPossé2
c 
CHROMagar 
STEC Possé mPossé1 mPossé2 
16272 O26:NT Bovine stx1 + 0/2 0/2 0/2 0/2 0/2 0/2 0/2 0/2 
DEC10E O26:H11 Bovine stx1 + 1/2 1/2 0/2 0/2 1/2 0/2 0/2 1/2 
B8227-
C8 
O45:H2 Bovine stx1 + 1/2 0/2 0/2 0/2 0/2 0/2 0/2 0/2 
D88-
28058 
O45:NM Bovine stx1 + 1/2 0/2 0/2 0/2 1/2 0/2 0/2 0/2 
236-5 O103:NT Bovine 
stx1 
and 
stx2 
+ 1/2 1/2 0/2 0/2 1/2 1/2 0/2 1/2 
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RW1372 O103:H2 Bovine stx1 + 0/2 0/2 0/2 0/2 0/2 0/2 0/2 0/2 
8266-1 O111:NT Bovine 
stx1 
and 
stx2 
+ 1/2 1/2 0/2 0/2 1/2 1/2 0/2 0/2 
10049 O111:H11 Bovine 
stx1 
and 
stx2 
+ 1/2 0/2 0/2 0/2 0/2 0/2 0/2 0/2 
DA-37 O121:H19 Human stx2 + 0/2 0/2 0/2 0/2 0/2 0/2 0/2 0/2 
8-084 O121:H19 Bovine stx2 + 1/2 0/2 0/2 1/2 1/2 0/2 0/2 0/2 
1234 O145:H28 Bovine 
stx1 
and 
stx2 
+ 0/2 0/2 0/2 1/2 1/2 0/2 0/2 1/2 
B6820-
C1 
O145:NM Bovine stx2 + 0/2 0/2 0/2 0/2 0/2 0/2 0/2 0/2 
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S2006#1 O157:H7 Bovine 
stx1 
and 
stx2 
+ 1/2 0/2 1/2 1/2 1/2 0/2 0/2 1/2 
S2006#2 O157:H7 Bovine 
stx1 
and 
stx2 
+ 1/2 1/2 0/2 1/2 1/2 0/2 0/2 1/2 
Total     9/28 4/28 1/28 4/28 8/28 2/28 0/28 5/28 
a
NM, non-motile. NT, not-typed. 
b
Possé differential agar with 5.0 mg/liter novobiocin, 0.05 mg/liter cefixime trihydrate, and 0.15 mg/liter potassium tellurite. 
c
Possé differential agar with 5.0 mg/liter novobiocin and 0.5 mg/liter potassium tellurite. 
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Table 4. Quantification of Shiga toxin-producing E. coli in inoculated cattle feces by a spiral plate method 
Strain Serotype
a 
Source stx eae Resistance 
Inoculum 
CFU/g
 
Estimated CFU/g
 
CHROMagar 
STEC
 
CHROMagar 
STEC + Rif
b 
mPossé2
c 
mPossé + 
Rif
d 
H30 O26:H11 Human stx1 + Rifampicin 1.0 x 10
3 
NQ
e 
NQ NQ NQ 
1.0 x 10
4 
NQ NQ NQ NQ 
1.0 x 10
5 
NQ 8.2 x 10
3 
NQ 1.1 x 10
4 
CDC 96-
3285 
O45:H2 Human stx1 + Rifampicin 8.8 x 10
2 
NQ NQ NQ NQ 
8.8 x 10
3 
6.2 x 10
3 
9.1 x 10
3 
NQ NQ 
8.8 x 10
4 
8.0 x 10
4 
1.1 x 10
5 
NQ 1.2 x 10
4 f
 
CDC 90-
3128 
O103:H2 Human stx1 + Rifampicin 7.7 x 10
2 
NQ NQ NQ NQ 
7.7 x 10
3 
5.2 x 10
3 f
 8.1 x 10
3 
NQ NQ 
7.7 x 10
4 
1.1 x 10
5 
1.1 x 10
5 
6.1 x 10
4 
4.7 x 10
4 
JB1-95 O111:NM Human stx1 and stx2 + Rifampicin 6.2 x 10
2 
NQ NQ NQ NQ 
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6.2 x 10
3 
NQ NQ NQ NQ 
6.2 x 10
4 
NQ NQ NQ NQ 
CDC 97-
3068 
O121:H19 Human stx2 + Rifampicin 8.9 x 10
2 
NQ NQ NQ NQ 
8.9 x 10
3 
NQ NQ NQ NQ 
8.9 x 10
4 
9.7 x 10
3 
9.6 x 10
4 
3.1 x 10
4 
4.8 x 10
4 
83-75 O145:NM Human stx2 + Rifampicin 9.0 x 10
2 
NQ NQ NQ NQ 
9.0 x 10
3 
NQ NQ 1.3 x 10
4 
NQ 
9.0 x 10
4 
5.8 x 10
3 f
 8.1 x 10
3 
6.8 x 10
3 
6.6 x 10
3 
a
NM, non-motile. 
b
CHROMagar STEC without the supplement and with 100 mg/liter rifampicin. 
c
Possé differential agar with 5.0 mg/liter novobiocin and 0.5 mg/liter potassium tellurite. 
d
Possé differential agar without novobiocin and potassium tellurite and with 100 mg/liter rifampicin. 
e
NQ, not quantified. 
f
Quantified from one plate.
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Abstract 
Shiga toxin-producing Escherichia coli (STEC) are foodborne pathogens that 
naturally colonize the intestines of ruminants and cause hemorrhagic colitis and 
hemolytic uremic syndrome in humans. In order to colonize the intestine STEC must 
produce adherence factors. In this study, representative strains of STEC O26, O45, O103, 
O104, O111, O121, and O145 were used to test the ability of these organisms to adhere 
to intestinal epithelial cells. Strains were tested by polymerase chain reaction for intimin, 
flagella, fimbria, and other adhesin genes and tested for adherence to cattle colonic 
explants and Caco-2 cells. Quantitative adherence and invasion assays were performed 
using Caco-2 cells. Non-O157 STEC strains were positive for 8 to 10 of 18 fimbrial 
genes tested. All non-O157 STEC adhered to colonic explants from cattle and intimin-
positive STEC caused attaching-effacing lesions on Caco-2 cells. One strain, MT#80, 
was found to invade into cattle colonic mucosal epithelial cells, which was confirmed 
using an invasion assay with Caco-2 cells. In addition, this study found that a STEC 
O104 outbreak strain can attach to bovine colonic mucosal epithelial cells and had 
significantly higher levels of adherence on Caco-2 cells compared to other STEC.  This 
research suggests that interventions which block the effects of intimin and fimbria in non-
O157 STEC may be effective for pre-harvest control.   
 
 
 
 
 
163 
 
 
 
Introduction  
Shiga toxin-producing Escherichia coli (STEC) are foodborne pathogens that 
pose a threat to public health.  Ruminants, specifically cattle are a known reservoir for 
STEC (Gyles, 2007). Clinically evident disease caused by STEC infections in cattle is 
usually limited to nursing calves <5 weeks old, whereas disease in human patients is 
often seen at any age (Moxley and Smith, 2010; Croxen et al., 2013). STEC serogroups 
other than O157 are termed non-O157 STEC (Bettleheim, 2007). Scallan et al. (2011) 
estimated that non-O157 STEC account for approximately 64% of foodborne illness 
caused by STEC in the U.S. Over 400 serotypes of STEC have been isolated from 
clinical disease (Blanco et al., 2004),  however, the most frequently isolated non-O157 
STEC from clinical patients fall within 6 serogroups, O26, O45, O103, O111, O121, and 
O145 (Brooks et al., 2005).  
In cattle and humans, STEC cause attaching-effacing (A/E) lesions through 
production of the adherence factor intimin and secretion of the translocated intimin 
receptor (Tir) along with effector proteins through a type III secretion system encoded on 
the locus of enterocyte effacement (McDaniel et al., 1995).  Other adhesion factors have 
been described for STEC, including flagella (Mahajan et al., 2009) and fimbria (Gonyar 
and Kendall, 2014). Fimbriae serve as initial adherence factors before intimate adherence 
(Farfan and Torres, 2012)  
STEC of different serogroups may vary with regard to their preferred site of 
localization in the intestinal tract. STEC O157 has been found along the entire 
gastrointestinal tract in cattle (Keen et al., 2010). Girard et al. (2007) found that a STEC 
O26 strain adhered more extensively to the terminal ileum and rectum compared to the 
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terminal colon.  Lewis et al. (2015) showed that STEC colonize and form A/E lesions 
using in vitro organ culture of human colonic biopsy samples. This suggests that in 
humans the colon is a major site of attachment. 
 The overall goal of this study was to compare the abilities of STEC O26, O45, 
O103, O111, O121, and O145 to colonize cattle and human colonic epithelial cells. The 
specific objectives were to compare STEC O26, O45, O103, O111, O121, and O145 
isolates of varying flagellar and intimin type composition for adherence and A/E lesions 
in mucosal explants and primary epithelial cell cultures. 
 
Materials and Methods 
 Bacterial strains. Strains were obtained from Dr. Shannon Manning (STEC 
Center at Michigan State University), Dr. John B. Luchansky (USDA, Agricultural 
Research Service, Eastern Regional Research Center), or from our collection representing 
STEC serogroups O26, O45, O103, O104, O111, O121 and O145. STEC O157:H7 
strains 86-24 and 933 were used as positive controls for virulence genes. Enteroinvasive 
E. coli strain 43893 was used as a positive control for invasiveness in gentamicin 
protection assays. E. coli G58-1 was used as a negative control for adherence for explant 
experiments. E. coli K-12 strain DH5α was used as a negative control for virulence 
genes, adherence, and invasion of Caco-2 cells.  
 Molecular determination of O-antigen, Shiga toxin, EHEC-hemolysin, 
flagellin, fimbria, and intimin type.  Bacterial strains were streaked for isolation onto 
blood agar and incubated 24 h at 37°C. A single colony was picked, placed into 50 μl of 
water, heated for 10 min at 100°C, centrifuged for 3 min at 16,000 x g, and the 
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supernatant was transferred to a fresh tube for use as DNA template. Strains were tested 
for the presence of genes specific for O-antigen type (wbqEF or wzx), Shiga toxin (stx1 
and stx2), enterohemolysin (ehxA), flagellin (fliC), and intimin (eae) by PCR using 
primers and conditions previously described (Wang et al., 2003; Blanco et al., 2004; Bai 
et al., 2012). Additionally, strains were tested for irgA homologue adhesin (iha), E. coli 
factor for adherence (efa1), and 18 fimbrial loci (Wu et al., 2010; Wurpel et al., 2013; 
Gonyar and Kendall, 2014).  
 Flagella detection. Strains were tested for flagella by motility media, staining for 
flagella, and agglutination. Strains were streaked on trypticase soy broth (TSB) agar and 
incubated 24 h at 37°C. A single colony was stabbed with a needle down the center of a 
tube of Motility Test Medium w/ TTC Indicator (MTM; Remel, Lenexa, KS) and 
incubated 24 h at 37°C. MTM tubes were examined for motility and if the test was 
negative, it was re-passaged a maximum of 10 times in MTM before the strain was 
recorded as non-motile. 
STEC strains were stained for flagella according to the manufacturer’s 
instructions (Presque Isle Cultures, Erie, PA). After staining, slides were examined by 
light microscopy for detection of flagella. For H-antigen agglutination reactions, MTM 
tubes were inoculated with a single colony and incubated at 37°C for 24 h. Using a 
Pasteur pipet, aspirated “core” samples from the most motile area of the MTM tubes were 
used to inoculate 10 ml Nutrient Broth (Oxoid) and incubated for 6 h at 37°C. The 
surfaces of blood agar plates were swabbed with the broth culture and incubated 
overnight at 37°C. Bacteria were transferred from approximately one-quarter of the 
plate’s surface to 10 ml Nutrient Broth. Cultures were incubated for 6 h at 37°C, and then 
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135.1 μl of 37% formaldehyde solution was added and incubated at room temperature for 
30 min. One hundred μl of this killed bacterial suspension was added to an equal volume 
of the appropriate H antisera in each microtiter plate well, and plates were incubated for 
1.5 h in a humidified chamber at 50-52°C. Microtiter reactions were evaluated with an 
inverted light microscope and scored as – for no agglutination or 1+ to 4+ for increasing 
levels of agglutination, with either 3+ or 4+ reactions considered a positive result. 
 Bovine colonic mucosal explants.  Bovine colonic mucosal explants and 
bacterial strains were prepared and cultured by methods previously described (Baehler 
and Moxley, 2000, 2002) with minor modifications. Bacterial strains were grown 
statically overnight in TSB at 37°C and then transferred 1:10 into fresh TSB and for 6 h.  
Mucosal tissues from the colon were taken at the junction of the centrifugal and 
centripetal coils of the spiral colon. These tissues were obtained from three steers at 
slaughter with each animal representing a single experiment. The time lapse between 
death and initiation of explant cultures was approximately 2 h. Upon collection, the 
mucosal surfaces of these tissues were washed with cold water, rinsed with chilled 0.9% 
saline, immersed in chilled RPMI 1640 medium, and transported to the laboratory on ice. 
Tissues were cut into 4 x 8 mm explants and 3 explants were placed mucosal side up onto 
biopsy foam pads (Simport, Montreal, Canada), with one foam pad per well in six-well 
polystyrene tissue culture plates. Explants were inoculated with 2 x10
7
 CFU, which was 
confirmed by serial dilution and plating on TSB agar. Five ml of RPMI 1640 complete 
media (RPMI 1640 supplemented with 10% FBS, 0.25% lactalbumin hydrolysate, 0.10 
μg/ml human insulin, and 1% D-+-mannose) was added to each well, and plates were 
incubated at 37°C in 5% CO2 on a rocker (16 cycles/min). Media was changed once per h 
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starting at the second h of incubation. After 8 h incubation, the explants were harvested 
for sample collection. One explant per well was collected for histopathology, scanning 
electron microscopy, and confirmational bacterial culture. Samples for confirmational 
bacterial culture were homogenized, serially diluted and plated on differential Possé 
media without novobiocin and potassium tellurite (Possé et al., 2008b). 
Histopathology and immunohistochemistry (IHC). Samples for histopathology 
were fixed in 10% neutral buffered formalin, dehydrated through a graded alcohol and 
xylene series, embedded in paraffin, sectioned 5 μm thick, stained with H&E, and 
examined in detail by light microscopy. H&E stained tissue sections were used to 
examine explants for evidence of enterocyte necrosis and renewal, and bacterial 
adherence. IHC was used to specifically identify the bacteria that were adherent to 
enterocytes in explants. Sections of paraffin-embedded explant tissues were stained with 
rabbit anti-O26, -O45, -O103, -O104, -O111, -O121, and -O145 as the primary antisera 
to detect the corresponding O-antigen inoculum strains. Alkaline phosphatase-labeled 
goat anti-rabbit serum, Fast Red, and hematoxylin counterstain were used in the IHC 
staining procedures. 
 Scanning electron microscopy (SEM). Explants for SEM were fixed in 2.5% 
glutaraldehyde, dehydrated in a graded alcohol series, critical-point dried, sputter coated, 
and examined with a Hitachi S-3000N SEM. 
 Transmission electron microscopy (TEM). Paraffin blocks containing 
epithelial-adherent STEC were deparaffinized and processed as previously described 
(Baehler and Moxley, 2000). 
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 Caco-2 cells. Caco-2 cells were grown in 75 cm
2
 flasks  in 9.6 g/L of minimal 
essential medium with non-essential amino acids, 2.2 g/L of sodium bicarbonate, 20% 
fetal bovine serum, and 1% D-+-mannose (Caco-2 media). Caco-2 cells were seeded onto 
12 mm coverslips (Fisher) in 24-well plates at a concentration of 1 x 10
5
 cells per ml and 
incubated for 14 days at 37°C in 5% CO2. 
 Quantitative adherence assay. Adherence to Caco-2 cells was tested three times 
independently, each time in triplicate. Strains were streaked for isolation on TSB agar 
and incubated at 37°C for 24 h. A single colony was picked, transferred into 5 ml of TSB, 
and incubated at 37°C for 24 h. A 300-μl aliquot was removed, diluted 1:10 into fresh 
TSB, and incubated at 37°C for 6 to 8 h. This culture was centrifuged at 16,000 x g for 3 
min, and the supernatant was removed. The bacterial pellet was washed with PBS, 
centrifuged, the supernatant was removed, and bacterial cells were resuspended in Caco-2 
medium. Cultures were diluted to 10
7
 CFU/ml in Caco-2 cell medium, and each well was 
inoculated with 10
7
 CFU and incubated at 37°C in 5% CO2 for 6 h. The inoculum 
concentration was confirmed by serial dilution in PBS and spread plating. At 3 h after 
inoculation, the Caco-2 medium was changed. At 6 h, cells were Giemsa stained and 
examination by light microscopy. Giemsa staining of cells was done by a protocol 
adapted from Yin et al. (2011). Briefly, cells were washed twice with PBS and fixed for 
10 min in a 1:1 mixture of methanol and PBS. The fixative was removed and fresh 
anhydrous methanol was added for 2 min, and then discarded. The monolayer was then 
rinsed with anhydrous methanol, discarded, and the cells were allowed to dry. The cells 
were then stained with 10% Giemsa stain for 20 min, rinsed with hematology rinse 
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(Volu-Sol, Inc.) for 20 sec, and rinsed with water. A coverslip was then applied to the 
slide with mounting medium (Cytoseal 60). 
 Invasion assay.  Invasion in Caco-2 cells was tested three times independently, 
each time in triplicate Invasion assays were conducted by methods previously described 
(Small et al., 1987; Luck et al., 2005). Bacterial inocula were prepared by growing 
strains overnight in TSB at 37°C, diluting them 1:10 into TSB, and incubating further for 
3 h.  A 1 ml aliquot was centrifuged at 13,000 x g, washed with PBS, resuspended in 1 ml 
of Caco-2 medium, and diluted to a concentration of 1 x 10
7
 CFU/ml. Inoculum 
concentrations were confirmed by serially dilution in PBS and plating on TSB agar. 
Caco-2 cells were seeded at a concentration of 1 x 10
5
 cells per ml into 6-well plates 
(Falcon 353046), 24 h prior to the experiment. Cell monolayers were washed twice with 
PBS, inoculated with 10
7
 CFU, and incubated for 2 h in 5% CO2 at 37°C.  After 2 h, cell 
monolayers were washed 5 times with PBS, and Caco-2 media with 100 μg/ml 
gentamicin was added and incubated for an additional 2 h in 5% CO2 at 37°C.  
Afterward, cell monolayers were washed 5 times with PBS and flooded with 1% Triton 
X-100 for 10 min.  One ml of contents was then removed from each well, serially diluted 
in PBS, and spread-plated on TSB agar to quantify the number of intracellular bacteria.  
 Fluorescent-actin staining (FAS). FAS assays were conducted in three 
independent experiments by a combination of methods previously described (Knutton et 
al., 1989; Abu-Ali et al., 2010). Caco-2 cells were cultured and inoculated with bacterial 
strains as described above for the Caco-2 cell adherence assay with the exception that the 
300-μl aliquot that was removed was diluted 1:10 into fresh TSB containing 44 mM 
sodium bicarbonate and incubated at 37°C for 2 h. At the conclusion of the 2 h-
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incubation step, the cells were washed with serum-free Caco-2 medium and PBS, and 
then fixed by adding 400 μl of 4% paraformaldehyde for 15 min. The fixative was 
removed and cells were washed twice with PBS. Triton-X-100 (100 μl, 0.1% solution) 
was added, and after 5 min was removed and cells were washed twice with PBS. RNase 
A (100 μg/ml) was added and the cells were incubated at 37°C for 20 min, removed and 
cells were again washed twice with PBS. One unit of Alexa Fluor 488 phalloidin 
conjugate (Life Technologies) in 1% bovine serum albumin was added and incubated for 
20 min. The cells were washed with PBS, propidium iodide (5 μg/ml) was added, and 
cells were incubated for 15 min. The cells were then washed twice with PBS and 
coverslips were mounted onto glass microscope slides with Fluoro-gel with tris buffer 
(Electron Microscopy Sciences, Hatfield, PA) and let stand at room temperature for 1 h. 
The slides were stored at 4°C, and later examined with a Nikon A1 confocal system on a 
Nikon 90i upright fluorescence microscope. 
 Statistical analysis. Mean percent invasion and adherence were compared by an 
ANOVA with Fisher’s least significant difference using SAS v 9.2. 
 
Results 
 Characterization of strains. STEC strains were characterized by PCR for O-
antigen (wbqEF or wzx), intimin (eae), flagellin (fliC), and Shiga toxin (stx); in addition, 
they were characterized by standard methods for motility and flagella. The results are 
summarized in Table 1. Of the 6 strains that produced flagella, all were motile. Within 
the O groups in the following H antigen and/or [fliC] types and eae types were detected: 
O26:H11 (eae-β1); O45:H2 (eae-ε); O103:H2 (eae-ε); O104:[H4] (eae-negative); 
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O111:H10 (eae-negative); O121:[H19] (eae-ε); and O145:[H28] (eae-γ1). Non-O157 
STEC were characterized for 18 fimbrial loci by PCR as shown in Table 2. 
 Adherence to bovine colonic mucosal explants. Bacterial strains were tested for 
adherence to epithelial cells in bovine colonic mucosal explants. Three independent 
experiments using colonic tissues from different steers on different days were conducted. 
By light microscopy, H&E- and IHC-stained sections of non-inoculated colonic explants 
had normal mucosal morphology and no evidence of STEC bacteria. Explants inoculated 
with the non-pathogenic E. coli strain G58-1 had minimal bacterial adherence to intact 
epithelial cells. In contrast, all non-O157 STEC adhered to the adhered to the apical 
surfaces of mucosal epithelial cells (Fig. 1). This is the first report that has demonstrated 
E. coli O104:[H4] binding to colonic mucosal explants from cattle. MT#80 was found 
intracellularly in epithelial cells. 
 FAS test for A/E adherence. STEC strains that were tested for adherence to 
bovine mucosal explants were also tested for A/E adherence by the FAS test (Table 1). 
STEC O157:H7 strain 86-24 which produces eae-γ1 was used as a positive control, and 
DH5α was used as a negative control. A positive FAS result consisted of polymerized 
actin (intense green staining) immediately beneath bacteria (red-staining) attached to the 
host cell membrane (Fig. 2). Based on the FAS test, 5 of 5 eae-positive non-O157 STEC 
strains which collectively contained β1, ε, and γ1 variants of eae produced A/E lesions. 
Also, all STEC strains tested that were eae-negative, gave negative FAS test results.  
 SEM and TEM for detection of A/E lesions and other patterns of adherence. 
SEM and TEM were conducted on sub-specimens obtained from the above-described 
explant experiments to test for ultrastructural evidence of A/E lesions and other patterns 
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of adherence. Since the surfaces of explant tissues were not washed at the conclusion of 
experiments, most had a heavy mucus layer that covered the epithelial surface and A/E 
lesions were not visible by SEM. Classical A/E lesions in explants, including pedestals, 
were detected by TEM as a result of infection with STEC O103:H2 (eae-ε) strain MT#80 
(Fig. 2).  
 Invasion of STEC in Caco-2 cells. STEC strains MT#80 and CDC 1994-3024 
were tested for their ability to invade Caco-2 cells. MT#80 was significantly (P < 0.05) 
more invasive than DH5α, but not different from CDC 1994-3024. Interestingly, MT#80 
was significantly (P < 0.05) more invasive compared to the enteroinvasive E. coli strain 
43893 (Fig. 3). 
 Quantitative Adherence to Caco-2 cells. STEC strains were tested for adherence 
to Caco-2 cells. TY-2482 had significantly higher levels of adherence than all STEC 
strains except for STEC strain RD8 (Fig. 4). The intimin-positive STEC strains 
(DEC10B, B8227-C8, MT#80, DA-37, and GS G5578620) were not significantly 
different from each other or significantly different compared to DH5α. 
 
Discussion 
 Seven non-O157 STEC strains were characterized for serotype, adherence factors, 
and virulence factors. Flagella were observed for all strains that were positive for motility 
in MTM media. Five of seven strains had intimin and only intimin-positive strains tested 
positive for efa-1. Thus, intimin-negative strain must use other adherence factors to 
colonize the intestine. Non-O157 STEC strains tested positive for 8 to 10 of 18 fimbrial 
loci. RD8 lacked intimin but tested positive for 8 of 18 fimbrial loci. Previously, RD8 
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tested positive for aggregative adhesion fimbria type II and was suspected to be as 
pathogenic as typical intimin-positive STEC in humans (Czeczulin et al., 1999). The 
phenotype of this strain on Caco-2 cells was consistent with an enteroaggregative strain. 
TY-2482 also lacked intimin and previously tested positive for aggregative adherence 
fimbria (Bucholz et al., 2011). 
 Non-O157 STEC strains from all six serogroups currently classified as adulterants 
in raw non-intact beef (O26, O45, O103, O111, O121, and O145) expressing different 
flagellar types (e.g., H2, H4, H10, H11, H19, and H28) and variants of intimin, viz., β1, 
ε, and γ1, adhered to bovine colonic epithelium and induced the formation of A/E lesions. 
Non-O157 STEC strains lacking intimin were also shown to adhere to bovine colonic 
epithelium; hence, must utilize other mechanisms for attachment. Also, adherence studies 
were conducted with an enteroaggregative STEC O104:H4 strain that caused a large 
foodborne epidemic attributable to a non-beef source in Germany in the summer of 2011 
(Bucholz et al., 2011). STEC O104:H4 adhered to epithelial cells at a significantly higher 
level compared to intimin-positive STEC. Higher levels of adherence could give a strain 
an advantage to deliver Shiga toxin to the host. These studies showed this strain has the 
ability to adhere to bovine colonic epithelium and may do so via fimbria. Hence, if this 
strain enters the cattle population it may be able to colonize cattle and persist. 
 STEC are typically thought of as non-invasive pathogens. One STEC strain 
(MT#80) was consistently observed intracellularly in bovine epithelial mucosal explants. 
Invasion was confirmed with MT#80 using Caco-2 cells in a gentamicin protection assay. 
Similarly, Cordeiro et al. (2013) found STEC in intracellular compartments of Caco-2 
cells with strains persisting up to 96 h, which indicates multiplication. The mechanism by 
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which STEC enter cells is unknown. Uhlich et al. (2002) reported a role for the fimbrial 
protein curli in invasion of STEC O157 strain ATCC 43894.  MT#80 tested positive for 
curli (loc 7) by PCR. Interestingly, Uhlich et al. (2002) also found higher percent 
invasion in the STEC O157 strain compared to enteroinvasive E. coli 43893. Invasion by 
STEC O157 was also shown in primary bovine rectal epithelial cell cultures (Sheng et al., 
2011). Previous studies have shown that application of phages was effective in reducing 
STEC O157 in an ex vivo rumen model but not in live cattle (Rivas et al., 2010).  
Intracellular invasion in of STEC in colonic epithelial cells could reduce the effectiveness 
of antimicrobials and the ability of cattle to clear the pathogen.  
 In summary, all non-O157 STEC tested adhered to both bovine colonic explants 
and a human colonic cell line. In colonic explants, STEC O103:H2 strain MT#80 was 
found to invade epithelial cells. Invasion assays confirmed that MT#80 invaded Caco-2 
cells. STEC O104:[H4] strain TY-2482 adhered to Caco-2 cells at a significantly higher 
level compared to intimin-positive STEC. This study demonstrates that interventions that 
block the effects of intimin and fimbria in non-O157 STEC may be reduce STEC 
colonization.   
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Table 1. Characterization of non-O157 Shiga toxin-producing Escherichia coli strains and tests for the ability to adhere and induce 
attaching-effacing lesions using bovine colonic mucosal explants and Caco-2 cells 
Strain Source Serotype Motile
a 
Flagella
b 
stx eae efa-1 iha ehxA
 
 Adh
c
/FAS
d 
DEC10B human O26:H11 + + stx1 β1 + + + +/+ 
B8227-C8 bovine O45:H2 + + stx1 ε + - - +/+ 
MT#80 human O103:H2 + + stx1 ε + - + +/+ 
TY-2482 human O104:[H4] + + stx2 - - + - +/- 
RD8 human O111:H10 + + stx2 - - - - +/- 
DA-37 human O121:[H19] + + stx2 ε + - + +/+ 
GS G5578620 human O145:[H28] - - stx1 γ1 - - + +/+ 
a
Motility detected after culture in motility test medium for 1 to 10 passages. 
b
Flagella detected in cultured bacteria by Presque-Isle 
staining method. 
c
Detection of bacterial adherence to epithelial cells in bovine colonic mucosal explants by light microscopy of tissue 
sections immunohistochemically stained with antibodies specific for O antigen of inoculum strain. 
d
Fluorescent actin staining for 
detection of attaching-effacing lesions on Caco-2 cells. 
 
 
 
 
 
 
 
1
76 
 
Table 2. Characterization of fimbrial loci in Shiga toxin-producing Escherichia coli  
Strain Serotype 
Fimbrial gene (locus) 
Z0024 
(loc1) 
Z0146 
(loc2) 
Z0686 
(loc3) 
Z0872 
(loc4) 
Z1290 
(loc5) 
Z1538 
(loc6) 
csgD 
(loc7) 
Z2204 
(loc8) 
Z3279 
(loc9) 
Z3597 
(loc10) 
Z4501 
(loc11) 
Z4971 
(loc12) 
Z5221 
(loc13) 
Z5917 
(loc14) 
Z0360 
(loc15) 
Z0118 
(loc16) 
cs1-like 
(loc17) 
yqi-like 
(loc18) 
DEC10B O26:H11 - - + - + - + + - - + - - + + + + + 
B8227-C8 O45:H2 - - + - + - + + - - + - - + + + + + 
MT#80 O103:H2 - - + - + - + + - - + - - + + + + + 
TY-2482 O104:[H4] - - + - + - + + - - + - - - + + + + 
RD8 O111:H10 - - + - - - + + - - + - - - + + + + 
DA-37 O121:[H19] - - + - + - + - - - + - - + + + + + 
GS G5578620 O145:[H28] + - + + - - + + - - - + - + + + - - 
933 O157:H7 + + + + + + + + + + + + + + + + - - 
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Figure 1. Light photomicrographs of bovine colonic mucosal explants uninoculated, inoculated 
with non-pathogenic G58-1, and inoculated with STEC O103:H2 strain MT#80. Light 
photomicrograph of 4-μm thick paraffin sections of bovine mucosal explants stained 
immunohistochemically using control rabbit antiserum, or anti-O101 serum, or anti-O103 
antibodies for corresponding bacterial O-antigen, alkaline phosphatase-labeled goat anti-rabbit 
serum, Fast Red and hematoxylin counterstain. (A) Non-inoculated control tissue has surface-
layer epithelial cells with normal columnar morphology.  (B) Inoculated with non-pathogenic 
E.coli strain G58-1, G58-1 bacteria (stained red) are seen overlying the mucosal surface among 
sloughed epithelial cells and mucus, but none are adherent to intact, cuboidal epithelium. Intact 
cuboidal epithelial cells are immature replacement enterocytes that have emerged from the 
intestinal crypts. (C) Inoculated with STEC O103: [H11] strain 15612-1. Mucosal epithelial cells 
are cuboidal in shape, indicating they are immature replacement enterocytes that have emerged 
from the intestinal crypts.  
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Figure 2. (A) Confocal laser scanning photomicrograph of fluorescent-actin staining (FAS) of 
Caco-2 cells and (B) transmission electron photomicrograph of bovine mucosal explant infected 
with STEC O103:H2 strain MT#80. The FAS test was performed to detect attaching-effacing 
(A/E) lesions in which the actin cytoskeleton is aggregated immediately beneath the bacteria and 
anchors it to the host cell. Nucleic acids (hence Caco-2 cell nuclei and bacteria) are stained red 
by propidium iodide, and actin is stained green by Alexa Fluor 488 phalloidin. (B) Transmission 
electron photomicrograph of MT#80 colonizing the epithelial surface of a bovine mucosal 
explant. Numerous bacteria colonize the epithelial surface and several in this field have induced 
attaching-effacing lesions (vertical arrows). Bacteria also have been taken up into phagosomes 
(horizontal arrows). 
B A 
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Figure 3. Percentage of Caco-2 cell invasion by various E. coli strains.  Means with the 
same letter are not statistically significant. Error bars represent standard deviations. 
EIEC, enteroinvasive E. coli; STEC, Shiga toxin-producing E. coli. 
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Figure 4. Adherence of Shiga toxin-producing E. coli strains to Caco-2 cells.  Adherence 
was quantified by recording the total number of adherent bacterial cells per 100 cells.  
Error bars represent standard deviations. Means with the same letter are not significantly 
different.
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